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Abstract 
Rift Valley fever is a mosquito-borne viral disease of ruminants, camels and 
humans. In Tanzania, outbreaks have occurred at intervals of 10 - 20 years with 
major epidemics reported in 1977, 1997/98 and 2006/2007.  Our ability to prevent 
future epidemics is limited by poor understanding of how the virus circulates 
between major epidemics. This study aimed to investigate the epidemiology of 
inter-epidemic RVFV infections in northern Tanzania.  
This study involved (a) collection and characterisation of mosquitoes; (b) RVFV 
serological analysis of serum samples from cattle (n=3582), sheep (n=2586), goats 
(n=3303) and human populations (n=565) collected through cross-sectional 
household surveys; (c) analysis of risk factors for livestock and human 
seropositivity; (d) molecular detection of RVFV in mosquitoes and diagnostic 
materials collected during investigation of 190 livestock abortion events.  
Generalised Linear Mixed-Effects Models (GLMMs) were used to examine predictors 
of vector mosquito abundance, and risk factors for RVFV exposure in livestock and 
humans. Maximum Entropy (MaxEnt) algorithm was used to model vector mosquito 
habitat suitability and spatial distribution.  
A total of 2224 mosquitoes were collected including Culex spp (n = 1123), 
Anopheles spp (n=1006), Mansonia spp  (n=56), Aedes spp (n=34), and 
Coquillettidia spp  (n=5) with significant variation in abundance with percentage 
difference in normalised difference vegetation index (NDVI). No RVFV infections 
were detected in any of the mosquitoes collected.  RVFV seroprevalence was  
higher in cattle 4.4% (95% CI:3.7-5.1), than in sheep 2.6%, (95% CI: 2.0-3.3) and 
goats 1.4% (95%CI: 1.0-1.8), with seropositivity in young animals providing evidence 
of recent virus circulation.  Seropositivity  in livestock increased with age (OR=1.3, 
CI: 1.2 - 1.4, p<0.001) consistent with endemic circulation and was associated with 
a history of abortion in goats (OR=2.5, 95%CI: 1.1 - 5.4, P=0.023) and sheep 
(OR=2.7, 95%CI: 1.1 - 6.3, P=0.025).  Human seroprevalence was 8.5% (95% CI: 6.4 - 
11.2) and varied between villages and between households  within villages.  
Handling of aborted material (OR=4.3, 95% CI: 1.7-10.8) and consumption of  raw 
milk (OR=4.1, 95%CI: 1.8 - 9.3, P=0.001) were significant risk factors for human 
seropositivity. RVFV was detected in a cluster of 14 (7.4%) abortion cases including 
the milk of three aborting dams. This provides strong evidence for continuous RVFV 
circulation in livestock between major epidemics in Tanzania and that unboiled 
milk is an important potential source of infection for people.  
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Chapter One 
1 Introduction and Literature review 
1.1 Background 
Rift Valley fever (RVF) is an arthropod-borne viral disease of ruminants, camels and 
humans (Gerdes, 2004). The Rift Valley Fever virus (RVFV) can be transmitted 
through mosquito bites or by exposure to infectious blood and bodily fluids (Balkhy 
and Memish, 2003). Unprotected handling of the afterbirth, aborted material 
(Fontenille et al., 1998), and drinking raw, unpasteurized milk from infected 
animals have been suggested as potential routes of transmission  (Balkhy and 
Memish, 2003). The disease in humans is often asymptomatic, but clinical signs in 
severe cases can manifest as flu-like illness (Davies et al., 1985), haemorrhagic 
disease with liver involvement (Gerdes, 2004) and ocular or neurological lesions 
(Gerdes, 2004; Pepin et al., 2010). In ruminants, RVF may be inapparent in non-
pregnant adults (Davies et al., 1985) but outbreaks are characterised by the onset 
of abortions and high neonatal mortality (Swanepoel and Paweska, 2011b).  
Rift Valley Fever was first identified in 1931 on a farm in the Rift Valley of Kenya 
(Daubney et al., 1931).  Since then, outbreaks have been reported largely in sub-
Saharan Africa, West Africa, North Africa (Seufi and Galal, 2010) and in 2000 in the 
Arabian peninsula (Bird et al., 2007) (Figure 1.1). The disease is considered to be 
endemic in sub-Saharan African countries, with periodic major outbreaks, 
associated with episodes of heavy rainfall and flooding (Davies et al., 1985, Nderitu 
et al., 2010). Outside sub-Saharan Africa, RVF epidemics have been confirmed in 
Egypt in 1977 (El-Akkad, 1978), Mauritania and Senegal in West Africa  (Fontenille 
et al., 1998, Diallo et al., 2005), Saudi Arabia and Yemen in the Arabian Peninsula 
(Jupp et al., 2002), and Madagascar and the Comoros islands in the Indian Ocean 
(Morvan et al., 1991, Sissoko et al., 2009). The spread of RVFV outside its endemic 
region raises concerns about threat of RVFV introductions to new geographical 
areas (Pepin et al., 2010).  
Since the 1970s, periodic epidemics of RVF have been reported in an increasing 
number of countries in Eastern and Southern Africa including Kenya, Somalia, 
Sudan, Tanzania, Zimbabwe, and South Africa (Nderitu et al., 2010). The RVF 
epidemic of 1997–1998 that affected Kenya, Somalia, and Tanzania was 
characterized by outbreaks that started in the North Eastern Province of Kenya in 
November 1997 and ended with cases reported from the north-central region of 
16 
Tanzania in June 1998 (WHO, 2007, CDC, 2007). Another RVF epidemic occurred in 
2006–2007 in these three countries, with cases first reported in the North Eastern 
Province of Kenya and later in Tanzania, where the last livestock and human cases 
were reported in June 2007 (Mohamed et al., 2010, Munyua et al., 2010). Recent 
outbreaks in East Africa were reported in 2018 in Kenya, Rwanda and Uganda 
involving livestock and humans (Anyamba et al., 2018) and in South Sudan (WHO, 
2018). 
In Tanzania, epidemics over the past five decades have occurred at 10-20 years 
interval with major epidemics reported in 1977, 1997/98 and 2006/2007 (Mohamed 
et al., 2010, Karimuribo et al., 2012, Fyumagwa et al., 2012).  The RVF epidemics 
(outbreaks) of 1977 and 1997/98 were largely confined to northern Tanzania but 
that of 2006/2007 extended to central and southern parts of the country with 
animal and human cases reported (Mohamed et al., 2010, Fyumagwa et al., 2012). 
Despite recent reports of RVF in Kenya, Rwanda and Uganda until early September 
2018, no human or animal cases were officially documented in Tanzania since 2007. 
Due to RVF reports in the region, in June 2018 an RVF alert was issued by the 
Ministry of Livestock and Fisheries (http://www.xinhuanet.com/english/2018-
06/19/c_137263241.htm). 
17 
 
Figure 1.1 Map of Africa showing countries with history of RVF outbreaks  and those 
with reported evidence of RVFV circulation. Map recreated in QGIS 2.14.0 -Essen, 
2016 using data from (Mansfield et al., 2015, Kenawy et al., 2018) and shape files 
for country administrative boundaries available at www.arcgis.com 
 
1.2 Rift Valley fever virus 
Rift Valley fever virus (RVFV) is an enveloped spherical (80 - 110 nm) particle with 
tri-segmented negative-sense single-stranded RNA virus belonging to the order 
Bunyavirales, genus Phlebovirus within the Phenuiviridae family (Adams et al., 
2017, Bird et al., 2009). Several members of the  Phenuiviridae family are 
responsible for fatal hemorrhagic fevers: Rift Valley fever virus (Phlebovirus), 
Crimean-Congo hemorrhagic fever virus (Nairovirus), Hantaan, Sin Nombre and 
related viruses (Hantavirus), and recently Garissa, now identified as Ngari virus 
(Orthobunyavirus) (Flick and Bouloy, 2005). The  RVFV viral genome (approx 11.9 
kilobases) consists of three segments designated large (L), medium (M) and small 
(S), which encode the viral RNA-dependent RNA polymerase, the viral glycoproteins 
Gn and Gc and non-structural protein NSm, and the viral nucleocapsid protein N 
18 
and the non-structural virulence protein, NSs, respectively (Havranek et al., 2019, 
Bird et al., 2009, Bouloy and Weber, 2010) (Figure 1.2). These viral proteins, in 
conjunction with host proteins, ensure that the virus can replicate its genome 
during a productive infection (Havranek et al., 2019, Bouloy and Weber, 2010). All 
the replication steps occur in the cytoplasm of infected cells and virions mature by 
budding in the Golgi compartment (King et al., 2012). During the replication cycle, 
each segment is transcribed into mRNA and is replicated through a process 
involving synthesis of the exact copy of the genome, called complementary RNA 
(cRNA) or antigenome. The cRNA representing the copy of the S ambisense segment 
serves as a template for the synthesis of the NSs mRNA. Since the S cRNA is present 
in the input virus, the protein is expressed early, a good indication that it has an 
important role during infection (Pepin et al., 2010, Ikegami et al., 2005). During 
the viral cycle, the glycoproteins play an essential role for the penetration of the 
virus and their proper processing is crucial for the maturation and budding of the 
virion (Liu et al., 2008, King et al., 2012). The glycoproteins, being the most 
exposed components of the virus during infection, are recognized by the immune 
system and induce the production of neutralizing antibodies, which play a 
predominant role in protection (Filone et al., 2006, Pepin et al., 2010).  
 
Figure 1.2 Schematic illustration of RVFV genome containing  small (S), medium 
(M), and large (L) RNA segments and surface glycoproteins (Gn and Gc) 
incorporated into the lipid bilayer. Schematic representation of RNA segments and 
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respective proteins encoded by each segment, L = L protein; NSm = non-structural 
protein M; glycoproteins Gn, Gc; N = nucleoprotein; NSs = non-structural protein S. 
 
1.3 Rift Valley Fever virus transmission 
Rift Valley Fever virus transmission usually occurs in epizootics/epidemics 
associated with periods of heavy rainfall (Davies et al., 1985). It is now known that 
the development of epidemic-associated transmission is dependent on large-scale 
weather events such as the warm El Niño Southern Oscillation (ENSO), which can 
lead to heavy precipitation over eastern and southern Africa (Bird et al., 2009). 
Such heavy rainfall  triggers the emergence of large numbers of mosquito vectors 
through creation of aquatic larval habitats (Fontenille et al., 1998). Mosquitoes are 
thought to be the only biological vectors of RVFV (Linthicum et al., 1985, Bird et 
al., 2009).  
Rift Valley fever virus (RVFV) has been isolated from at least 40 species of 
mosquitoes (Meegan, 1979, Fontenille et al., 1998, Turell et al., 2008) belonging to 
six taxa: Aedes, Culex, Anopheles, Eretmapodites, Mansonia, and Coquillettidia 
(Bird et al., 2009). It has been widely suggested  that RVFV is maintained through 
transovarial transmission in the floodwater mosquitoes of the Aedes genus (Davies 
et al., 1985, Lancelot et al., 1990, Gerdes, 2004). Aedes mosquitoes are regarded 
as primary vectors due to their ability of transovarial transmission of RVFV which 
provides the virus with a potential mechanism of persistence of infected eggs in dry 
conditions for several years during inter-epidemic periods (Logan et al., 1991, 
Gerdes, 2004). During periods with normal (non-excessive) amounts of rainfall, 
RVFV is likely maintained by low-level enzootic/endemic (locally present 
infections) activity within the mosquito vector population involving transovarial 
transmission with occasional infection and amplification of virus in wild animals 
such as African buffaloes (Syncerus caffer) or susceptible livestock including cattle, 
sheep and goats (Bird et al., 2009). Then excessive flooding following heavy rains 
allows for massive mosquito emergence and an increase in the number of both 
primary (Aedes) and secondary (Culex) vectors (Sang et al., 2010, Davies et al., 
1985). Transovarially-infected primary mosquito vectors include Ae. mcintoshi,  Ae. 
(Neomelaniconion) circumluteolus (Theobald, 1908), Ae. albopictus, (Sang et al., 
2010, Pepin et al., 2010, Tesh and Shroyer, 1980) and Ae. aegypti (Cruz et al., 
2015) that feed on susceptible ruminants (Coetzer, 1977). In turn, infected 
ruminants can infect secondary bridge mosquito vectors such as Culex spp, 
Mansonia spp or Anopheline spp (Coetzer, 1977, Bird et al., 2009, Sang et al., 
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2010) which pick up the virus, and amplify transmission to generate an outbreak 
(Davies et al., 1985, Sang et al., 2010). The transmission cycle is summarised in 
schematic diagram in Figure 1.3.  
RVFV was isolated from Culex spp following the 1998-1999 outbreak in Mauritania 
and Senegal (Diallo et al., 2005) and  from Aedes spp and Culex spp following the 
outbreak of year 2000 in Saudi Arabia (Jupp et al., 2002). Aedes spp, Culex spp, 
Mansonia spp and Anopheles spp were implicated with the RVF outbreak 2006/2007 
in Kenya (Sang et al., 2010, LaBeaud, 2011), whereas  Anopheles spp, Culex spp 
and Mansonia spp were found naturally infected in Madagascar (Ratovonjato et al., 
2011). So far, RVFV in mosquitoes has mostly been detected following  outbreak 
periods and unusual heavy rainfall and floods. The role of vectors or other 
transmission routes (infected bodily fluids) in maintaining  RVFV circulation 
between epidemics is not fully understood largely because detection and/or 
isolation of the virus during the inter-epidemic period (IEP) has not been achieved 
(Lichoti et al., 2014a). In addition, epidemics in the region have been generally 
irregular which could be attributed to climate variability (Martin et al., 2008), 
emphasising the need for continuous surveillance and exploration of all possible 
factors contributing to disease epidemics.  
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Figure 1.3 Schematic diagram showing potential RVFV transmission routes involving 
vectors and host species. Dotted lines indicate uncommon but potential horizontal 
transmission between wild and domestic ruminants. 
1.4 Potential Rift valley fever virus (RVFV) vectors in northern 
Tanzania 
Although a number of RVF epidemics have been reported in Tanzania, the relative 
importance of different vector species implicated in epidemic and inter-epidemic 
transmission is still uncertain, and no surveys have yet detected RVFV in 
mosquitoes in Tanzania.  An entomological  study by Mweya et al. (2015) in 
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Ngorongoro district in northern Tanzania reported the occurrence of potential 
vectors Aedes aegyti and Culex pipiens complex (Mweya et al., 2015). Other 
species recorded in area include Culex antennatus, Culex tigripes, Culex 
annulioris, Culex cinereus, Anopheles arabiensis, Anopheles squamosus, Anopheles 
pharoensis and Mansonia uniformis (Mhina et al., 2015). These studies suggests 
associations of previous RVF epidemics with abundance and distribution of Aedes 
spp and Culex spp in Ngorongoro district (Mweya et al., 2015, Mweya et al., 2013).   
Both of these  studies (Mweya et al., 2015, Mhina et al., 2015) were carried out in 
the same (Ngorongoro) district, and were unable to detect presence of RVFV  in 
mosquitoes. Surveillance of mosquito vectors from other areas including those 
which experienced repeated RVF outbreaks will expand understanding of the 
ecology and distribution of potential vector species, and guide identification of 
which groups may be primarily responsible for RVFV circulation in the area.    
1.5 Ecology and feeding preference of potential RVFV Vectors 
The distribution of RVFV vectors in endemic regions were previously found to be 
associated with the ecology and habitats of the regions (Tantely et al., 2015, Sang 
et al., 2017). In the Arabian Peninsula outbreaks have been linked to Aedes spp and 
Culex spp  found in areas suitable for vector larval development including 
temporarily flooded agricultural fields or pasture land, and permanent or 
semi-permanent aquatic habitats (Jupp et al., 2002, Elfadil et al., 2006). In West 
Africa, Aedes spp and Culex spp linked to the outbreaks in Senegal and Mauritania 
in the Sahelian and Sudano-Sahelian region are found in temporary ponds where 
livestock concentrate during the rainy season (Diallo et al., 2005, Biteye et al., 
2018). The abundance and composition of vectors varied with rainfall, season, land 
use, proximity to water bodies, and drainage and/or soil properties (Jupp et al., 
2002, Gerdes, 2004, Diallo et al., 2005, Sang et al., 2010, Glancey et al., 2015, 
Biteye et al., 2018). Mosquitoes (Aedes, Culex Mansonia and Anopheles) implicated 
in RVF outbreaks in  Kenya, East Africa (Logan et al., 1991, Sang et al., 2010) were 
associated  with semi-arid areas (Sang et al., 2010, Sang et al., 2017), which 
experience sporadic rainfall with occasional torrential storms that cause extensive 
flooding in the lowlands (Sang et al., 2010, Sang et al., 2017). In South Africa, the 
outbreaks between 2008 and 2011 were associated with above average rainfall, in 
shrubland, low fynboes, grassland, and agricultural areas in close  proximity to 
water bodies, including rivers and drainage areas (Glancey et al., 2015). These 
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studies suggest a range of ecological characteristics where RVF and vectors have 
been recorded previously in other endemic countries.  
The distribution and abundance of mosquito vectors is also influenced by feeding 
ecology. The role of livestock in the feeding ecology of mosquitoes has been the 
subject of extensive study in relation to mosquito vectors (Diatta et al., 1998, 
Deichmeister and Telang, 2011, Lutomiah et al., 2014).  However, little is known 
about how the presence, abundance or density of livestock might affect RVF 
transmission risk. The presence of livestock could influence mosquito vector 
species abundance and distribution as previously  demonstrated  (Mayagaya et al., 
2015a, White, 1971, Besansky et al., 2004, Costantini et al., 1998, Diatta et al., 
1998). It has also been suggested that zooprophylaxis, the diversion of disease 
carrying insects from humans to animals, may reduce transmission of mosquito-
borne diseases (MacDonald, 1957, WHO, 1982, Service, 1976) and has therefore 
been recommended as a potential environmental strategy to reduce transmission of 
mosquito borne diseases (Saul, 2003). Studies involving Anopheles spp (Mahande et 
al., 2007, Muriu et al., 2008) and similar studies involving Aedes and Culex spp 
(Hess and Hayes, 1970) suggest that domestic animals would have the highest 
potential values for zooprophylaxis against RVFV vectors. Conversely,  other studies 
have shown that, in situations where livestock are kept close to humans, animals 
may actually increase the risk of individual humans being bitten (zoopotentiation) 
by attracting mosquitoes to the household environment (Bouma and Rowland, 1995, 
Schultz, 1989, Hasyim et al., 2018), suggesting that keeping livestock in the 
household contributes more to risk than prophylaxis (Mayagaya et al., 2015b, 
Hasyim et al., 2018). Investigating the influence of livestock on local abundance 
and distribution of potential RVF vectors at household level will broaden our 
understanding of risk factors for RVFV transmission in livestock and human 
populations in different agro-ecological settings.   
Host odours play a major role in the orientation of nocturnal mosquitoes towards 
their hosts (Takken and Kline, 1989). The animal breath and skin odour influences 
mosquito host-seeking behaviour. Adult female mosquitoes use host-emitted odour 
to locate hosts to obtain blood meals (Takken and Kline, 1989, Takken and 
Verhulst, 2013). When searching for hosts for blood meals, some mosquitoes 
express preferential feeding behaviour (Takken and Verhulst, 2013).  Most known  
RVFV vector species have zoophagic behaviour, feeding mostly on animals (cattle, 
sheep, and goat), and some of them are described as opportunistic anthropophagic 
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feeders, feeding mostly on humans (White, 1971, Tantely et al., 2013). A study in 
Madagascar suggests cattle were the main domestic host for five species (An. 
squamosus, An. coustani, Cx. antennatus, Cx. univittatus and Cx. pipiens), and 
that vectors preferred these to other domestic animals (Tantely et al., 2013). 
Similar observations were reported in Kenya where Aedes spp, Culex spp, and 
Mansonia spp prefered cattle to other livestock species (Tchouassi et al., 2016). 
Another similar study in Senegal observed that Culex spp. fed most often on 
humans, Aedes spp fed almost equally on all animal species tested (cattle, goats, 
sheep and chickens), while Anopheles spp preferred cattle over humans, goats and 
sheep. In Mauritania An. funestus and An. pharoensis were observed to feed on 
human and ovine hosts respectively (Dia et al., 2009). These studies demonstrate 
different feeding behaviour and host preference of the vector species suggesting 
potential different exposure risks of different host species. To better understand 
the risk of RVFV transmission associated with having livestock at a household, it is 
important to examine the occurrence, abundance and distribution of the RVFV 
vector species at households with and without livestock.  
1.6 Serological survey for RVFV infection in Tanzania 
Rift Valley fever cases in livestock and humans are usually reported during large 
outbreaks. However, the maintenance and transmission of the virus to livestock 
and humans during the inter-epidemic period (IEP) when there is low or no disease 
activity is not well understood (Lancelot et al., 1990, Gerdes, 2004, Martin et al., 
2008, Sang et al., 2010, Mroz et al., 2017). It is possible that RVF cases are passing 
undetected due to inadequate surveillance in livestock and human populations 
during inter-epidemic periods. This may occur due to an assumption that cases can 
only occur during periods of extreme rainfall (Beechler et al., 2015, Sindato et al., 
2015). Wild ruminants are suggested as potential  reservoirs  of the virus, playing a 
role in inter-epidemic maintenance of the virus (Beechler et al., 2015, Evans et al., 
2008).  This is supported by detection of neutralizing antibodies in buffaloes from 
the Kruger National Park and Hluhluwe-iMfolozi Park in South Africa (Beechler et 
al., 2015, Fagbo et al., 2014), buffaloes  in Botswana (Jori et al., 2015) and seven 
wildlife species in Kenya, including African buffalo, black rhino, lesser kudu, 
impala, African elephant, kongoni, and waterbuck including animals born during 
the 1999–2006 IEP (Evans et al., 2008). In Egypt, RVFV antibodies were detected in  
buffaloes born after the last Egyptian RVF epidemic in 2003 (Mroz et al., 2017). 
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These studies suggest that wildlife could be playing an important role in the inter-
epidemic circulation of RVFV. 
There is some evidence of inter-epidemic RVFV infections on the basis of 
serological surveys in the region including in sheep and goats in Mozambique 
(Blomström et al., 2016), cattle, sheep, and goats in Kenya (Lwande et al., 2015, 
Mbotha et al., 2018, Lichoti et al., 2014a) and Madagascar (Jeanmaire et al., 
2011). Inter-epidemic seroprevalence in humans has been reported in Gabon 
(Pourrut et al., 2010), Saudi Arabia (Mohamed et al., 2014), Kenya (Cook et al., 
2017), and Central African Republic (Nakouné et al., 2016). In Tanzania,  
antibodies against RVFV have been detected in cattle, and small ruminants 
(Sumaye et al., 2013, Wensman et al., 2015, Sindato et al., 2015).  Serological 
evidence for human exposure to RVFV infections in the inter-epidemic period has 
been reported in Morogoro and the Mbeya regions of south-western Tanzania 
(Heinrich et al., 2012a, Sumaye et al., 2015) and the  in the Serengeti ecosystem, 
northern Tanzania (Ahmed et al., 2018).   Although all these studies show some 
level of (inter-epidemic) RVFV circulation in livestock and humans in Tanzania, 
little is still known about spatial patterns, risk factors and outcomes of inter-
epidemic infection in northern Tanzania.  These infections could be driven by 
either host factors (i.e. species, sex, age, susceptibility) as well as vector ecology 
and feeding behaviour and further knowledge of these factors will be important for 
understanding the dynamics of inter-epidemic infection.  
1.7 Risk factors for RVFV inter-epidemic infections in livestock and 
humans  
Rift valley fever outbreaks in livestock and humans have been well documented to 
be  associated with unusual heavy rainfall periods coupled with floods and massive 
breeding of mosquitoes (Davies et al., 1985, Gerdes, 2004). Human infections have 
been linked with contacting infected animals and/or animal materials (Gerdes, 
2004, Evans et al., 2008). The means by which infections are maintained in 
livestock or human populations in the inter-epidemic periods is not fully 
understood. To further explore this question it is essential to identify what factors 
are associated with RVFV infections between epidemics. Identification of risk 
factors will provide insight into the transmission routes and will advance our 
understanding of maintenance of RVFV infections which will inform surveillance, 
prevention and control strategies and programmes.  
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A wide range of factors have been associated with RVFV infections in livestock in 
different settings. Animal species, sex and age (young and old) were associated 
with RVFV seropositivity in Egypt (Mroz et al., 2017), Kenya (Lichoti et al., 2014b), 
Mauritania (Rissmann et al., 2017) and Tanzania  (Sumaye et al., 2013). Older age 
and heavy rainfall were considered as potential risk factors for RVFV seropositivity 
among the Sudanese one-humped camel (Camelus dromedaries) in Khartoum State, 
Sudan (Abdallah et al., 2015). In Madagascar, cattle seropositivity was associated  
with older age, humid environments and high cattle density (Olive et al., 2016). In 
addition, animal introductions and history of abortions have also been reported as  
risk factors in a previous study in Tanzania (Sindato et al., 2015). These findings 
suggest that seropositivity in different livestock species can be influenced by 
different factors or similar factors in different ways.  
Risk factors for seropositivity in humans have been reported in a number of studies 
and mostly related to behaviours, occupation, household responsibilities and 
traditions. Studies in different endemic countries have identified factors that are 
consistent across the region or apply only to local settings. In Madagascar, human 
exposures to RVFV were found to be associated with the presence of temporary and 
artificial water points and frequent handling/consumption of raw milk (Olive et al., 
2016). In Kenya, human seropositivity was found to be associated with being male 
and a herdsperson, handling aborted animal foetus,  consuming or handling 
products from sick animals (Anyangu et al., 2010), consuming raw milk (Nicholas et 
al., 2014) and birthing an animal (Woods et al., 2002, Anyangu et al., 2010). 
Whereas in Uganda RVFV seropositivity were greater in participants who were 
butchers  and those who reported handling raw meat (Nyakarahuka et al., 2018).  
Understanding factors that drive RVFV infection in local settings will help inform 
appropriate intervention strategies. 
Livestock abortions have been associated with RVF outbreaks following periods of 
unusual rainfall and floods, but unreported abortions in the inter-epidemic periods 
and their association with RVFV infections in livestock and humans have not been 
well studied. It is also worth investigating other potential factors for RVFV 
infections in the inter-epidemic period. Factors related to management of livestock 
in different agro-ecological settings which have not been well studied in relation 
RVF, including farming systems (small-holder, agro-pastoral and pastoral), seasonal 
movement following pasture and water in dry seasons, and animal introductions. It 
is important therefore, to examine and identify potential risk factors associated 
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with RVFV infections in livestock and humans in small-holder, agro-pastoral, 
pastoral communities in Tanzanian in order to inform appropriate control 
strategies. 
1.8 Detection of Rift Valley Fever virus infections 
Rift Valley fever virus infections or exposure status can be detected using various 
techniques, including virus isolation, viral nucleic acid detection, antigen detection 
and detection of specific antibodies (Pepin et al., 2010, Swanepoel et al., 1986). 
RVFV infection is generally associated with a high and early humoral response. The 
immune response developed  following infection, involves the production of 
detectable neutralizing antibodies from the 4th–8th day after infection (Hubbard et 
al., 1991, Morrill et al., 1987, Pepin et al., 2010). These antibodies, which are 
primarily directed against the viral glycoproteins, Gn and Gc, are also accompanied 
by the production of IgM and IgG antibodies raised against the nucleoprotein, N, 
and the non-structural protein, NSs (McElroy et al., 2009). The detection of IgM and 
IgG antibodies coupled with the results of molecular (RT-PCR) assays is critical to 
accurately stage the time since infection (Pepin et al., 2010).  
1.8.1 Serological detection of RVFV infections 
The presence of  immunoglobulin M (IgM) is usually interpreted as an indicator of 
recent infection (Morvan et al., 1992). Immunoglobulin M antibodies are associated 
with a primary immune response which provide first line defence and are frequently 
used to detect acute exposure to an immunogen or pathogen in 5-8 days of being 
infected (Schroeder and Cavacini, 2010). In most cases IgM antibodies do not persist 
beyond the 50th day after infection (Paweska et al., 2003b) (Figure 1.4). On the 
other hand, immunoglobulin G (IgG) are the predominant antibodies found in the 
body picking up after IgM as secondary antibodies and have the longest serum half-
life of all immunoglobulins (Schroeder and Cavacini, 2010). They may provide 
protection against specific pathogens for several years. Immunoglobulin G are the 
only antibodies that can pass from mother to foetus via the placenta and are also 
secreted into the mother's milk and is taken up from the gut of the neonate into the 
blood, providing protection for the newborn against infection (Alberts et al., 2002). 
Anti-RVFV IgM antibodies do not persist beyond the 50th day after infection and 
confirms recent infections (Paweska et al., 2003b, Morvan et al., 1992). This is 
supported by a study involving 195 naturally infected cattle in Madagascar including 
37 aborted females and 158 other infected animals (Morvan et al., 1992). Only 27% 
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of animals had detectable IgM two months post infection, and no animals had 
detectable IgM after 6 months. 
 
 
Figure 1.4 Schematic representation of time course viraemia and antibody response 
against RVFV in experimentally infected animals. Diagram adapted from Pepin et 
al., 2010. 
 
1.8.1.1 Virus Neutralization Test 
The virus neutralization test (VNT) regarded as the gold standard serological assay 
for RVF (Schreur et al., 2017), is a specialized type of immunoassay because it does 
not detect all antigen–antibody reactions. It only detects antibodies that can block 
(neutralize) virus replication, which is important because closely related groups of 
viruses may share common antigens, but only a fraction of these antigens are 
targets of neutralizing antibody. The VNT is the only assay available to measure the 
presence of virus neutralizing antibodies (VNAb) (Monath and Vasconcelos, 2015). 
The test protocol involves mixing dilutions of test sera with a fixed amount of virus 
and incubating to allow VNAb to neutralise the virus. The serum/virus mix is then 
added to a monolayer of permissive cells and incubated for a period sufficient for 
the virus to infect cells and produce a cytopathic effect (CPE). Cells are then 
viewed under the microscope, the presence of VNAb is determined by the absence 
of CPE, as VNAb in the serum have successfully neutralised the virus. For viruses 
which do not produce CPE, labelled antibodies directed against the virus can be 
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used to detect virus in the cell culture. Although the VNT is considered the gold 
standard for detection of antibody against RVFV, its use in most of the endemic 
countries is limited by being expensive, requires high-containment facilities for 
working with live virus, requires the use of cell culture, and involves incubation for 
5-7 days for completion (Pepin et al., 2010, Paweska et al., 2003b). Additionally, 
the test is laborious and few samples can be investigated simultaneously (Mather et 
al., 2013). This can limit serosurveillance efforts for such viruses as RVFV in regions 
where such facilities are not available.  
1.8.1.2 Enzyme-linked immunosorbent assay (ELISA) 
Antibody detection by enzyme-linked immunosorbent assay (ELISA) can be used to 
confirm presence of specific IgG and IgM antibodies. These assays are useful for 
epidemiological surveillance and control programmes, import/export veterinary 
certification, early detection of infection, and for monitoring of immune response 
in vaccinated animals (Paweska et al., 2003b). An ELISA can be used to detect 
either the presence of antigens  or antibodies  in a sample, depending on how the 
test is designed (Ma and Shieh, 2006, Gaastra, 1984). To detect antibodies using the 
ELISA test (Figure 1.5), antigen is coated onto a 96-well plate and test sera are 
added. Secondary antibody coupled to an enzyme, specific to the host species being 
tested, is then added to the plate wells. Enzyme substrate is then added allowing a 
colour change to be determined by measuring the optical density measured in a 
spectrophotometer. Depending on the ELISA platform used, either the presence or 
absence of colour indicates the presence of antibodies (Ma and Shieh, 2006). IgM or 
IgG antibodies can be detected using isotype-specific secondary antibodies. The 
antibodies detected may be either neutralising or non-neutralising and the tests 
cannot differentiate between the two.  
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Figure 1.5 Schematic representation of the ELISA test and procedure involved in 
detecting specific antibodies in a given sample. 
 
When testing for anti RVFV antibodies, non-specific background has been observed 
using ELISAs (Faburay et al., 2013) suggesting  antibody cross-reactivity, as 
antibodies raised against other members of the family Phenuiviridae and  genus 
Phlebovirus have shown to cross-react (Szymczak et al., 2015, Xu et al., 2007), 
which make results interpretation difficult. In addition, most of the available ELISAs 
have raised concerns with their performance, sensitivity and specificity (Paweska et 
al., 2003a). However, ELISAs remain the most commonly and widely utilised method 
for sero-epidemiology of RVFV (Mansfield et al., 2015) in endemic areas. 
Commercial RVFV ELISAs based on the viral nucleoprotein are available and detect 
IgM and/or IgG. These ELISAs allow for large scale sero-surveillance outside of high 
containment facilities and are much more convenient for ‘in field’ testing (Van 
Vuren and Paweska, 2010). ELISAs based on recombinant N-protein, which can 
perform as well as VN and HI tests (Fafetine et al., 2007), have the potential to 
complement the traditional assays for serological detection of RVFV infections. 
Advantages of the N-protein are its safety, stability and cost-effectiveness in use 
and production (Fafetine et al., 2007) and the RVFV-N-based ELISAs can be useful in 
large-scale epidemiological investigations. It is imperative therefore, to develop a 
cheap, safe, thermal stable, and easy to use ELISA that can be used in endemic 
countries. In this study, the performance an inhouse RVFV-N based ELISA developed 
by the University of Glasgow was evaluated using commercially available ELISA as a 
reference. 
31 
1.8.2 Molecular detection of RVFV infections 
Rift Valley fever virus (RVFV) is a member of the family Phenuiviridae and as such is 
an enveloped virus that has a negative stranded RNA genome consisting of three 
segments. The M (medium) and L (large) segments are of negative orientation, 
whereas the S (small) segment has an ambisense polarity.  The M segment encodes 
the two glycoproteins Gn and Gc and the non-structural protein NSm, while the L 
segment encodes the RNA-dependent RNA-polymerase. The small segment encodes 
the nucleocapsid (N) protein and a non-structural protein NSs using an ambisense 
coding strategy (Paweska, 2014, Pepin et al., 2010). The N protein is highly 
conserved and it is one of the most immunodominant viral proteins among members 
of the Phenuiviridae family (Pepin et al., 2010) 
 
Detection of nucleic acids of RVFV has been shown to be useful in field diagnostics 
(Drosten et al., 2002). Molecular methods are increasingly used for a rapid and 
accurate detection of viral nucleic acid in blood, tissue and mosquito samples 
(Drosten et al., 2002). Molecular techniques such as reverse-transcriptase 
polymerase chain reaction (RT-PCR)  and other newly developed techniques allow 
for a rapid and accurate detection of RVFV (Escadafal et al., 2013).  The RT-PCR is 
often used as a method of detection for a great number of arboviruses, which 
facilitates phylogenetic studies (Garcia et al., 2001).  Other molecular methods 
that have been developed recently include: single-tube RT-PCR,  quantitative RT-
PCR (qRT-PCR) and more recently real-time reverse-transcription loop-mediated 
isothermal amplification (RT-LAMP) (Le Roux et al., 2009) and recombinase 
polymerase amplification assays (RPA) (Euler et al., 2012). Despite some limitations 
in terms of costs and the level of expertise required of technicians, RT-PCR is a 
rapid, sensitive, specific, and reliable assay for detection of RVFV infection (Sall et 
al., 2002). RT-PCR has shown to detect viral infections in the very early phase of 
the disease, before the appearance of IgM antibodies and the decline of viremia 
(Burt et al., 1998). The RT-PCR is therefore recommended as an efficient diagnostic 
tool for the investigation of enzootic circulation of the RVFV. It allows the 
detection of low viral RNA loads adapted for the investigations of reservoirs or 
specific epidemiological situations such as during inter-epidemic periods (Maquart 
et al., 2014).  
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1.9 Rationale for the study 
1.9.1 Problem Statement 
Available serological evidence suggests that, across many countries and settings in 
Africa, RVFV continues to circulate in livestock and humans in the periods between 
large epidemics.  However, little is still known about patterns and risk factors of 
inter-epidemic infection in northern Tanzania where repeated large outbreaks have 
occurred previously.  While no cases have ever been reported in Tanzania between 
the large RVF epidemics,  it is possible that RVF cases are going undetected or are 
not being reported during inter-epidemic periods, either because of limited 
surveillance and awareness of the possibility of cases during this periods and/or 
because inter-epidemic infections present differently, for example with only low-
level clinical or subclinical signs.  
1.9.2 Study Justification 
Understanding of how the virus circulates in livestock and humans between 
epidemics, as well as the risk factors and outcomes of these infections in different 
agro-ecological settings will help and inform intervention strategies to control and 
prevent future epidemics.  
1.10 Objectives 
1.10.1 General Objective 
This study sought to investigate patterns of RVFV infection in livestock and humans 
in the inter-epidemic period in northern Tanzania, in order to inform surveillance, 
preparedness, and control strategies and/or programmes. 
1.10.2  Specific Objectives 
This study specifically sought to:  
a) Determine the occurrence, abundance, distribution and infection status of 
potential RVFV mosquito vectors in northern Tanzania;  
b) Investigate inter-epidemic seroprevalence and risk factors for RVFV 
infections in livestock and human populations in northern Tanzania; and 
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c) Investigate RVFV as a possible cause of livestock abortions during inter-
epidemic periods in northern Tanzania.  
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Chapter Two 
2 Core Methods 
The  methods described here are the general methodology for the study including 
field sample collection, laboratory work and statistical analyses. Detailed 
statistical analyses  for specific study components are described under specific 
chapters of this thesis. Samples and data described here were collected as part of 
three study projects, namely Social, Economic and Environmental Drivers of 
Zoonoses (SEEDZ), Supporting evidence based interventions to achieve agricultural 
development goals in Tanzania (SEBI-TZ) and an earlier study on bacterial zoonoses 
(BacZoo). Therefore, a number of people have contributed in different study 
activities as summarised in Table 2.1.  
 
Table 2.1 Activities that relates to completion of my PhD along with the roles of 
people who participated in various activities. 
Activities 
 
 
Concept  
Development 
 
Field 
implementation 
 
Laboratory and  
data  analyses 
 
Mosquito surveys  
 
 
 
 
M.J. Nyarobi 
H. Ferguson  
W. de Glanville 
 
 
M.J. Nyarobi 
 
 
 
 
M.J. Nyarobi   
W. de Glanville  
H. Ferguson  
P. Johnson 
 
Livestock sero-
epidemiological 
studies 
 
 
W. de Glanville  
S. Cleaveland  
M.J. Nyarobi 
 
 
W. de Glanville  
SEEDZ & BZ field 
teams 
M.J. Nyarobi 
 
M.J. Nyarobi  
W. de Glanville   
P. Johnson 
 
 
Human sero-
epidemiological 
studies 
 
 
 
W. de Glanville  
S. Cleaveland 
M.J. Nyarobi 
 
 
 
W. de Glanville 
SEEDZ & BZ field 
teams  
M.J. Nyarobi 
 
 
M.J. Nyarobi  
W. de Glanville 
P. Johnson 
 
 
 
ELISA assay studies 
 
B. Willet  
M.J. Nyarobi 
 
M.J. Nyarobi 
 
VNT assay 
 
B. Willet 
M.J. Nyarobi 
 
A. Szemiel 
 
Mosquito PCR assay 
 
 
M.J. Nyarobi  
H. Ferguson 
 
 
M.J. Nyarobi  
R. Carter  
K. Allan 
Livestock PCR assays 
 
 
S. Cleaveland 
W. de Glanville 
 
T. Kibona  
SEBI field teams 
 
M.J. Nyarobi 
R. Carter  
K. Allan 
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Activities 
 
 
Concept  
Development 
 
Field 
implementation 
 
Laboratory and  
data  analyses 
 
  
 
 
 
K. Thomas 
 
Mosquito habitat 
suitability analyses 
 
 
W. de Glanville 
S. Cleaveland 
M.J. Nyarobi 
 
 
M.J. Nyarobi  
W. de Glanville 
 
 
 
2.1 Study Area 
The study involved samples and data collected as part of the three epidemiological 
studies in three regions of northern Tanzania namely Arusha, Kilimanjaro and 
Manyara. The study area covered six districts in Arusha region (Arusha, Ngorongoro, 
Longido, Monduli, Karatu, Meru), four districts in Kilimanjaro region (Hai, Moshi 
Municipality, Moshi rural and Rhombo) and three districts in Manyara region 
(Simanjiro, Mbulu, and Babati), (Figure 2.1). These districts were selected as part 
of the project on Social, Economic and Environmental Drivers of Zoonoses (SEEDZ), 
between February and November 2016. The SEEDZ project aimed at examining and 
assessing the drivers, risks and impacts of a wider range of zoonotic diseases, 
including brucellosis, Q fever and Rift Valley Fever, that affect livestock and 
human health, livelihoods and poverty in pastoral, agro-pastoral and peri-urban 
communities in Tanzania. In addition to SEEDZ study districts, other samples 
included in the current study were collected in 2013 as part of other studies on 
bacterial zoonoses (BacZoo) and 'Supporting evidence based interventions to 
achieve agricultural development goals in Tanzania (SEBI-TZ)'. The SEBI study 
sought to extend and broaden the range of diseases investigated under the SEEDZ 
project with a particular focus on investigating the causes of abortions in livestock. 
The aim of the SEBI project was to develop effective and sustainable intervention 
strategies that will result in a reduction in abortion losses in cattle, sheep and 
goats. The study area has a high level of interaction between livestock, wildlife 
and humans (Prins, 1992, Newmark et al., 1994); and cases of RVF were reported 
during outbreaks in1977, 1998 and 2006/2007 (Mohamed et al., 2010, Fyumagwa et 
al., 2011, Chengula et al., 2013). The study included pastoral, agro-pastoral and 
small-holder communities. In pastoral communities such as Maasai and Barbaig, 
livestock (cattle, goats and sheep) are kept in animal enclosures (bomas) made of 
thorny acacia tree logs and branches within household compounds. Young animals 
(e.g. kids and lambs) often sleep in the same house as people. In agro-pastoral or 
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peri-urban areas, livestock are kept in sheds made of tree branches and mud or 
cow dung, thatched with grass or iron sheets within household compounds. In some 
cases, animals have a partition in the same house as people.  
 
  
Figure 2.1 Map of northern Tanzania showing districts in the study area including 
those with record of previous RVF outbreaks and location of villages where the 
study was carried out. Map created in QGIS 2.14.0 -Essen, 2016 using RVF outbreaks 
data from (Sindato et al., 2014) and shape files for country administrative 
boundaries available at www.diva-gis.org 
 
2.2 Village and household selection 
For administrative, governance and provision of social services in Tanzania, there 
are different levels of regional and local government authorities apart from the 
national government. In the order of highest to lowest local government 
administrative unit, they include region, district, ward, village, sub-village (in rural 
settings) or mtaa/street (in urban settings). The SEEDZ study involved 20 villages 
and BacZoo involved 15 villages which were randomly selected. Villages were 
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selected using a Generalised Random Tessellation Stratified (GRTS) sampling 
approach (McDonald, 2004, Stevens Jr and Olsen, 2004)  in order to achieve a 
spatially representative sample. Villages in the study area contained four or more 
sub-villages. Two sub-villages per village were randomly selected for inclusion in 
the SEEDZ study. Within sub-villages, households were randomly selected.  Here 
livestock keepers were invited to a central point (e.g. dip tank, crush) where 
livestock sampling was conducted. The sub-village chairperson was notified at least 
three days in advance of the sampling event, and a meeting arranged with the 
chair person and cell (10 households) leaders at least a day before the event. The 
“Supporting Evidence Based Interventions in Tanzania” (SEBI-TZ) study established 
a real-time surveillance platform covering 16 randomly selected sentinel wards in 
Arusha, Manyara and Kilimanjaro Regions of Tanzania. Livestock (cattle, sheep and 
goats) samples were collected in response to reported abortion events from the 
SEBI study villages.  
2.3 Ethical Clearance 
The SEEDZ protocols, questionnaire tools and consent and assent procedures were 
approved by the ethical review committees of the Kilimanjaro Christian Medical 
Centre (KCMC/832), National Institute of Medical Research (NIMR/2028), and 
Commission for Science and Technology (2015-244-ER-2005-141) in Tanzania, and in 
the UK by the ethics review committee of the College of Medical, Veterinary and 
Life Sciences, University of Glasgow (Ref: 200140152). Approval for the animal 
elements of the study was provided by the Clinical Research Ethics Committee at 
the University of Glasgow School of Veterinary Medicine (39a/15). The BacZoo 
protocols were approved by NIMR, protocol number: NIMR/HQ/R.8a/Vol.IX/1499) 
and the Tanzanian Wildlife Research Institute (TAWIRI). Ethical approval for human 
sampling and testing was granted from the Kilimanjaro Christian Medical Centre 
(KCMC) Research Ethics Committee, NIMR and the Institutional Review Boards of 
Duke University Medical Center and the United States for the Centers for Disease 
Control. In the UK, the University of Glasgow College of Medicine, Veterinary 
Medicine and Life Sciences Ethics Committee (protocol number: 200140152).  
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2.4 Sample collection and preparation 
2.4.1 Animal Sampling 
Animal sampling was performed by the respective project field teams led by a 
registered veterinarians. Livestock keepers from different bomas (households) were 
encouraged to bring cattle, goats and sheep of different ages and sex at the 
central point (identified sampling point) for sampling.  Animals from different 
households (bomas) were brought to the central point for sampling.  At the central 
sampling point, the aim, purpose and benefits of the study were explained to 
livestock keepers, and written consent was obtained before sampling animals from 
a selected boma. Animals were sampled in relative proportion to the size of the 
herd. The target sample size for livestock sampling was 10 bomas from a sub-
village, and 10 each of cattle, sheep and goats selected per boma. In cases where a 
boma had less than 10 animals in a herd or flock, all animals would be sampled. 
From all animals, a 10ml blood sample was collected by jugular venepuncture 
following appropriate restraint in an existing or temporarily constructed livestock 
crush. About 2-5 mls of sera was obtained from each blood sample through 
centrifugation, and transferred into screw capped cryovials and stored at -80 °C for 
further serological analysis. For the BacZoo study, a list of all livestock keeping 
households in each village was generated and up to six households randomly 
selected. Households were visited and, where numbers allowed, 12 of each of 
cattle, sheep and goats sampled.   
Under the SEBI study samples were collected following the report of an abortion or 
peri-natal mortality event, by recruited Livestock Field Officers (LFOs) or members 
of the study field team who visited the dam/ewe/doe(s)  to collect samples within 
72 hours of the abortion/still birth event. In addition to basic farm level data, the 
following samples were collected: (i) Blood samples from the cow/ewe/doe; (ii) 
Milk samples; (iii) Vaginal swabs from the cow/ewe/doe; (iv) Tissue from the 
placental inter-cotyledonary space; (v) Placental cotyledon; (vi) Foetal organs 
(liver, lung and kidney, thymus); and (vii) Foetal stomach contents. Only four 
sample types were used in the current study, namely vaginal swabs from the 
aborted dam, swabs from aborted foetus, placenta cotyledon tissue samples and 
milk samples. Samples were double packed according to UN3373 protocols and 
transported to the project laboratory at the Kilimanjaro Clinical Research Institute 
(KCRI) in the town of Moshi via a project vehicle or by courier.  
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2.4.2 Human sampling 
Human diagnostic samples were collected from selected livestock-owning 
households from which animals were sampled. Questionnaire surveys were 
conducted to gather data on residents (e.g. demographics, livestock interaction 
practices, and clinical history) and household characteristics. An adult head of 
household from each household was asked to provide informed written consent for 
questionnaire data gathered. In addition, human blood sampling was carried out if 
there were consenting participants in a household. Participants for blood sampling 
were approached on an individual basis for consent for individual specific data 
collection.  The individual themselves or head of household (in the case of minors 
aged <18 years) provided informed written consent. Blood sampling was performed 
by a Practitioner Nurse from Kilimanjaro Christian Medical Centre (KCMC) using 
vacuum extraction method as per World Health Organization guidelines (WHO, 
2010). 
2.4.3 Mosquito Sampling 
2.4.3.1 Selection of mosquito sampling sites 
Mosquito sampling was carried out in 12 villages randomly selected from the 20 
SEEDZ study villages. The target was sampling two sub-villages from a village, and 
four households from each sub-village. However, there were logistical challenges 
coupled with size of some villages (some with larger geographical coverage) with 
large distance between household locations,  and limited number of non-livestock 
keeping households in some villages hence uneven number of sampled sub-villages 
and households respectively. Mosquitoes were sampled  from  households with and 
without livestock in both agro-pastoral and pastoral settings. Livestock households 
were randomly selected from a list of animal sampled households. Non livestock 
keeping households were randomly selected from the list provided by the village 
and sub-village authorities. Numbers based on the list of households, were written 
in bottle tops, placed in a plastic container, shuffled each time a household 
number was selected.  
In addition to households, potential mosquito breeding habitats (Figure 2.2) such as 
dambos (flooded depressions), rivers, open wells, swamps, ponds, rice field and 
animal water points (Fontenille et al., 1998, Gerdes, 2004, Davies et al., 1985, 
Diallo et al., 2005, Jupp et al., 2002)  were purposefully identified for mosquito 
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trapping. This was carried out to identify mosquito species emerging from the 
breeding sites and that could be tested for RVFV infection status as obtained from 
trans-ovarial infection and were also compared with those sampled in and around 
households to determine which species were most likely to feed on infected 
livestock and humans. 
Permission of community leaders and informed consent were sought from each 
head of household where trapping were carried out.  Aims of the study, methods 
and potential benefits of participation were explained to the head of the household 
in Swahili or translated into the local language. Geographic co-ordinates of each 
selected household or mosquito trapping site were captured using a Garmin eTrex® 
10 Handheld GPS. 
 
Figure 2.2 Pictures of different potential mosquito breeding habitat that were 
considered for trapping in the study area. (a) annual river near a village, (b) pond 
flooded by rain water, (c) stagnant water on ground, and (d) old tyre near animal 
enclosure 
2.4.3.2 Mosquito collection methods 
For mosquito collection, four trapping methods were tested to assess the risk of 
biasing collection data when using one trap over another. The following mosquito 
trapping methods (Figure 2.3) were used at each household: (1) BG Sentinel trap 
(BG) (Biogents AG, Regensburg, Germany) to target outdoor host seeking 
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mosquitoes. BG-Sentinel traps  were used in combination with the BG-Lure, a 
dispenser which releases emanations such as those found on human skin (lactic 
acid, ammonia, and caproic acid) to attract host seeking species (Maciel-de-Freitas 
et al., 2006).  This trap has been shown to be effective for collecting Aedes spp 
(Bhalala and Arias, 2009); (2) Mosquito Magnet traps (MM) (Woodstream 
Corporation,  Pennsylvania, USA) to target outdoor host seeking mosquitoes 
particularly Aedes spp, Ochlerotatus spp, Culex spp, Mansonia spp, and Anopheles 
spp (Bell et al., 2005). The trap uses propane gas and produce CO2, warmth and 
moisture to attract mosquitoes; (3) CDC Light traps (LT) (John W. Hock Company, 
Florida, USA) to target night time indoor host seeking species such as Anopheles 
spp and Culex spp (Mboera et al., 1998, Davis et al., 1995); and (4) Resting Bucket 
(RB) locally made from (20l) plastic buckets bought from the local shops, and lined 
with black cloth on the inside to target outdoor resting mosquitoes as previously 
described (Kreppel et al., 2015). This method has been previously evaluated for 
malaria vectors in Tanzania, and was shown to be effective for sampling Anopheles  
and Culicinae (Aedes, Culex and Mansonia) mosquitoes (Kreppel et al., 2015).  
 
Figure 2.3 Different types of mosquito traps that were used for mosquito 
collections. (a) BG Sentinel trap, (b) Mosquito Magnet trap, (c) CDC Light trap (d) 
Resting Bucket trap. 
2.4.3.3 Mosquito trap setting 
In each sub-village one day and one night of sampling was carried out near the 
identified mosquito breeding habitat sites, and one day (8 am - 6 pm) and night 
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(7pm - 6am) at each of the four selected households (2 households per day and 
night trapping). Except for the light traps that were set to collect mosquitoes 
during night time, all other traps were set for day and night catches including one 
Mosquito Magnet trap, one BG Sentinel trap and 10 Resting Buckets were placed in 
the outdoor environment of each household.  
Light traps were suspended at approximately 1.5 m above the floor on the foot side 
of the bed where a person is protected by mosquito net (Bhalala and Arias, 2009, 
Davis et al., 1995), or well above the reach of the animals in an animal room.  No 
light trap was used outside, instead other outdoor traps were used. The Mosquito 
Magnet traps were placed outside in a shaded place within the household 
compound but about 5m away from the houses or livestock shelter/enclosure. BG-
Sentinel traps were placed in shaded or partially shaded locations (where 
applicable) under vegetation outside (Cilek and Hallmon, 2005, Hiwat et al., 2011) 
in the household compound or the selected breeding site. In order to avoid 
interference among the traps (BG Sentinel and Mosquito Magnets) they were placed 
in different locations (15 m distance apart) of the household compound as 
suggested  by (Brown et al., 2014)  depending on the size and orientation of the 
household compound. 
When setting the Resting Bucket traps, the inside of traps was sprinkled with water 
to make the lining cloth wet and increase humidity. Traps were placed haphazardly 
within a 5 m  range of the  house or animal enclosure/shelter in relatively shady 
areas, ideally next to or under vegetation (Bidlingmayer, 1971, Burkett-Cadena et 
al., 2008). Bucket traps were placed on their sides with the opening facing the 
nearest structure, a house or livestock enclosure/shelter. Mosquitoes resting inside 
the resting buckets were collected using a CDC backpack aspirator by aspirating for 
10–20 seconds at the open end of the bucket. Mosquito catches from all traps were 
collected between 6:00 am and 7:00 am in the morning, and between 6:00 pm and 
7:00 pm in the evening. 
2.4.3.4 Mosquito sorting  
Mosquitoes from all trapping methods were anesthetized by asphyxiation with 
chloroform before sorting and identification. All mosquitoes caught were 
morphologically identified to genera or species level using morphological 
identification keys (Gillies and Coetzee, 1987, Huang, 2001, Jupp, 1996). Using a 
magnifying hand lens (X5) and forceps, mosquitoes from each trap  were sorted 
according to genera, sex, trap type, site and date of collection, in pools of 1-25 
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mosquitoes and preserved in labelled 2 ml cryo vials containing Trizol reagent 
(Figure 2.4). Pools of mosquitoes were kept in a car fridge initially for 4-5 days and 
then transported to the laboratory at Kilimanjaro Clinical Research Institute (KCRI) 
for storage in the -800C freezer for further RNA extraction at a later stage.  
 
 
Figure 2.4 Plate showing mosquito sorted from other insects using magnifying hand 
lens and forceps, morphologically identified and stored in labeled cryovials. 
2.4.3.5 Environmental data 
In addition to mosquito collections, data on vegetation cover of the area was 
essential as a potential determinant of mosquito abundance and distribution. Data 
on normalized difference vegetation index (NDVI) which quantifies vegetation by 
measuring the difference between near-infrared (which vegetation strongly 
reflects) and red light (which vegetation absorbs) was obtained from 
https://earthexplorer.usgs.gov/. NDVI was MOD12A3 data for each month with  a 
spatial resolution of 0.05 decimal degrees by 0.05 decimal degrees. NDVI ranges 
from -1 to +1. Negative values indicates that it’s highly likely that it’s water  and 
NDVI value close to +1 indicates that there’s a high possibility that it’s dense green 
vegetation. To provide control for potential differences in rainfall between 
sampling days, the percentage difference in NDVI at the household between the 
month of the visit to the household and NDVI for that household over the whole 
study period (i.e. between 2015 and 2017) was calculated. A positive percentage 
difference could be expected to reflect a “greener” than average time of year and 
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to therefore broadly represent of a wet period. A negative percentage difference 
would reflect a “browner” than average time of year, and therefore broadly 
represent a dry period. It could be expected that more mosquitoes would be 
trapped during a wetter (greener) time of year than during a dryer (browner) time 
of year.  
2.5 Laboratory analyses 
2.5.1 Serological detection of RVFV antibodies in livestock and 
human sera 
Considerable challenges remain in the reliable detection of RVFV antibodies, 
particularly in relation to the ability of tests to distinguish exposure to RVFV from 
other closely related phleboviruses that may be circulating in the East African 
region. In this study, livestock sera were analysed for presence of  anti-RVFV 
antibodies (IgG/IgM) using two enzyme linked immuno-sorbent assays (ELISAs), with 
results from a subset of samples compared using the virus neutralization test 
(VNT). A recombinant nucleocapsid-based in-house ELISA developed at the 
University of Glasgow was first used as screening test, with further tests carried 
out using a commercial  ID Screen® Rift Valley fever multi-species competitive 
ELISA (ID.Vet Innovative Diagnostics, Grabels, France), and an in-house VNT. Due to 
limited number of commercial ELISA kits, all in-house ELISA positive (goat and 
sheep) sera and 10% of randomly selected negative sera samples were repeated by 
commercial ID Screen® Rift Valley fever multi-species competitive ELISA. All cattle 
sera samples were tested by the commercial cELISA.  
To test for any recent infections in livestock based on anti-RVFV immunoglobulin M 
(IgM), a sub-set (14% dictated by the number of test kits available) of positive and 
negative (goat and sheep) sera samples were randomly selected and tested by 
commercial ID Screen® IgM capture ELISA as described by the manufacturer (ID.Vet 
Innovative Diagnostics, Grabels, France)  as IgM antibodies to RVFV are produced 
first before IgG and can only be detected up to two months after infection (Morvan 
et al., 1991, Paweska et al., 2003a).  All human sera samples were tested by 
commercial ID Screen® Rift Valley fever multi-species competitive ELISA. ELISA 
results were validated by virus neutralization test (VNT) of a subset of  livestock 
and  human randomly selected positive and negative samples.  
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2.5.1.1 In-house ELISA 
The assay used a recombinant nucleocapsid-based in-house ELISA developed at the 
University of Glasgow. Briefly, 6His-tagged recombinant N protein was expressed in 
E. coli and purified using nickel-affinity chromatography.  The RVFV recN protein 
was used as an antigen coated on the plates to detect presence of anti-RVFV 
antibodies in sera samples. The protein (RVFV recN) was genorously prepared by 
Dr. Ping Li, University of Glasgow. 
2.5.1.1.1 Preparation of reagents and working dilutions 
PBS (Phosphate Buffered Saline) 0.001M, pH 7.4 was prepared by dissolving 1 
sachet of PBS powder in 1L of distilled water. Wash buffer (PBS Tween 0.1%) was 
prepared by dissolving 1 ml of Tween 20  in 1 L PBS. Marvel powdered skimmed 
milk (Premier Foods, Thame, UK) was used for preparation of diluent and blocking 
buffers. Diluent buffer was prepared by adding 2% of skimmed milk in PBS (2 g milk 
in 100 ml PBS), where as blocking buffer was prepared by adding 10% of skimmed 
milk in PBS (10 g milk in 100 ml PBS). Carbonate bicarbonate buffer (for protein 
dilutions) was prepared by adding 8.4 g sodium bicarbonate (NaHCO3) and 3.56 g 
anhydrous sodium carbonate (Na₂CO₃)  in 1L distilled water. Proteins were diluted 
in carbonate bicarbonate buffer to 500ng/ml. RVF-N protein (12.5µl) was diluted in 
10 ml carbonate bicarbonate buffer. 
2.5.1.1.2 Assay Procedure 
Plates were coated by adding 100 ml (50mg) diluted RVFV-N protein  to each well of 
the ELISA plates, covered by plate sealers and incubated at 40C overnight. The next 
day protein was removed and the plate washed 3 times with wash buffer. Two 
hundred microliters of blocking buffer (10% skimmed milk in PBS) was added to 
each well, covered and incubated for 1 hour at room temperature. During the 
blocking stage, control and test sera were diluted to 1:400 in diluent buffer. After 
incubation, blocking buffer was removed and plates washed 3 times with wash 
buffer. Then 100ml diluted positive control sera was added to wells A1-2 (in 
duplicate), negative control sera to wells B1-2 of the plate, followed by 100ml of 
each of the test sera added to the remaining wells in duplicate, covered and 
incubated at room temperature for 2 hours. After washing plates 3 times with wash 
buffer, 100ml of horseradish peroxidase (HRP)-conjugated anti-species (cattle, goat 
or sheep) antibody (Thermo Fisher Scientific,  Massachusetts, USA)  diluted to 
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1:1000, was added to each well, covered and incubated at room temperature for 1 
hour. After incubation plates were washed 5 times with wash buffer and then 100ml 
of TMB (3,3',5,5'-Tetramethylbenzidine) was added to each well and the plates kept 
in the dark for 15 minutes to allow colour change. Plates were read on a Multiskan 
Ascent ELISA plate reader (MTX Lab Systems, Florida, USA) at 650nm. Arrangement 
of controls and test sera on a plate is shown in Figure 2.5. 
 
 1 2 3 4 5 6 7 8 9 10 11 12 
A C+ C+ S7 S7 S15 S15 S23 S23 S31 S31 S39 S39 
B C- C- S8 S8 S16 S16 S24 S24 S32 S32 S40 S40 
C S1 S1 S9 S9 S17 S17 S25 S25 S33 S33 S41 S41 
D S2 S2 S10 S10 S18 S18 S26 S26 S34 S34 S42 S42 
E S3 S3 S11 S11 S19 S19 S27 S27 S35 S35 S43 S43 
F S4 S4 S12 S12 S20 S20 S28 S28 S36 S36 S44 S44 
G S5 S5 S13 S13 S21 S21 S29 S29 S37 S37 S45 S45 
H S6 S6 S14 S14 S22 S22 S30 S30 S38 S38 S46 S46 
Figure 2.5 In-house plate layout showing the arrangement of control and test 
samples in plate wells. C+ = positive control, C- = negative control, S1-S46 = test 
samples. 
2.5.1.1.3 Interpretation 
A specific activity of each test serum was calculated by subtracting the background 
activity in the wells with the negative control from the specific activity in wells 
with positive control. The raw absorbance (OD) values were expressed as a 
percentage positive (PP) of the positive control, using the following formula: (Mean 
OD of test samples/Mean OD of positive control - mean OD of negative control) x 
100. A percent positive (PP) value of  ≥30% was considered to be positive. 
2.5.1.2 ID Screen® Rift Valley Fever Competition Multi-species 
ELISA 
A commercial, indirect competition ELISA (cELISA) kit (ID Screen Rift Valley fever 
multi-species ELISA; ID.Vet Innovative Diagnostics, Grabels, France) was used 
according to the manufacturer’s instructions for detecting RVFV specific 
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antibodies. Given that it is reported to have a validated high diagnostic sensitivity 
and specificity (Comtet et al., 2010, Kortekaas et al., 2013), the assay was used as 
reference for evaluating the In-house ELISA.  
2.5.1.2.1 Preparation of reagents and working dilutions 
The ID.Vet kits contained ready to use reagents which were diluted to the 
recommended concentration.  Wash Buffer (1X) was prepared by adding 50 ml of 
Wash Concentrate (20X) to 950 ml distilled water. Anti-nucleoprotein-horseradish 
peroxidase (Anti-RVF-NP-HRP Conjugate 1X) was prepared by adding 1 ml of Anti-
RVF-NP-Po conjugate (10X) to 9 ml Dilution Buffer 19. Other reagents that were 
ready to use without dilution include Dilution Buffer 19, Substrate Solution, Stop 
Solution and Control sera (Positive and Negative Control sera). 
2.5.1.2.2 Assay procedure 
Sera samples were diluted in dilution plates, where 50 µl of dilution buffer was 
added to each well of the dilution plates, followed by 50 µl of either the control 
sera or the test sera. All samples were analysed in duplicate. Next, 100µl per well 
of the diluted samples were transferred to pre-coated test plates using a 
multichannel pipette. The plates were incubated for 1 hour at 370C and then 
washed three times with 300 µl per well of washing buffer. The anti-RVF-NP-HRP 
conjugate was diluted in dilution buffer and 100 µl added per well. The plates were 
then incubated for 30 min at room temperature and washed as before, after which 
100 µl of ready-to-use TMB substrate (ID.Vet Innovative Diagnostics) was added to 
each well and incubated in the dark for 15 min. Then, 100 µl of stop solution was 
added per well and the absorbance (OD) was read at 450 nm.  
2.5.1.2.3 Interpretation 
The results were calculated as percentage inhibition (competition), using the 
following formula: Suspect or negative (S/N) = (OD Sample/OD Negative control) x 
100. A suspect or negative (S/N) value of ≤ 40% was considered to be positive, 
otherwise negative.  
Comparing the two ELISA assays (Figure 2.6), a sample was confirmed positive if it 
was tested positive by both tests (In-house and cELISA) or tested positive by the 
commercial cELISA only.  
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Figure 2.6 ELISA plates showing comparison of two assays, In-house ELISA (blue) and 
ID Screen Multi-species Competitive ELISA (yellow). Deep blue color on the top 
plate indicates specific antibody activity and no color or faint color indicates 
background activity. On the bottom plate no color or faint color indicates specific 
antibody activity whereas yellow color indicates background activity. 
2.5.1.3 ID Screen® Rift Valley Fever IgM Capture 
Immunoglobulin M (IgM) appears early in infection (5-7 days), rises rapidly in the 
disease course and can be detected within 6-8 weeks after infection (Morvan et al., 
1991), and is usually less virus cross-reactive than IgG (Martin et al., 2000). IgM 
Capture ELISA is an important assay for detection of recent viral infections. A 
commercial IgM Antibody Capture ELISA (MAC-ELISA) designed specifically to detect 
IgM antibody was used in this study to detect IgM antibodies directed against the 
Rift Valley Fever (RVF) nucleoprotein (N) in bovine, ovine and caprine serum or 
plasma. Antibody capture ELISAs use two types of antibody specific for different 
epitopes of the antigen molecule. The primary antibody (known as capture 
49 
antibody) is coated to the wells followed by adding the sample solution. Then a 
secondary enzyme linked antibody (known as detection antibody) added to detect 
the presence of the captured antigens in the sample.  
2.5.1.3.1 Preparation of reagents and working dilutions 
Wash Solution(1X) was prepared the by diluting the Wash Concentrate(20X) in 
distilled water (50 µl Wash Concentrate 20X added to 950 µl distilled water). RVF 
Nucleoprotein 10X  was prepared by adding 1ml of Reconstitution Buffer to the 
Freeze-dried RVF Nucleoprotein vial and mixed well to homogenize the solution. 
The reconstituted RVF Nucleoprotein (10X)  was then diluted to 1X concentration 
by adding 1 ml RVF Nucleoprotein to 9 ml Dilution Buffer 13. Anti-nucleoprotein-
horseradish peroxidase (Anti-RVF-NP-HRP Conjugate 1X) was prepared by adding 1 
ml of Anti-RVF-NP-Po conjugate (10X) to 9 ml Dilution Buffer 11. Other ready  to 
use reagents that were supplied in the kit include Reconstitution Buffer, Dilution 
Buffer 11, Dilution Buffer 13, Dilution Buffer 18, Substrate Solution (TMB), Stop 
Solution (0.5 M)  and Control sera (Positive and Negative Controls). 
2.5.1.3.2 Assay Procedure  
All reagents were mixed by inversion or vortexing. Plates were already pre-coated 
with anti-bovine-ovine-caprine IgM polyclonal antibodies. Samples were deposited 
in duplicate in adjacent even and odd-numbered wells (Figure 2.7). Forty 
microlitres of Dilution Buffer 18 was added to each well. Thereafter, 10 µl of the 
Negative Control was added to wells A1, B1 and A2, B2. Next, 10 µl of the Positive 
Control was added to wells C1, D1 and C2, D2. After that 10 µl of each sample to 
be tested in duplicate was added to the remaining wells (each sample was 
deposited twice in adjacent even and odd numbered wells). The plate was then 
incubated for 1 hour at 37°C. After incubation, plates were washed three times 
with approximately 300 µl per well of the Wash Solution. Then 50 µl of the RVFV 
nucleoprotein 1X was added to the even-numbered plate columns only and 50 µl of 
Dilution Buffer 13 to the odd numbered columns and incubated for 1hour at 37°C. 
Next, each well was washed three times with approximately 300 µl of the Wash 
Solution. Then 50 µl of the Conjugate 1X was added to each well, incubated for one 
hour at 37°C, after which each well was washed three times with approximately 
300 µl of the Wash Solution. Then 100 µl of the Substrate Solution was added to 
each well, incubated for 15 min at room temperature (21°C ± 5°C) in the dark to 
allow coloration, after which 100 µl of the Stop Solution was added to each well in 
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order to stop the reaction. The absorbance was read by a plate reader and 
recorded the OD at 450 nm.  
 
 D13 RVFV-
NP 
D13 RVFV-
NP 
D13 RVFV-
NP 
D13 RVFV-
NP 
D13 RVFV-
NP 
D13 RVFV-
NP 
A C- C- S5 S5 S13 S13 S21 S21 S29 S29 S37 S37 
B C- C- S6 S6 S14 S14 S22 S22 S30 S30 S38 S38 
C C+ C+ S7 S7 S15 S15 S23 S23 S31 S31 S39 S39 
D C+ C+ S8 S8 S16 S16 S24 S24 S32 S32 S40 S40 
E S1 S1 S9 S9 S17 S17 S25 S25 S33 S33 S41 S41 
F S2 S2 S10 S10 S18 S18 S26 S26 S34 S34 S42 S42 
G S3 S3 S11 S11 S19 S19 S27 S27 S35 S35 S43 S43 
H S4 S4 S12 S12 S20 S20 S28 S28 S36 S36 S44 S44 
Figure 2.7 Plate layout showing how controls, test samples and RVFV-nucleoprotein 
were added to plate wells. C+ = positive control, C- = negative control and S1-S44 = 
test samples 
  
2.5.1.3.3 Interpretation 
Results were determined by the net OD using the following formula:  
Net OD = OD even well – OD odd well.   
The test was validated if: the mean value of the net Positive Control OD (net OD 
PC) > 0.350 or the ratio of the mean values of the net Positive and Negative Control 
ODs (net ODPC and net OD NC) > 3. Results were interpreted by the S/P percentage 
(S/P %): S/P % = net OD sample/net OD PC x 100. Samples presenting a S/P 
percentage (S/P %) less than or equal to 40% were considered negative, between 
40% and 50% were considered as intermediate and greater than or equal to 50% 
were considered positive.  
2.5.1.4 Virus Neutralization Test 
Although ELISAs are convenient diagnostic tools, the virus neutralization test (VNT) 
is regarded as superior and is therefore considered the gold standard serological 
51 
assay due to its high specificity (Schreur et al., 2017).  It is a specialized type of 
immunoassay because it does not detect all antigen–antibody reactions. It only 
detects antibodies that can block (neutralize) virus replication, which is important 
because closely related groups of viruses may share common antigens, but only a 
fraction of these antigens are targets of neutralizing antibody. In this assay 
a recombinant live attenuated MP-12 strain of RVFV (rMP-12) was used. The MP-12 
attenuated vaccine strain is the only RVFV strain used outside high containment 
laboratories and can be handled at BSL-2 in USA facilities (Lokugamage et al., 
2012) and CL-3 in the UK. Strain MP-12 is different from its parental pathogenic 
RVFV strain, strain ZH548, because of the presence of 23 mutations (Ikegami et al., 
2015). The neutralisation assay presented here was performed by Dr. Agnieszka 
Szemiel (Centre for Virus Research, University of Glasgow, Glasgow, UK) 
2.5.1.4.1 Preparation of reagents and dilutions 
The overlay was prepared by mixing 1.2% Avicel solution with 2XMEM (minimum 
essential medium, Gibco) containing 4% FCS (foetal calf serum) v/v) in 1:1 ratio. 2X 
MEM was made by combining 20% (v/v) 10X Modified Eagle’s Medium (MEM) (Gibco), 
2% (v/v) L-glutamine, 0.435% (v/v) NaHCO3, diluted in distilled water. Crystal 
Violet stain was prepared by mixing 10 ml Methanol and 200 ml Ethanol absolute 
and 1 g Methyl Violet (Crystal Violet), mixed well by shaking to dissolve the methyl 
violet. Then added 100 ml Formaldehyde solution (41%) and added distilled water 
up to 1L. 
2.5.1.4.2 Assay procedure 
The Virus Neutralisation Test (VNT) was performed using Vero E6 cells,seeded a day 
prior to infection in 12 well plates at a cell density of 1.5 x 105 cells per well. The 
next day, 4-fold dilutions (from 1/32 to 1/32768) of the sera samples were 
prepared in a 96 well plate in DMEM (Dulbecco's modified eagle medium, Gibco) 
supplemented with 2% FCS (150ul per well). Then 150ul of DMEM containing 100 pfu 
of rMP-12 virus was added to diluted sera into each well and plates were incubated 
at 370C for 1h. Next the media was removed from the cells. Thereafter, 200ul of 
each mixture of serum and rMP-12 virus was added to infect confluent monolayers 
of Vero E6 cells in 12-well plates. After 1h incubation at 370C  the supernatant was 
removed, then 1ml overlay (0.6% Avicel, 2x MEM, 2% FCS) was added per well, 
incubated at 370C for 4 days, after which the cells were fixed with 1ml of 8% 
formaldehyde in PBS (v/v) per well and incubated for at least 1h at room 
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temperature. Formaldehyde and avicel overlays were removed and plates washed 
in water, then stained with crystal violet stain followed by washing the plates with 
water and left to dry. Then the plaques were counted.  
2.5.1.4.3 Interpretation  
Counts from replicate wells were averaged, and the average was multiplied by the 
dilution factor of the inoculum, which produced that number, and the volume of 
inoculum plated to calculate the plaque forming units (PFU) per mL of the original 
stock virus preparation. Results were calculated using this formula: the average 
number of plaques in replicate wells × dilution factor ÷ virus inoculum volume (in 
mL) = titer in PFU/mL.  
2.5.2 Molecular detection of Rift Valley fever virus in  Mosquitoes, 
aborted materials and milk  
Quantitative reverse transcription polymerase chain reaction (RT-qPCR) was used  
as previously described (Drosten et al., 2002) when the starting material is RNA. In 
this method, RNA is first transcribed into complementary DNA (cDNA) by reverse 
transcriptase. The cDNA is then used as the template for the qPCR reaction. 
2.5.2.1 RNA Purification from mosquito samples  
Mosquito samples collected in the field were preserved in Trizol in pools (each pool 
containing 1-25 mosquitoes). Samples stored in cryovials were transferred into 
Lysing Matrix, impact-resistant tubes containing 1.4 mm ceramic beads (MP 
Biomedicals, CA, USA) .The samples were disrupted by bead beating at 10,000 x g 
for 1min and homogenised by centrifugation. Transferred the supernatant into 
labelled RNase-free tubes. Then 300 µl of ethanol (100%) was added to each sample 
lysed in a previous step and mixed thoroughly. Next, the mixture was transferred 
into a Zymo-Spin™ IIICG Column2 in a Collection Tube (provided in the kit) and 
centrifuged at 12000 x g  for 30 seconds. The column was then transferred to a new 
collection tube and the flow-through discarded. 400 µl of RNA Wash Buffer was 
added to the column and centrifuged for 30 seconds, followed by adding 80 µl 
DNase I, incubated at room temperature (20-30°C) for 15 minutes.  The column 
was washed two times by adding 400 µl Direct-zol™ RNA PreWash to the column and 
centrifuged for 30 seconds and the flow-through discarded.  Then 700 µl RNA Wash 
Buffer was added to the column and centrifuged for 2 minutes to ensure complete 
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removal of the wash buffer and the column carefully transferred into RNase-free 
tube. RNA was eluted by adding 100 µl of DNase/RNase-Free Water directly to the 
column matrix and centrifuged for 30 seconds. RNA quantity (concentration) was 
measured by NanoDrop™ 2000  Spectrophotometer (Thermo Scientific) and RNA was 
stored frozen at -80°C. 
2.5.2.2 RNA preparation from swabs, placenta tissue  and milk 
using RNeasy® Mini Kit 
The RNA preparation process described here is based on the Qiagen RNeasy Mini kit 
with slight modification. Four volumes of 100% ethanol were added to Buffer RPE 
for a working solution, then RNA shield stabilized tissue/swabs were removed from 
the reagent using forceps. Next, 30mg of each tissue sample was added to sterile 
2ml micro centrifuge tubes with glass beads and 600µl RLT buffer (OR 200µl of milk 
sample into 600µl RLT buffer). The tissue samples were disrupted using a bead-
beater at 10000 x g for 1 minute. Milk samples were homogenised directly without 
bead beating. Next, the supernatant was pipetted to new micro centrifuge tubes, 
then 590 µl RNase free water and 10 µl Proteinase K were added and incubated at 
550 C for 10 minutes. After cooling to room temperature, the samples were 
centrifuged at 10000 x g for 3 minutes then supernatant transferred to new 
Eppendorf tubes,  0.5 volumes of 96-100% ethanol to the lysate (if 700 µl were 
transferred, then 350 µl ethanol were added and mix well by pipetting. The 700µl 
of lysate and ethanol mixture were then transferred to spin column, centrifuged 
for 3 min at maximum speed and then the supernatant was removed by pipetting.  
One volume of 70% ethanol was added to the lysate, and mixed well by pipetting, 
then 700 µl of the sample, including any precipitate were transferred to an RNeasy 
Mini spin column 16 placed in a 2 ml collection tube, lid closed and centrifuged for 
15 s at ≥8000 x g and discarded the flow-through. Next, 700 µl Buffer RW1 was 
added to the RNeasy spin column and centrifuged for 15 s at ≥8000 x g, the flow-
through discarded followed by adding 500 µl Buffer RPE to the RNeasy spin column 
and centrifuged for 15 s at ≥8000 x g discarded the flow through and added 500 µl 
of Buffer RPE to the RNeasy spin column, and centrifuged for 2 min at ≥8000 x g.  
Then the RNeasy spin column was placed in a new 1.5 ml collection tube and 50 µl 
RNase-free water was added directly to the spin column membrane, the lid was 
then closed and the tube centrifuged for 1 min at ≥8000 x g to elute the RNA. 
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2.5.2.3 Positive and negative control RNA 
Positive and negative control RNA were generously offered by Dr. Agnieszka 
Szemiel (Centre for Virus Research, University of Glasgow, Glasgow, UK). The MP-
12 viral RNA and mosquito total RNA from clean uninfected Aedes mosquitoes from 
the Centre for Virus Research, University of Glasgow, were used as positive and 
negative controls respectively. These RNA samples were extracted by the Trizol 
method as described previously (Rio et al., 2010).  Briefly, RVFV (MP-12) virus-
infected cell cultures were centrifuged at 3000 x g for 15 min and RNA was 
extracted from 100 µl aliquots of the supernatant by the Trizol method  (Gibco 
BRL, Gaithersburg, MD). Mosquitoes were homogenized in 1 ml of Trizol reagent, 
and 100 µl of the homogenates were processed for RNA extraction by the Trizol 
method. 
2.5.2.4 PCR Mastermix preparation 
The PCR mastermix was prepared in a designated RNA/DNA-free room. Reagents 
were homogenised before preparing mastermix by brief pulse-vortexing and 
centrifuging.   Master mix was prepared as indicated in Table 2.2. 
Table 2.2 PCR Master Mix components, concentrations, and volumes used in the 
test 
Component Concentration μl per 
reaction 
Final 
concentration 
Mix for 72 
rxns (36 
duplicate 
rxn) (μl) 
QuantiNovaTM 
Probe RT-PCR 
Master Mix  
2 x 10 μl 1x 720 μl 
QN Probe RT-Mix   0.2 μl 1x 14.4 μl 
20x primer–probe 
mix 1  
 
 1 μl 0.8 μM 
forward 
primer 1 
0.8 μM reverse 
primer 1 
0.2 μM TaqMan 
probe 1 
72 μl 
 
72 μl 
 
72 μl 
RNase-free water   Variable -  
RNA template   5 μl   
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Component Concentration μl per 
reaction 
Final 
concentration 
Mix for 72 
rxns (36 
duplicate 
rxn) (μl) 
Total reaction 
volume 
 20 μl -  
 
To minimise risk of contaminating stock reagents, aliquots of appropriate volumes 
were made and working aliquots stored at ~3°C. Stock reagents were stored at -
20°C until when further aliquots were required.   
2.5.2.5 Real time Quantitative Reverse Transcription Polymerase 
Chain Reaction (RT-qPCR)  
Detection of RVFV by  one-step quantitative reverse-transcription real-time PCR 
(RT-qPCR) using RNA samples was carried out as previously described by Drosten et 
al., 2002. One-step assays combine reverse transcription and PCR in a single tube, 
using a reverse transcriptase along with a DNA polymerase and utilizing sequence-
specific primers. The procedure detailed here is for the Qiagen Rotor-Gene Q/6000 
qPCR platform and associated Rotor-Gene Q Series Software for analysis. Primers 
and dual-labelled probe for RVFV Gc gene  were used for this study. Sequences are 
detailed in Table 2.3. 
Table 2.3 Sequences of Primers and Probe used in the PCR reaction 
Virus (GenBank 
accession no.) 
 
Sense primer, antisense primer, probe 
(sequence [position]) 
 
Genomic 
target 
region 
Amplicon 
length (bp) 
 
RVFV 
(AF134508)  
RVS (AAAGGAACAATGGACTCTGGTCA  
[349-371]) 
Gc gene 94 RVAs (CACTTCTTACTACCATGTCCTCCAAT 
[443-417]) 
RVP (FAM-
AAAGCTTTGATATCTCTCAGTGCCCCAA-
BHQ1 [388-416]) 
 
The reaction was set by adding 15μl of the master mix into each of the strip-tube 
wells using sterile filter pipette tips, while inside the laminar flow hood followed 
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by adding 5μl of sample RNA (template) in duplicate to each well to obtain a final 
reaction volume of 20μl.  The negative extraction control (NTC) well, and then 
positive control (RVFV- MP-12 supernatant RNA) well were added last and all caps 
secured. A 72 well rotor disc  was used for the runs in the Rotor-Gene machine and 
the cycling conditions involved reverse transcription at 45°C for 10 min, initial 
denaturation at 95°C for 5 min, and 40 cycles with 95°C for 5 s and 60°C for 30 s. 
Fluorescence was read at the combined annealing-extension step at 60°C. Curves 
produced were read in ‘linear scale’ and Ct values < 40 was considered positive. 
2.6 Statistical Analysis 
Details of specific statistical analyses for different study components are described 
in Chapters 3,4,5 and 6. Regression analysis was performed to explore 
determinants of mosquito abundance in each household, focusing on exploring 
differences between livestock and non-livestock keeping households. The response 
variable was the count (abundance) of mosquitoes in each genera collected per 
household. Type of household (livestock keeping or non-livestock keeping) and NDVI 
(relative green-ness) were included as fixed effects. Random effects were included 
at the household and village level in all models. Regression analysis was performed 
in R version 3.5.3 (R Core Team, 2018) using the glmmTMB package, and negative 
binomial regression models were used for these count data. A likelihood ratio test 
was used to assess the contribution of each fixed effect to model fit. Mosquito 
species distribution modelling was performed by Maximum Entropy (MaxEnt) 
algorithm (Phillips et. al., 2008)  and QGIS (QGIS 2.14.0 -Essen, 2016) using 
mosquito occurrence data and environmental variables to predict habitat suitability 
and the spatial distribution of potential RVFV vectors as described previously (Elith 
et. al., 2011). All Maps were produced using QGIS (QGIS 2.14.0 -Essen, 2016).  
In assessing the determinants of  RVFV seropositivity in livestock and humans the 
binomial Generalised Linear Mixed Models (GLMMs) was used to allow modelling of 
random and fixed effects of the explanatory variables  (Bolker et al., 2009). Village 
and households were considered as random effects, RVFV seropositivity was the 
response variable. In livestock (cattle, goats or sheep) fixed effects included sex, 
age, farming classification (small holder, agro-pastoral or pastoral), herd/flock 
size, animal introductions, seasonal movements/camps, history of abortions, 
presence/history of standing water/flood, history of animal deaths related to 
disease, animal management (confining cattle with small ruminants) and vector 
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habitat suitability derived from species distribution modelling detailed in Chapter 
three. Variables considered as fixed effects on seropositivity in human populations 
included occupation, sleeping in the same house as domestic ruminants, engaging 
in milking animals, birthing animals, handling placenta, handling aborted materials, 
handling animal carcasses, slaughtering animals, consuming raw meat or milk and 
seropositivity in livestock. Purposeful selection was used in variable and model 
selection as previously described (Hosmer Jr et al., 2013).   
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Chapter Three 
3 The ecology of RVFV mosquito vectors in northern 
Tanzania 
3.1 Introduction 
Rift Valley fever virus was first discovered and characterised in the Rift Valley of 
Kenya in 1931 (Daubney et al., 1931), but outbreaks probably occurred before this 
time (Gerdes, 2004). The virus is transmitted through mosquito bites or by 
exposure to infectious blood and bodily fluids (Balkhy and Memish, 2003). This 
arthropod-borne infection affects a wide range of vertebrates, but clinical disease 
is limited to domestic ruminants and humans (Gerdes, 2004).  
The virus can be transmitted by mosquitoes of at least six genera, including Aedes, 
Culex, Anopheles, Eretmapodites, Mansonia, and Coquillettidia (Bird et al., 2009) 
with over 30 different species shown to be competent vectors (Turell et al., 2008). 
Earlier studies suggest  that RVFV is transmitted  transovarially from females to 
eggs in some mosquito species of the Aedes genera (Logan et al., 1991, Gerdes, 
2004). Aedes spp emerge in huge numbers from flooded depressions in soil and 
other habitats where oviposition has occurred. These eggs can survive desiccation 
for many years between flooding periods and re-emerge as infected adult 
mosquitoes to cause major epidemics during periods of extreme rainfall (Sang et 
al., 2010, Davies et al., 1985). 
While the emergence of Aedes has been widely reported to initiate RVF outbreaks, 
virus amplification typically also involves secondary vectors such as Culex.  So far, 
all evidence implicating mosquito vectors in RVFV transmission comes from periods 
of epidemics following heavy rainfall and flooding. The role of vectors in 
maintenance of RVFV between epidemics is not well understood largely due to lack 
of evidence of detection and/or isolation of the virus from mosquitoes during the 
inter-epidemic period (IEP) (Lichoti et al., 2014a). Examining the ecology and role 
of vectors in inter-epidemic transmission is crucial for understanding RVFV 
epidemiology and control.   
In order to further understand the role of mosquitoes in inter-epidemic RVFV 
circulation, the study sought to: (1) assess the abundance, and diversity of 
mosquito vectors during an inter-epidemic period in northern Tanzania, (2) assess 
the role of household livestock ownership on the abundance of potential RVF 
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vectors, and (3) use environmental characteristics to predict mosquito vector 
distribution. 
3.2 Methods 
This section briefly describes the methods used for purposes of this chapter. 
Further details are provided in the core methods chapter (Chapter Two).  
3.2.1 Study Area 
The study was carried out in Arusha and Manyara Regions of northern Tanzania 
(Figure 3.1) where mosquitoes were sampled in November 2015, between March 
and September 2016, and between July and October 2017. Sampling included 12 of 
the 20 SEEDZ villages selected in districts across northern Tanzania, as described in 
Chapter Two. 
 
 
Figure 3.1 Map of northern Tanzania showing districts and locations of study 
villages (orange circles) where mosquitoes were collected. Map created in QGIS 
2.14.0 -Essen, 2016 using shape files for country administrative boundaries 
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available at www.diva-gis.org and geo coordinates for study sites recorded during 
the study.  
3.2.2 Mosquito Sampling 
3.2.2.1  Selection of sampling sites 
Mosquitoes were sampled from households with and without livestock in both agro-
pastoral and pastoral settings in the study area. Livestock households were 
randomly selected from a list of households selected for animal sampling by the 
SEEDZ study within a particular sub-village. Non-livestock keeping households were 
randomly selected from a list of all non-livestock keeping households in the sub-
village generated by the village and sub-village authorities. In addition to 
households, potential mosquito breeding habitats were also purposefully identified 
for mosquito trapping. Permission from community leaders and informed consent 
were sought from each head of household where mosquito trapping was carried 
out.  Geographic co-ordinates of each selected household or mosquito trapping site 
were captured using a Garmin eTrex® 10 Handheld GPS. 
3.2.2.2  Mosquito collection 
In each sub-village, one day (8 am - 6 pm) and one night (7pm - 6am) of sampling 
was carried out at each of the selected households or near the identified mosquito 
breeding habitat sites. Four mosquito trapping methods were used for mosquito 
collection: (1) BG Sentinel trap (BG) (Biogents AG, Regensburg, Germany) to target 
outdoor host seeking mosquitoes; (2) Mosquito Magnet traps (MM) (Woodstream 
Corporation,  Pennsylvania, USA) to target outdoor host seeking mosquitoes; (3) 
CDC Light traps  (LT) (John W. Hock Company, Florida, USA) to trap indoor host 
seeking mosquitoes; and (4) locally made Resting Bucket traps (RB) to sample 
outdoor resting mosquitoes as previously described (Kreppel et al., 2015). All 
mosquitoes collected were morphologically identified to genera level using 
morphological identification keys (Gillies and Coetzee, 1987, Huang, 2001, Jupp, 
1996). 
3.2.2.3  Environmental data 
Household co-ordinates were used to extract data on the normalized difference 
vegetation index (NDVI) from satellite imagery of the area surrounding the 
household at the time of the sampling visit. The NDVI quantifies the amount of 
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vegetation cover by measuring the difference between near-infrared (which 
vegetation strongly reflects) and red light (which vegetation absorbs). NDVI data 
(MOD12A3) were obtained from https://earthexplorer.usgs.gov/ for each month 
between 2015 and 2017. These data have a spatial resolution of 0.05 decimal 
degrees by 0.05 decimal degrees (around 900 x 900 metres in the study area). 
Household-level NDVI values were extracted from rasters covering the study area in 
R statistical software version 3.5.3 (R Core Team, 2018) using the raster package. 
3.2.3 Data analysis 
3.2.3.1   Determinants of mosquito vectors abundance  
Regression analysis was performed to explore determinants of mosquito abundance 
in each household, with a particular focus on exploring differences between 
livestock and non-livestock keeping households. Here the response variable was the 
count (abundance) of mosquitoes in each genera collected. Mosquitoes of a 
particular genus collected from different trapping methods were pooled per 
household. Type of household (livestock keeping or non-livestock keeping) were 
included as fixed effects. Percentage difference in NDVI was also included as a 
fixed effect to control for the relative “green-ness” of the household environment, 
and therefore the expected levels of rainfall preceding the study visit. For this, the 
percentage difference in NDVI at the household was estimated by comparing the 
NDVI for the month of the visit with the average NDVI value at that household over 
all study years (i.e. between January 2015 and December 2017). A positive 
percentage difference could be expected to reflect a “greener” than average time 
of year and therefore represent a sampling visit during a relatively wet period. A 
negative percentage difference would reflect a “browner” than average time of 
year, and therefore represent a sampling visit during a relatively dry period.  
Regression analysis was performed in R using the glmmTMB package (Brooks et al., 
2017). Poisson and negative binomial regression models were used for these count 
data. Performance of the latter compared to the former was assessed using a 
likelihood ratio test. Random effects were included at the household and village 
level in all models. A likelihood ratio test was used to assess the contribution of 
each fixed effect to model fit and the output from the full model (i.e. with all 
fixed effects) is presented.  
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3.2.3.2  Mosquito vectors distribution    
Prediction of mosquito vector distribution using environmental characteristics was 
performed on the basis the Maximum Entropy (MaxEnt) algorithm (Phillips et. al., 
2008) in QGIS (QGIS 2.14.0 -Essen, 2016).  There are a range of potential species 
distribution modelling methods (Elith et. al., 2011), with MaxEnt found to perform 
particularly well (Elith et al., 2011, Peterson, 2006, Huerta and Peterson, 2008). 
MaxEnt is a maximum entropy-based machine learning programme that estimates 
the probability distribution for a species’ occurrence based on environmental 
constraints (Phillips et al., 2006). It requires only species presence data and 
environmental variable layers for the study area and generates an estimate of the 
suitability of a particular location for the occurrence of a species that varies from 0 
to 1, with 0 being the lowest and 1 the highest suitability.  
In this study, adult mosquito occurrence data were used to model the vector 
distribution. Occurrence records and/or locations (Figure 3.2) of potential RVFV 
vectors were obtained from the study described above and unpublished data from 
an additional study that was performed in the Serengeti ecosystem between 2012 
and 2013 (Nyarobi et al.). 
 
Figure 3.2 Map of northern Tanzania showing mosquito occurrence locations used in 
species distribution modeling. Map created in QGIS 2.14.0 -Essen, 2016 using shape 
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files for country administrative boundaries available at www.diva-gis.org and geo 
coordinates of the mosquito occurrence records. 
Twenty-four environmental variables were considered as potential predictors of the 
RVFV vector species habitat distribution. These variables were chosen based on 
their biological relevance to mosquito species distributions (Phillips et al., 2006, 
Pearson et al., 2007). Nineteen bioclimatic variables related to temperature and 
rainfall generated from an interpolation of average monthly climate data from 
stations around the world (Hijmans et al., 2005) were obtained from WorldClim 
dataset (http://www.worldclim.org/bioclim.htm).  Elevation (Digital Elevation 
Model (DEM)) data were also obtained from the WorldClim website (at 1 km spatial 
resolution), and soil layers (sand, clay and silt) obtained from the World Soil 
Information (https://www.isric.org/projects/soil-and-terrain-soter-database-
programme). The variables included in the MaxEnt procedure were: 
1) Bio1 = Annual Mean Temperature  
2) Bio2 = Mean Diurnal Range (Mean of monthly (max temp – min temp))  
3) Bio3 = Isothermality (P2/P7)*(100)  
4) Bio4 =Temperature Seasonality (standard deviation*100)  
5) Bio5 = Max Temperature of Warmest Month  
6) Bio6 =Min Temperature of Coldest Month  
7) Bio7 =Temperature Annual Range (P5-P6)  
8) Bio8 =Mean Temperature of Wettest Quarter  
9) Bio9 =Mean Temperature of Driest Quarter  
10) Bio10 =Mean Temperature of Warmest Quarter  
11) Bio11 =Mean Temperature of Coldest Quarter  
12) Bio12 =Annual Precipitation  
13) Bio13 =Precipitation of Wettest Month  
14) Bio14 =Precipitation of Driest Month  
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15) Bio15 =Precipitation of Seasonality (Coefficient of Variation)  
16) Bio16 =Precipitation of Wettest Quarter  
17) Bio17 =Precipitation of Driest Quarter  
18) Bio18 =Precipitation of Warmest Quarter  
19) Bio19 =Precipitation of Coldest Quarter  
20) Elevation 
21) EVI - Enhanced vegetation index 
22) Clay soil 
23) Sand soil 
24) Silt soil 
All the 24 predictor variables were processed using QGIS (QGIS 2.14.0 -Essen, 
2016). The processing steps included clipping raster data to the extent of the study 
area and re-sampling all the predictors layers to the same spatial resolution (1 km) 
and file types (TIF/ACS). All the variables were tested for multicollinearity by 
examining cross-correlations (Pearson correlation coefficient, r) based on individual 
mosquito genera occurrence records and the randomly generated background. 
Initially 11 temperature related variables were examined, followed by eight rainfall 
related variables. Collinearity between each pair of the eight precipitation 
predictor variable layers and pairs of eleven temperature layers (Figures 3:6 - 3:8) 
was assessed using Pearson correlation analyses in R. Selection of variables from a 
set of highly cross-correlated variables (r > 0.75) was based on the potential 
biological relevance of each of a correlated pair to the occurrence and distribution 
of the genera, and the ease of interpretation (Merow et al., 2013).  
3.2.3.3  Modelling procedure 
MaxEnt software (Version 3.4.1) was used (Phillips et al., 2017) 
http://biodiversityinformatics.amnh.org/open_source/maxent/. Distribution 
modelling focused on Aedes and Culex as important primary and secondary vectors 
of RVFV in the study area. The distribution of these mosquitoes was compared with 
the distribution of Anopheles spp. Each model was run with the selected 
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temperature and rainfall variables in addition to soil, elevation and vegetation 
variables. Since the sample size was moderately low for the vector genera,  only 
linear and quadratic features were used and other settings were maintained as 
default (Phillips et al., 2004). The regularization multiplier was set to default 1 and 
number of replications set to 10 and a maximum of 5000 iterations at a 
convergence threshold of 0.00001, with cross validation replicate type in order to 
limit model over fitting. The output was set to a logistic format, so that the 
predictions of habitat suitability would assume probability scores between 0 and 1 
(Elith et al., 2006, Huerta and Peterson, 2008, Phillips et al., 2006). 
Due to the limited number of the vector occurrence localities, default settings 
were maintained without data partitioning to allow MaxEnt to employ data used to 
develop the model (also called training data) and to also test the model. The 
performance of the predictor represented by the average training gain over the 10 
replicate runs was normalized to percentages. The higher the percentage 
contribution of the predictor, the greater the importance of that particular 
variable in predicting habitat suitability for RVFV vector genera occurrence (Warren 
et al., 2010). The jacknife approach was also used to assess the contribution of 
individual variables on the basis of regularised training gain (Phillips et al., 2017). 
For this, variables were removed one at a time, and a habitat suitability model 
created using all remaining variables. Each variable was also used on its own to 
create a habitat suitability model. The training gain reflects how well the resulting 
models fit the data. MaxEnt also generates the receiver operating curve (ROC) 
curve of the full model predicting suitability of a particular vector genera. The 
area under the curve (AUC) values allow comparison of performance of one MaxEnt 
model with another. An AUC value of 0.5 indicates that the performance of the 
model is no better than random, while values closer to 1.0 indicate an excellent 
model performance. 
3.3 Results 
3.3.1 RVFV vector species abundance and composition  
A total of 2224 mosquitoes were sampled from 132 households in 12 villages 
(summarized in Table 3.1) representing five different genera including Aedes, 
Anopheles, Culex, Coquillettidia and Mansonia. The mosquitoes collected were 
morphologically identified as Aedes spp, Culex spp, Mansonia spp, Anopheles spp 
and Coquillettidia spp. Of the total mosquitoes collected, the majority were Culex 
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spp (50.5%), followed by Anopheles spp (45.0%), Mansonia spp (2.5%), Aedes spp 
(1.5%), and Coquillettidia spp (0.2%).  
Table 3.1 Mosquito species collected across study villages in northern Tanzania 
Village 
Aedes 
spp 
Anopheles 
spp 
Culex 
spp 
Coquilletidia 
spp 
Mansonia 
spp Total 
Endanyawish 0 539 43 0 0 582 
Engikareti 0 3 7 0 0 10 
Ilkerin 3 7 82 0 0 92 
Kansay 6 26 39 0 2 73 
Long 0 66 44 0 0 110 
Lositete 0 1 1 0 0 2 
Maheri 2 5 6 0 0 13 
Malambo 2 10 15 1 0 28 
Naiti 4 17 34 4 33 92 
Nambala 10 136 806 0 2 954 
Ruvu-remiti 7 194 33 0 19 253 
Sarame 0 2 13 0 0 15 
Total 34 1006 1123 5 56 2224 
 
Culex and Anopheles mosquitoes were recorded in all sampled villages and were 
the most abundant mosquitoes. The abundance of these mosquitoes was   
particularly high in three villages: Endanyawish, Nambala and Ruvu remiti. Aedes 
spp were relatively rarer and recorded in 7 out of 12 sampled villages. Mansonia 
spp were recorded in 4 villages, and Coquillettidia spp recorded in 2 villages only.    
3.3.2 Predictors of mosquito abundance 
Due to missing data, two villages (Engikareti and Lositete) were excluded from the 
regression analysis. Water points were also excluded. The number of households 
included in the regression was therefore 132. Regression analysis was also confined 
to Culex spp and Anopheles spp due to relatively low numbers of other genera 
(Aedes, Coquillettidia and Mansonia) collected. The data for both genera were 
over-dispersed and a negative binomial rather than Poisson regression was 
therefore used for analysis.  
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Although Anopheles spp abundance was higher (n=730) in livestock keeping 
households than in non-livestock households (n=233), the difference was not 
statically significant (p=0.142) in the negative binomial regression model (Table 
3.2). The difference in Culex abundance between livestock households (n=438) and 
non-livestock households (n=644) was also not statistically significant (p=0.221). 
While regression analysis was not performed for Aedes, it is notable that of the 28 
Aedes collected at households, most were from livestock keeping households (20 
versus 8 at non-livestock households).  The abundance of both Culex and Anopheles 
spp was positively and significantly associated with visiting households during a 
greener than average period (i.e. on the basis of % difference in NDVI) (p<0.001). 
 
Table 3.2 Summary of the Generalized Mixed-effect Model showing factors 
associated with Anopheles and Culex abundance in northern Tanzania 
Predictors Anopheles     Culex     
 
Estimates 95% CI P-value1 Estimates 95%CI P-value1 
Type of household 
        Livestock Ref. 
  
Ref. 
  
  Non-livestock 
0.65 0.31 - 1.41 0.275 0.71 0.38 - 1.31 0.268 
% difference in 
NDVI 
2.32 1.41 - 3.88 0.001 2.15 1.45 - 3.20 <0.001 
1 Estimated from likelihood ratio test.   
3.3.3 RVF vector genera distribution modelling 
Assessment of co linearity between each pair of the eight precipitation predictor 
variables (BI012-BIO19) and pairs of eleven temperature variables (BIO1-BIO11) 
(Figure 3.3, Figure 3.4 and Figure 3.5) demonstrated high levels of cross-
correlation. 
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Figure 3.3 Correlation matrices of (I) temperature- and (II) precipitation-related 
bioclimatic variables related to Aedes spp occurrence data. Circle size vary with 
correlation between variables ranging from 0 to 1 or 0 to -1 indicated by blue-red 
colour scale. 
 
Figure 3.4 Correlation matrices of (I) temperature- and (II) precipitation-related 
bioclimatic variables related to Culex spp occurrence data. Circle size vary with 
correlation between variables ranging from 0 to 1 or 0 to -1 indicated by blue-red 
colour scale. 
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Figure 3.5 Correlation matrices of (I) temperature- and (II) precipitation-related 
bioclimatic variables related to Anopheles spp occurrence data. Circle size vary 
with correlation between variables ranging from 0 to 1 or 0 to -1 indicated by blue-
red colour scale. 
In modelling mosquito distribution, the included environmental variables had 
variable influence on the prediction of suitability of all the three vector species 
(Table 3.3).  Precipitation of wettest month made the greatest contribution in 
predicting Aedes spp distribution, while elevation was most important in predicting 
Culex spp distribution. Enhanced vegetation index (EVI) had the greatest 
contribution to predicting the distribution of Anopheles spp.  
Table 3.3 Environmental variables used in modeling species distribution and their 
percent predictive contribution of each variable as generated by MaxEnt. 
Variable Percent contribution 
Aedes spp 
 
BIO13 = Precipitation of Wettest 
Month 28.8 
BIO3 = Isothermality 23.1 
Elevation 21.1 
EVI = Enhanced Vegetation Index 17.6 
Clay soils 9.5 
 
Culex spp 
 Elevation 26.1 
BIO4 = Temperature seasonality 23 
Clay soils 19.9 
BIO18 = Precipitation of Warmest 
Quarter 18.7 
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Variable Percent contribution 
EVI = Enhanced Vegetation Index 12.4 
 
Anopheles spp 
 EVI = Enhanced Vegetation Index 53.8 
Clay soils 25.7 
BIO4 = Temperature seasonality 9.7 
Elevation 6 
BIO18 = Precipitation of Warmest 
Quarter 4.8 
 
3.3.4 Jackknife test of regularized training gain for RVF vectors 
species habitat suitability 
The results of the jackknife regularized training gain for Aedes spp indicated that 
the environmental variable with highest gain when used in isolation was 
precipitation of the wettest month (BIO13). Removal of isothermality (BIO3) 
resulted in the largest decrease in gain, suggesting this variable had the most 
information that wasn't present in the other variables (Figure 3.6).  
 
 
Figure 3.6 Jackknife test of variable importance for Aedes spp distribution 
prediction 
 
For Culex spp, elevation had the highest gain when used in isolation and therefore 
appeared to have the most useful information by itself, while temperature 
seasonality (BIO4) decreased the gain the most when omitted (Figure 3.7). 
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Figure 3.7 Jackknife test of variable importance for Culex spp distribution 
prediction 
 
For Anopheles spp, the environmental variable that showed highest gain when used 
in isolation was enhanced vegetation index (EVI), which had the most useful 
information by itself and the same variable decreased the gain the most when  
omitted (Figure 3.8). 
 
Figure 3.8 Jackknife test of variable importance for Anopheles spp distribution 
prediction 
3.3.5 Evaluation of Model performance 
The predictive performance of the three models based on AUC values was 
considered good (Figure 3.9, Figure 3.10 and Figure 3.11). The mean test AUC and 
standard deviation for 10 replicate runs of the three vector species were 0.681 ± 
0.155 for Aedes spp, 0.765 ± 0.071 for Culex spp, and 0.675 ± 0.120 for Anopheles.  
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Figure 3.9 The Receiver Operating Characteristic (ROC) Curve or AUC for Aedes spp 
showing the mean (red) and standard deviation (blue) averaged from the 10 
replicate runs 
 
 
Figure 3.10 The Receiver Operating Characteristics (ROC) Curve or AUC for Culex 
spp showing the mean (red) and standard deviation (blue) averaged from 10 
replicate runs 
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Figure 3.11 The Receiver Operating Characteristic (ROC) Curve of AUC for 
Anopheles spp showing the mean (red) and standard deviation (blue) averaged from 
10 replicate runs 
 
3.3.6 Habitat suitability maps for RVFV vector species 
Habitat suitability maps (Figure 3.12, Figure 3.13 and Figure 3.14) show 
heterogeneous distribution of habitat suitability for the three vector species. While 
there are overlaps in many parts, the distribution of Aedes spp and Culex spp 
appears to be fragmented, whereas the distribution of Anopheles spp is more 
spread out across the study area. It is also noted that the predicted distribution of 
Aedes spp covers most parts of the Serengeti National Park and districts in western 
Serengeti, Northern and Southern parts of the Ngorongoro Conservation Area, and 
most parts of Arusha Region. Other suitable areas include Southern and Eastern 
parts of Kilimanjaro Region.  
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Figure 3.12 Predicted habitat suitability for Aedes spp in Northern Tanzania. Blue 
color indicates low suitability and red indicates high suitability. 
 
Figure 3.13 Predicted habitat suitability for Culex spp in Northern Tanzania. Blue 
color indicates low suitability and red indicates high suitability. 
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Figure 3.14 Predicted habitat suitability for Anopheles spp in Northern Tanzania. 
Blue color indicates low suitability and red indicates high suitability. 
 
3.4 Discussion 
Overall small numbers of mosquitoes were collected in this study which were 
morphologically identified as belonging to five genera, Aedes, Anopheles, Culex, 
Mansonia and Coquillettidia. The identified mosquitoes include those known as 
primary and secondary vectors for RVFV and which have been implicated in RVF 
outbreaks in Kenya (Sang et al., 2010, LaBeaud, 2011), Madagascar (Ratovonjato et 
al., 2011), Mauritania and Senegal (Diallo et al., 2005) and Saudi Arabia (Jupp et 
al., 2002). The low abundance recorded in this study is likely to reflect the period 
of sampling that mainly included dry season periods, which is known limit mosquito 
abundance and distribution (Van Peenen et al., 1972, Minakawa et al., 2002, 
Deichmeister and Telang, 2011). However, vectors can be detected in many areas 
of northern Tanzania, including during the dry season.  
In the current study, the abundance of mosquitoes collected varied across villages. 
Although the difference was not statistically significant, more Anopheles were 
collected in livestock keeping households than the non-livestock keeping 
counterparts. Similar observations were reported previously in studies involving 
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Anopheles spp carried out in Moshi, Tanzania (Mahande et al., 2007), suggesting 
that the presence of livestock at a household can attract more host seeking 
mosquitoes and therefore influence local abundance. This would also pose 
potential risk for mosquito-borne disease transmission.  
The difference in the distribution of vectors across the study villages can be 
attributed to variation in the environmental characteristics of the study area 
(Sattler et al., 2005, Minakawa et al., 1999, Sang et al., 2017). In particular, 
ecologically wetter conditions are likely to increase the number of breeding sites 
for mosquitoes resulting in an increase in the number of vectors. The most 
influential environmental predictor variable for Aedes spp, Culex spp and 
Anopheles spp were precipitation of the wettest month, temperature seasonality, 
and enhanced vegetation index (EVI), respectively. Other predictors that 
contributed to prediction of habitat suitability of the three species were clay soils, 
precipitation of the warmest quarter and elevation. Other studies have reported 
temperature, rainfall, soil types and vegetation cover (NDVI or EVI) as important 
predictors for RVFV vector distribution (Anyamba et al., 2009, Sang et al., 2010, 
Sang et al., 2017, Njenga and Bett, 2019, Minakawa et al., 2002).  
Maps developed in this study indicate heterogeneities in the distribution of suitable 
habitat for Aedes, Culex and Anopheles mosquitoes. However, there was some 
important areas of overlap in the areas of high suitability for Aedes and Culex. 
These may represent areas at particularly high risk of RVFV outbreaks. It appears 
that different genera of mosquitoes have varied ecological requirements even if 
they share similar or overlapping habitat. The identified suitable areas include 
areas within and around the Serengeti ecosystem and districts in northern 
Tanzania, in which the distribution of RVFV vector species was not known. Some of 
the highly suitable parts of the study area include those which reported repeated 
RVF outbreaks hence supporting studies that identify this region as high-risk area 
for RVF outbreaks (Anyamba et al., 2009, Mweya et al., 2015, Sindato et al., 2015, 
Sindato et al., 2016, Njenga and Bett, 2019).  
This study provides a valuable contribution to our understanding of the distribution 
of RVFV mosquito vectors in northern Tanzania, with a  previous entomological 
study on RVF vectors limited to one district (Mweya et al., 2015). The current study 
collected vector samples from 12 districts including areas that have not been 
sampled before. Although MaxEnt was used for mapping the potential distribution 
of the mosquito genera using bioclimatic variables, the suitable habitat for RVFV 
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vectors may be overpredicted in some areas (Pearson et al., 2007).  However, the 
information produced from this analysis has value for example identifying high-risk 
areas for prioritizing surveillance and disease control interventions. Since the 
mosquito genera collected include potential vectors of RVFV, other arboviruses, 
and malaria, the predicted habitat suitability maps can inform further studies, 
surveillance, and control for these pathogens.  
3.5 Conclusions 
This study describes the inter-epidemic  abundance and composition of potential 
RVFV vectors in northern Tanzania, including areas that have not been sampled 
previously. The reported occurrence and predicted distribution identifies areas of 
potential risk for RVF during inter-epidemic periods. These findings can be used by 
researchers, policy makers, government agencies to inform surveillance and 
disease control interventions.  
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Chapter Four 
4 Evaluation of the diagnostic accuracy of an indirect in-
house ELISA for detection of Rift Valley fever virus-
specific antibodies in small ruminants  
4.1 Introduction 
A number of serological methods have been used for RVF diagnosis during outbreaks 
as well as during subsequent surveillance. Commonly used serological diagnosis 
methods include the virus neutralization test (VNT), the hemagglutination 
inhibition test (HAI), the complement fixation test (CF), the indirect 
immunofluorescence assay (IFA), and the enzyme-linked immunosorbent assay 
(ELISA) (Scott et al., 1986, OIE, 2016, Gerdes, 2004, Schreur et al., 2017).  ELISA 
and VNT are used to assess the serological response to infection and are considered 
appropriate surveillance tools (Pepin et al., 2010, OIE, 2016) and can detect RVFV 
IgM and IgG antibodies as early as four to eight days after infection (Morvan et al., 
1991, Pepin et al., 2010).  The virus neutralization test is highly accurate with little 
or no cross-neutralization with other phleboviruses (Tesh et al., 1982, Pepin et al., 
2010), and is regarded by OIE as the gold standard RVF serological assay. As such it 
is generally used for vaccine potency determination and is the OIE prescribed test 
for international trade (Pepin et al., 2010, OIE, 2016). The virus neutralization test 
is highly specific and, unlike some ELISA based assays in which species-specific 
detection reagents are used, can be applied to serum from a wide range of host 
species (Mansfield et al., 2015, Schreur et al., 2017). However, VNT is laborious, 
expensive, requires five to seven days for completion, and can be performed only 
when standardized stocks of live virus and tissue cultures are available (Pepin et 
al., 2010). It can therefore only be performed in suitable biocontainment facilities  
(Pepin et al., 2010, Van Vuren and Paweska, 2009), which can be found only in 
highly specialized reference laboratories which are limited in most RVFV-endemic 
countries. Therefore, there is an increasing demand for high quality and 
procedurally safe diagnostic tests which do not involve the handling of the virus 
(Pepin et al., 2010). 
Alternatives to the RVFV VNT are being developed and validated. Several RVFV 
ELISAs have been developed and the performance of some of these compared (Van 
Vuren and Paweska, 2010, Williams et al., 2011, Kim et al., 2012, Kortekaas et al., 
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2013). ELISAs have been developed and widely applied by OIE Reference 
Laboratories (Kortekaas et al., 2013, Pepin et al., 2010). Several have been 
developed using either whole cell lysate derived from infected cells or purified 
nucleocapsid protein as antigen (Fukushi et al., 2012, Paweska et al., 2003a, 
Paweska et al., 2005). However, some of the available RVFV ELISAs are limited by 
cross-reactivity between RVFV and other closely related phleboviruses (Pepin et 
al., 2010) and are commercial assays can be expensive. In an attempt to develop a 
cheap and simplified assay procedure, the University of Glasgow developed an in-
house indirect ELISA based on the recombinant nucleocapsid protein of RVFV for 
the detection of specific antibodies in ruminant sera. In this chapter, the 
performance of the University of Glasgow's in-house ELISA was evaluated with 
reference to the widely used commercial indirect competition ELISA (cELISA) kit (ID 
Screen Rift Valley fever multi-species ELISA; IDVet Innovative Diagnostics, Grabels, 
France). Given that it has a validated diagnostic sensitivity and specificity of 100% 
(Comtet et al., 2010, Ellis et al., 2014), the kit was used as the standard reference 
for evaluating the in-house ELISA. The virus neutralization test was used as a 
confirmation test for the ELISA results. The aim of the evaluation was to assess 
whether or not the in-house ELISA method is good enough to be used for screening 
RVFV exposure in ruminants.  
4.2 Methods 
4.2.1 Selection of sera samples 
In this study, livestock sera collected in the cross-sectional study (described in 
Chapter Two) were analysed for anti-RVFV antibodies using two enzyme linked 
immuno-sorbent assays (ELISAs). These were: (1) a recombinant nucleocapsid-based 
in-house ELISA developed at the University of Glasgow; and (2) a commercial 
competition ELISA (IDvet Innovative Diagnostics, Grabels, France) as the reference 
standard for the purpose of this evaluation. Results from a subset of samples were 
also confirmed using the OIE gold standard virus neutralization test (VNT) to 
confirm the reliability of the selected reference ELISA kit. A subset of randomly 
selected sera samples were screened first using the in-house ELISA beginning with a 
set of cattle (n=44), goat (n=44) and sheep (n=44) samples. This step was carried 
out to examine the ability of the in-house assay to test RVFV antibodies in sera 
samples from three different animal species (cattle, goats and sheep). The assay 
showed clear distinct (positives and negatives as compared to control sera) results 
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for goat and sheep sera but more false positives were observed with cattle sera. 
Therefore, goat and sheep sera were screened by in-house ELISA and  retested by 
commercial cELISA, where as all cattle sera were tested by commercial cELISA. A 
subset (n=30) of randomly selected ELISA positive and negative sheep and goat sera 
were further retested with VNT as a confirmation test. Details of the three assays 
(in-house ELISA, commercial cELISA, and VNT) are described in Chapter Two. 
4.2.2 Comparing the diagnostic accuracy between the in-house 
ELISA and the commercial IDVet cELISA  
The aim of this analysis was to assess the performance of the in-house ELISA which 
is not yet validated. Although gold standard data or knowledge of past exposure of 
the samples tested was not known, cELISA was considered to be sufficiently 
reliable to constitute a gold standard or reference test. However, the use of VNT as 
gold standard was hampered by the expense of testing ~2000 samples. The 
remaining option was to use VNT first to validate cELISA using 30 samples (13 VNT+ 
and 17 VNT-), then to use the cELISA to assess the performance of the in-house 
ELISA with 1861 samples. The confirmation of results of the 30 samples with the 
VNT was blindly carried out. Results of the tests were presented in a two-by-two 
contingency table of frequencies with the rows and columns indicating the 
categories of response as dichotomous outcomes (positive/negative results) for 
each method. Table 4.1 shows true exposure/infection status as determined by a 
standard/reference method (cELISA) and rows represent the test outcome as 
determined by a new index test (in-house ELISA). Test results of sera samples were 
classified as true positive (TP) or true negative (TN) if they were in agreement with 
the reference test results; alternatively, they were considered either false positive 
(FP) or false negative (FN) if they differed from the reference test results. The test 
accuracy was calculated as the proportion of samples correctly classified by the 
test using the formula [(TP+TN)/(TP+TN+FP+FN)].  
Table 4.1 A two by two contingency table for results of the index test and the 
reference standard tests.  
 
Infection status as determined by standard test 
index test Infection positive Infection negative Total 
Test positive True positive (TP) False positive (FP) TP + FP 
Test negative False negative (FN) True negative (TN) FN + TN 
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Total TP + FN FP + FN n  
 
4.2.1 Accuracy, sensitivity and specificity of the test 
Evaluation of the performance or accuracy of a diagnostic test involves calculating 
four objective measures of test performance, namely, sensitivity, specificity, 
positive predictive value (PPV) and negative predictive value (NPV). The sensitivity 
of a test refers to the ability of the test to correctly identify those subjects with 
the disease (Wong and Lim, 2011). Specificity refers to the ability of the test to 
correctly identify those subjects without the disease (Wong and Lim, 2011). Positive 
predictive value (PPV) is a measure of how likely is it that the subject has the 
disease given that the test result is positive, whereas negative predictive value 
(NPV) shows how likely is it that the subject does not have the disease given that 
the test result is negative. 
The sensitivity and specificity of a quantitative test are dependent on the cut-off 
value above or below which the test is positive. In general, the higher the 
sensitivity, the lower the specificity, and vice versa (Lalkhen and McCluskey, 2008). 
It is therefore recommended to subject samples that are initially positive to a 
screening test with high sensitivity/low specificity, to a second test with low 
sensitivity/high specificity or a reference test with high specificity and sensitivity. 
The selection of a cut-off value allowed test results to be divided into positive or 
negative categories. The test accuracy, sensitivity, specificity, positive predictive 
value, and negative predictive value, were calculated using the following formulas. 
Accuracy = (True positive + True negative)/Total population 
True positive fraction (TPF, sensitivity) = True positives/disease positives 
True negative fraction (TNF, specificity) = True negatives/Condition negatives 
Positive predictive value (PPV) = True positives/Test outcome positives 
Negative predictive value (NPV) = True negatives/Test outcome negatives 
4.2.2 Determining the cut-off points for the in-house ELISA 
The cut-off points for the in-house ELISA was determined by the receiver operator 
characteristic (ROC) curve. The ROC curve is a plot of (1−specificity) of a test on 
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the x-axis against its sensitivity on the y-axis for all possible cut-off points (Lalkhen 
and McCluskey, 2008, Hajian-Tilaki, 2013). ROC analysis is used in epidemiology to 
quantify how accurately diagnostic tests can discriminate between two disease 
exposure status, typically referred to as "disease positive" and "disease negative" 
(Green and Swets, 1966, Hajian-Tilaki, 2013). ROC analysis avoids distortion of the 
accuracy indices by fluctuations caused by the use of arbitrarily chosen decision 
criteria or cut-offs (Hajian-Tilaki, 2013). The area under the curve (AUC) 
represents the overall accuracy of a test, with values ranging from 0.5 (purely 
random discrimination) to 1.0 (perfect discrimination) indicating 100% sensitivity 
and specificity (Hanley and McNeil, 1982, Hajian-Tilaki, 2013). ROC curve analysis 
was used to determine diagnostic sensitivity and specificity for a range of cut-off 
values of the in-house ELISA test. easyROC, a web-tool constructed with the R 
package shiny for ROC curve analysis (version 1.3.1), was used as described by 
(Goksuluk et al., 2016). This tool is freely available through 
www.biosoft.hacettepe.edu.tr/easyROC. 
4.3 Results 
4.3.1 Confirmation of diagnostic accuracy of the commercial cELISA 
using VNT as the gold standard 
In validating the cELISA against the VNT, results summarised in Table 4.2, the 
accuracy was 97% (95% CI: 83-100%; one false negative out of 30 samples) 
indicating high performance of the cELISA at replicating the VNT results. 
Therefore, cELISA was used as reference test for evaluating the in-house ELISA. 
Results are summarised in Table 4.3. 
 
Table 4.2 Summary results of the test outcomes of the virus neutralization test 
(standard) and the commercial competition ELISA 
 
Virus neutralization test (VNT) 
 
cELISA RVFV positive RVFV negative Total 
Test positive 12 0 12 
Test negative 1 17 18 
Total 13 17 30 
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Table 4.3 Test outcomes of the commercial competition ELISA (reference) and the 
in-house ELISA, where percent positivity, PP >30  is taken as diagnostic of RVFV 
exposure using the in-house ELISA. 
 
cELISA 
 Inhouse ELISA RVFV positive RVFV negative Total 
Test positive 71 1100 1171 
Test negative 5 685 690 
Total 76 1785 1861 
 
4.3.2 Selection of cut -off point for the in-house ELISA 
The cut-off value for an ELISA can be adjusted for different target populations as 
well as for different diagnostic purposes (Jacobson, 1998).  The ROC curve analysis 
covers the whole range of possible PP values, giving corresponding sensitivity and 
specificity estimates. The distribution graphs in Figure 4.1 shows the pattern of 
distribution of the RVFV exposed and not exposed populations as identified by the 
in-house ELISA with suggested optimum cut-off. Table 4.4 shows the criterion 
values and coordinates of the ROC curve with PP cut-off values of the in-house 
ELISA ranging between 20 and 80. Applying the optimum cut-off of 43, the in-house 
ELISA  had a sensitivity of 0.73, 95% CI (0.61 - 0.82), specificity 0.68, 95% CI (0.66 - 
0.71), positive predictive value 0.09, 95% CI ( 0.08 - 0.15), and negative predictive 
value 0.98, 95% CI (0.97 - 0.99). At the cut-off point of 30 which was initially used 
for sample screening the sensitivity and specificity of the test was 0.95 and 0.33 
respectively. 
Table 4.4 Different cut-off points of the in-house ELISA and their corresponding 
sensitivity, specificity, positive likelihood ratio and negative likelihood ratio. 
Cut-off 
(PP) 
Sensitivity 
(95%CI) 
Specificity 
(95%CI) PLR (95%CI) NLR (95%CI) 
≥20 1.00 (0.95, 1.00) 0.22 (0.20, 0.24) 1.28 (1.25, 1.31) 0.00 (0.00, 0.00) 
≥25 0.97 (0.91, 1.00) 0.29 (0.27, 0.31) 1.36 (1.30, 1.43) 0.09 (0.02, 0.36) 
≥30 0.93 (0.85, 0.98) 0.38 (0.36, 0.41) 1.52 (1.41, 1.63) 0.17 (0.07, 0.40) 
≥35 0.83 (0.73, 0.91) 0.54 (0.51, 0.56) 1.79 (1.60, 2.00) 0.32 (0.19, 0.52) 
≥40 0.74 (0.62, 0.83) 0.65 (0.63, 0.67) 2.09 (1.81, 2.43) 0.41 (0.28, 0.59) 
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Cut-off 
(PP) 
Sensitivity 
(95%CI) 
Specificity 
(95%CI) PLR (95%CI) NLR (95%CI) 
≥45 0.67 (0.55, 0.77) 0.73 (0.71, 0.75) 2.48 (2.08, 2.95) 0.45 (0.33, 0.62) 
≥50 0.61 (0.49, 0.72) 0.80 (0.78, 0.82) 3.05 (2.49, 3.74) 0.49 (0.37, 0.65) 
≥55 0.54 (0.42, 0.65) 0.85 (0.83, 0.87) 3.59 (2.84, 4.55) 0.54 (0.42, 0.69) 
≥60 0.45 (0.33, 0.57) 0.89 (0.87, 0.90) 3.97 (3.00, 5.27) 0.62 (0.51, 0.76) 
≥65 0.42 (0.31, 0.54) 0.91 (0.89, 0.92) 4.58 (3.39, 6.19) 0.64 (0.53, 0.77) 
≥70 0.36 (0.25, 0.47) 0.93 (0.91, 0.94) 4.80 (3.40, 6.78) 0.70 (0.59, 0.82) 
≥75 0.30 (0.20, 0.42) 0.94 (0.93, 0.95) 4.91 (3.34, 7.23) 0.74 (0.64, 0.86) 
≥80 0.25 (0.16, 0.36) 0.95 (0.93, 0.96) 4.55 (2.95, 7.03) 0.79 (0.70, 0.90) 
                                              
The ROC curve analysis shows the area under a ROC curve, AUC = 0.77, 95% CI (0.72 
- 0.82) which is greater than 0.5 suggesting that the assay performs better than 
random chance (dotted line in the ROC curve, Figure 4.1). In Figure 4.1 the 
sensitivity and specificity of the in-house ELISA have been plotted against the 
whole range of possible PP values. The cross-over point of the two lines, indicate 
optimal sensitivity and specificity suggesting that a PP value at that point is the 
best possible cut-off value for minimizing both false positive and false negative 
results.  
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Figure 4.1 The ROC curve and distribution graphs of test results showing the cut-off 
points, corresponding sensitivity and specificity and distribution of positive and 
negative samples 
 
4.4 Discussion 
Enzyme linked immunosorbent assays (ELISAs) are widely used for RVF serological 
surveys. However, most of the commercially available ELISA kits are expensive 
hence the pressing need for a cheap, safe and simplified assay. The University of 
Glasgow's in-house ELISA the performance of which was assessed in this study in 
comparison with the commercial ELISA sought to bridge this gap. However, the 
evaluation results showed the assay to have lower accuracy as compared to that of 
the commercial cELISA. The low level of agreement between the two assays 
suggest that the in-house ELISA ability to correctly detect RVFV antibodies in 
infected subjects does not match up that of the cELISA.  
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In this study, ROC curve analysis determined a PP cut-off value of 43 for the assay 
to attain an equilibrium between sensitivity and specificity. The associated area 
under a ROC curve, AUC of 0.77, which is greater than 0.5 suggests that the assay 
performs better than random chance but it is not a high-perfoming test. An 
uninformative test (one no better at identifying true positives or negatives than 
flipping a coin) would have an AUC of 0.5 (Hajian-Tilaki, 2013).  
In addition, the poor specificity of the in-house ELISA, and its inability to 
distinguish results on cattle samples, suggest that the assay could be detecting 
cross-reactivity from other possible viral infections in the field collected samples. 
Livestock in endemic countries including Tanzania could be exposed to many other 
closely related viral infections. However, the sensitivity of 93% at a cut-off of 
PP>30 suggest that in cases where large numbers of samples need to be tested, the 
assay can still be useful as screening test prior to performing a confirmatory test 
for detecting RVFV specific antibodies to save some cost during high throughput 
testing. 
In comparing the cELISA with VNT, the accuracy of cELISA was 97%, but only a small 
number of samples (n=30) were used. The high accuracy of the cELISA in relation to 
the VNT supports the use of the cELISA as a standard reference for assessing the in-
house ELISA and its use for epidemiological surveys in Tanzania. 
4.5 Conclusion 
Although the recombinant RVFV nucleoprotein based in-house ELISA evaluated in 
this study performs poorly in comparison to the cELISA, particularly in relation to 
test specificity, the test could have application for high throughput screening of 
samples from RVF endemic regions.  
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Chapter Five 
5 Inter-epidemic seroprevalence and risk factors for Rift 
Valley fever virus seropositivity in domestic ruminants 
and human populations in northern Tanzania 
5.1 Introduction 
Rift Valley fever epidemics in Tanzania over the past 50 years have occurred at 
intervals of 10 - 20 years with major outbreaks reported in 1977, 1997/98 and 
2006/2007. Although there are some evidence of inter-epidemic RVFV infection in 
livestock and humans in endemic countries as reported by studies in Tanzania 
(Sumaye et al., 2015, Sumaye et al., 2013, Ahmed et al., 2018), Rwanda (Umuhoza 
et al., 2017), Kenya (LaBeaud et al., 2008, Lichoti et al., 2014a), Uganda (Magona 
et al., 2013, Nyakarahuka et al., 2018), Mauritania (Rissmann et al., 2017) and 
Egypt (Mroz et al., 2017), it is not fully understood how the virus persist during the 
inter-epidemic period. There are also questions on the dominant mode of animal-
to-animal and animal-to-human transmission between the epidemics. During 
epidemics, animal infections are attributed mostly to floodwater mosquitoes, 
which feed on viraemic animals and subsequently transmit RVFV to other animals 
and potentially to humans. Human infections are also linked to exposure to 
infectious animal tissues or bodily fluids such as the abortus, birthing fluids, milk, 
or blood. However, key elements of transmission during the inter-epidemic period 
are not well understood. Understanding which forms of exposure in both people 
and animals provide the greatest RVFV transmission risk between the epidemics 
may be useful for targeting interventions and public health education which can 
prevent future outbreaks or further spread of the virus to other areas. The aims of 
this study therefore were to: (1) determine whether inter-epidemic livestock and 
human RVFV transmission occurs in northern Tanzania, an area that has 
experienced repeated RVF outbreaks; (2) assess the risk factors associated with 
inter-epidemic RVFV infection in livestock and humans in northern Tanzania; and 
(3) evaluate whether seropositivity and risks differ amongst agro-ecological settings 
in northern Tanzania. 
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5.2 Methods 
5.2.1 Study Area 
The study was carried out in three regions of northern Tanzania, namely Arusha 
Kilimanjaro and Manyara Regions, with samples collected between 2013 and 2016 
as part of the Social, Economic and Environmental Drivers of Zoonoses project 
(SEEDZ) and an earlier study on bacterial zoonoses (“The Impact and Social Ecology 
of Bacterial Zoonoses in Northern Tanzania” project (BacZoo)). Sampled villages  
included pastoral, agro-pastoral and small-holder communities. Details of these 
studies are described in Chapter two.  Briefly, the SEEDZ study involved 20 villages 
randomly selected in Arusha and Manyara Regions using a Generalised Random 
Tessellation Stratified (GRTS) sampling approach (McDonald, 2004, Stevens Jr and 
Olsen, 2004). The BacZoo samples and data used in this study were collected from 
15 villages randomly selected from villages in the Kilimanjaro and Arusha Regions  
(BacZoo). Selected villages from both studies are shown in Figure 5.1. 
 
Figure 5.1 Map of northern Tanzania showing regions (Arusha, Kilimanjaro and 
Manyara), districts and location of the 35 study villages in the study area. 
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5.2.2 Sample collection  
The sampling procedure for the SEEDZ study is described in the methods chapter. 
Briefly, livestock keepers in each sub-village were encouraged to bring their 
animals to a central point in the subvillage. Ten households from those who 
attended were randomly selected for recruitment into the study and a target of 10 
cattle, sheep and goats selected in each household for sampling. In cases where a 
household had less than 10 animals in a herd or flock, all animals would be 
sampled. A 10ml blood sample was collected by jugular venepuncture and about 2-
5 ml of sera was obtained from each blood sample. For the BacZoo study, a list of 
all livestock keeping households in each village was generated and up to six 
households randomly selected. Households were visited and, where numbers 
allowed, 12 of each of cattle, sheep and goats were sampled. Animal blood 
collection was carried out as described in the SEEDZ study.  
A household questionnaire survey was carried out in households in which livestock 
sampling took place to collect data on household characteristics, demographics, 
and livestock management practices. In a random selection of SEEDZ study 
households, 10 ml of whole blood was collected from all assenting and/or 
consenting household members who had been occupant for the past 12 months and 
who were 5 years or older. An individual-level questionnaire focusing on risk factors 
for zoonotic disease was also conducted. Human blood samples and individual level 
questionnaire data were collected from all BacZoo households. Human blood 
sampling was performed by a medically qualified practitioner from Kilimanjaro 
Christian Medical Centre (KCMC) using vacuum extraction method as per World 
Health Organization guidelines (WHO, 2010). Serum samples obtained from 
livestock and human subjects were used for serological testing of RVFV exposure. 
5.2.3 Laboratory analyses 
In this study, livestock sera were analysed for anti-RVFV antibodies using two 
enzyme linked immuno-sorbent assays (ELISAs). A recombinant nucleocapsid-based 
in-house ELISA developed at the University of Glasgow was first used as screening 
test, then results confirmed using a commercial ELISA (ID Screen® Rift Valley fever 
multi-species ELISA; IDvet Innovative Diagnostics, Grabels, France).  
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All human sera samples were tested by commercial ID Screen® Rift Valley fever 
multi-species competitive ELISA. ELISA results were validated by virus 
neutralization test (VNT) of a subset of randomly selected (30 livestock and 30 
human) positive and negative samples. Since the commercial ELISA showed close 
agreement with results of the VNT, it was used as a method of choice for all 
livestock and human samples and results presented here are based on the 
commercial ELISA assay. Details of the assays and how the choices were made are 
described in Chapters two and four of the thesis, respectively. 
5.2.4 Statistical Analysis 
Statistical analyses were performed using R version 3.5.3 (R Core Team, 2018). The 
associations between the response variable and explanatory variables were 
assessed using binomial generalised linear mixed models (GLMMs), also known as 
mixed-effects logistic regression. Considering the hierarchical nature of the data, 
containing clusters of non-independent observational units such as village and 
households, GLMMs were the method of choice for modelling of random and fixed 
effects of the explanatory variables  (Bolker et al., 2009). GLMMs allows 
assessment of how the response variable is impacted by variation among individuals 
and variation among clusters/levels. Random effects allow estimation of variance 
in the response variable between  groups (clusters), and reduces the probability of 
false positives (Type I errors) and false negatives (Type II errors) (Harrison et al., 
2018). In this study, village and households were considered as random effects, 
RVFV seropositivity in livestock (cattle, goats or sheep) was the response variable, 
and other variables were considered as fixed effects. These fixed effects included 
sex, age, farming classification (small holder, agro-pastoral or pastoral), herd/flock 
size, animal introductions, use of seasonal movements/camps, history of abortions, 
presence/history of standing water/flooding in the household, history of animal 
deaths related to disease, animal management (confining cattle with small 
ruminants) and vector habitat suitability derived from species distribution 
modelling detailed in chapter three. Variables considered as fixed effects for 
seropositivity in people included occupation, sleeping in the same house as 
domestic ruminants, engaging in milking animals, birthing animals, handling 
placenta, handling aborted materials, handling animal carcasses, slaughtering 
animals, consuming raw meat or milk and seropositivity in livestock. Model 
selection was  based on purposeful selection as proposed by Hosmer and Lemeshow 
(Hosmer Jr et al., 2013). The purposeful selection process began with a univariable 
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analysis of each variable. Any variable that had a Wald test p-value < 0.25 from the 
mixed-effects logistic regression was selected as a candidate for the multivariable 
analysis (Bursac et al., 2008). A backward selection procedure was then used to 
remove variables from the model that were non-significant and which did not act 
as important confounders of other effects in the model. Significance was evaluated 
at the 0.05 alpha level and confounding as a change in any remaining parameter 
estimate greater than 20% when comparing the full model with the model without 
the confounder (Bursac et al., 2008, Hosmer Jr et al., 2013). At the end of this 
iterative process of deleting, refitting, and verifying, the model contained all 
significant covariates and potential confounders.  
5.3 Results 
5.3.1 Seroprevalence in livestock 
This study tested 3582 cattle, 3303 goats and 2586 sheep samples collected from 
537 households in northern Tanzania. The overall RVFV seroprevalence based on 
anti RVFV antibodies in livestock in northern Tanzania was 2.8% (n=9471, 95% 
CI:2.5-3.2), with higher seroprevalence in cattle 4.4% (n=3582, 95% CI:3.7-5.1),  
than in sheep 2.6%, (n=2586, 95% CI: 2.0-3.3) and goats 1.4% (n=3303; 95%CI: 1.0-
1.8). The odds of seropositivity in goats was about 70% less as compared to cattle 
(OR = 0.3, CI: 0.2-0.4, p<0.01) and the odds of seropositivity in sheep was 50% less 
as compared to cattle (OR=0.5, CI: 0.4-0.7, p<0.001)  In addition, anti RVFV IgM  
was detected in 7.5% (n=255, 95% CI: 4.7-11.6) of goats and 12.8% (n=180, 95% CI: 
8.4-18.7) sheep samples tested.  
Overall seropositivity varied across age groups. The odds of seropositivity increased 
1.3 times with increase in age by one year (OR=1.3, CI: 1.2-1.4, p<0.001). In this 
study seropositivity was detected in young animals (1-2 years) and increased with 
age in all three species (Figure 5.2 and Figure 5.3).   
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Figure 5.2 A plot of RVFV seroprevalence in different age groups of cattle in 
northern Tanzania 
 
 
Figure 5.3 A plot of seroprevalence in different age groups of small ruminants 
(sheep and goats) in northern Tanzania 
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Seroprevalence varied between villages (Table 5.1), ranging from 0% to 13%. In 
cattle seroprevalence varied by about 2 times (MOR = 2.12) between villages and 
almost 3 times (MOR=2.6) between households. In sheep, seroprevalence was 
notably higher in Ruvu remiti (23%) and generally low in other villages (Table 5.1) 
varying by around 3 times (MOR=3.2) between villages and 5 times (MOR=5.5) 
between households. Whereas in goats seroprevalence varied by almost 4 times 
(MOR=3.6) between villages and about 4 times (MOR=3.6) between households. The 
distribution of village-level seroprevalence in livestock  across northern Tanzania is 
shown in Figure 5.4. 
 
Figure 5.4. Map of northern Tanzania showing study regions, districts and the 
village-level seroprevalence in livestock  
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5.3.2 Risk factors for RVFV Seropositivity in livestock 
5.3.2.1 Univariable logistic regression analysis of risk factors for RVFV 
seropositivity in livestock 
Univariable analysis identified potential risk factors considered for inclusion in the 
multivariable analysis. Some of the variables were statistically significant (p<0.05) in the 
univariable analyses. These included species, sex, age, history of livestock abortions, use of 
seasonal camps, confining cattle with small ruminants, and mosquito vector suitability. Table 
5.2, Table 5.3 and Table 5.4 summarizes the potential risk factors for cattle, goats and sheep 
that were examined to be considered for inclusion in the multivariable logistic regression 
analysis.  
 
Table 5.2 Univariable analysis of risk factors RVFV seropositivity in cattle in northern Tanzania 
Variable 
 
 Tested 
(n) 
Positive  
(n (%)) OR 95% CI P- value 
Cattle 
     Sex 
     Female 2409 128 (5.3) Ref. Ref. Ref. 
Male 1169 28 (2.4) 0.4 0.3 - 0.7 <0.001 
Age 
     Age (years) 3582 156 (4.4) 1.2 1.1 - 1.2 <0.001 
      Farming classification 
Small-holder 146 7 (4.8) Ref. Ref. Ref. 
Agro-pastoral 973 35 (3.6) 0.7 0.3 - 1.7 0.479 
Pastoral 2463 114 (4.6) 0.9 0.4 - 2.1 0.926 
Herd size 
     Number of cattle  1.1 1.0 - 1.3 0.0389 
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Variable 
 
 Tested 
(n) 
Positive  
(n (%)) OR 95% CI P- value 
Number of cross breed cattle 0.7 0.4 - 1.3 0.272 
Number of exotic breed cattle 0.9 0.8 - 1.2 0.677 
Cattle introduced into compound 
No 2433 114 (4.7) Ref. Ref. Ref. 
Yes 973 37 (3.8) 0.8 0.6 - 1.2 0.259 
Cattle free range 
No 3250 144 (4.4) Ref. Ref. Ref. 
Yes 153 7 (4.6) 1.0 0.5 - 2.3 0.932 
Cattle herding 
No 298 12 (4.0) Ref. Ref. Ref. 
Yes 3109 139 (4.5) 1.1 0.6 - 2.0 0.757 
Cattle zero grazing 
No 3137 144 (4.6) Ref. Ref. Ref. 
Yes 266 7 (2.6) 0.5 0.3 - 1.2 0.142 
Cattle ronjo (seasonal camps) 
No 1553 52 (3.4) Ref. Ref. Ref. 
Yes 1164 57 (4.9) 1.5 1.0 - 2.2 0.043 
Graze cattle with small ruminants 
No 2605 118 (4.5) Ref. Ref. Ref. 
Yes 801 33 (4.1) 0.9 0.6 - 1.3 0.622 
Confine cattle with small ruminants 
No 3178 148 (4.7) Ref. Ref. Ref. 
Yes 228 3 (1.3) 0.3 0.1 - 0.8 0.0269 
See buffalo in village 
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Variable 
 
 Tested 
(n) 
Positive  
(n (%)) OR 95% CI P- value 
No 2365 90 (3.8) Ref. Ref. Ref. 
Yes 486 23 (4.7) 1.3 0.8 - 2.0 0.341 
Standing water in the compound 
No 3116 140 (4.5) Ref. Ref. Ref. 
Yes 285 11 (3.8) 0.8 0.5 - 1.6 0.62 
Cattle abortion 
No 2468 95 (4.0) Ref. Ref. Ref. 
Yes 936 56 (6.0 1.6 1.1 - 2.2 0.0074 
Cattle death by disease 
No 1963 65 (3.3) Ref. Ref. Ref. 
Yes 888 48 (5.4) 1.7 1.1 - 2.4 0.00857 
Aedes spp suitability  2.6 1.4 - 4.6 0.0018 
Culex spp suitability  2.1 1.1 - 3.8 0.0182 
 
Table 5.3 Univariable analysis of risk factors for RVFV seropositivity in goats 
Variable 
Tested 
(n) 
Positive 
(n (%)) OR 95% CI P- value 
Sex 
     Female 2533 40 (1.6) Ref. Ref. Ref. 
Male 770 5 (0.7) 0.4 0.2 - 1.0 0.0592 
Age 
  
1.6 1.4 - 1.8 <0.001 
Farming Classification 
Small holder 424 2 (0.5) Ref. Ref. Ref. 
Agro-pastoral 683 7 (1.0) 2.2 0.5 - 10.6 0.3311 
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Variable 
Tested 
(n) 
Positive 
(n (%)) OR 95% CI P- value 
Pastoral 2196 36 (1.6) 3.5 0.8 - 14.7 0.0843 
Flock size 
    Number of goats  
 
1.1 0.8 - 1.4 0.676 
Number of exotic breed goats 1.3 1.1 - 1.5 0.00204 
Goats intro into compound 
No 2440 35 (1.4) Ref. Ref. Ref. 
Yes 716 9 (1.3) 0.9 0.4 - 1.8 0.722 
Goats free range 
No 2964 34 (1.2) Ref. Ref. Ref. 
Yes 192 10 (5.2) 4.7 2.3 - 9.7 <0.001 
Goats herding 
No 475 12 (2.5) Ref. Ref. Ref. 
Yes 2681 32 (1.2) 0.5 0.2 - 0.9 0.0257 
Goats ronjo (seasonal camps) 
No 1472 17 (1.2) Ref. Ref. Ref. 
Yes 710 10 (1.4) 1.2 0.6 - 2.7 0.616 
Graze cattle with small ruminants 
No 2421 30 (1.2) Ref. Ref. Ref. 
Yes 721 14 (2.0) 1.6 0.8 - 2.9 0.181 
Confine cattle with small ruminants 
No 2945 42 (1.4) Ref. Ref. Ref. 
Yes 211 2 (1.0) 0.7 0.2 - 2.8 0.57 
See buffalo in village 
No 1932 22 (1.1) Ref. Ref. Ref. 
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Variable 
Tested 
(n) 
Positive 
(n (%)) OR 95% CI P- value 
Yes 373 5 (1.3) 1.2 0.4 - 3.1 0.74 
Standing water in the compound 
No 2849 39 (1.4) Ref. Ref. Ref. 
Yes 294 5 (1.7) 1.3 0.5 - 3.2 0.645 
Goats abortion 
No 1722 15 (1.0) Ref. Ref. Ref. 
Yes 1434 29 (2.0) 2.4 1.3 - 4.4 0.00763 
Goats death by disease 
No 1095 11 (1.0) Ref. Ref. Ref. 
Yes 1210 16 (1.3) 1.3 0.6 - 2.8 0.48 
Aedes spp suitability  1.8 1.5 - 2.3 <0.001 
Culex spp suitability  2.0 1.3 - 2.6 <0.001 
 
Table 5.4 Univariable analysis of risk factors for RVFV seropositivity in sheep 
Variable 
Tested 
(n) 
Positive 
(n (%)) OR 95% CI P- value 
Sex 
     Female 1971 62 (3.2) Ref. Ref. Ref. 
Male 615 5 (1.0) 0.3 0.1 - 0.6 0.00319 
Age (years) 1.5 1.3 - 1.7 <0.001 
Farming classification 
Small-holder 89 1 (1.1) Ref. Ref. Ref. 
Agro-pastoral 458 1 (0.2) 0.2 0.0 - 3.1 0.246 
Pastoral 2039 65 (3.2) 2.9 0.4 - 21.1 0.294 
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Variable 
Tested 
(n) 
Positive 
(n (%)) OR 95% CI P- value 
Flock size (continuous) 1.1 0.9 - 1.3 0.0976 
Sheep intro into compound 
No 1984 42 (2.1) Ref. Ref. Ref. 
Yes 492 19 (4.0) 1.8 1.1 - 3.2 0.0277 
Sheep herding 
No 316 5 (1.6) Ref. Ref. Ref. 
Yes 2160 56 (2.6) 1.7 0.7 - 4.2 0.284 
Sheep ronjo (seasonal camps) 
No 1222 19 (1.6) Ref. Ref. Ref. 
Yes 625 32 (5.1) 3.4 1.9 - 6.1 <0.001 
Graze cattle with small ruminants 
No 1857 55 (3.0) Ref. Ref. Ref. 
Yes 619 6 (1.0) 0.3 0.1 - 0.7 0.00855 
Confine cattle with small ruminants 
No 2340 59 (2.5) Ref. Ref. Ref. 
Yes 136 2 (1.5) 0.6 0.1 - 2.4 0.448 
See buffalo in village 
No 1582 45 (3.0) Ref. Ref. Ref. 
Yes 380 7 (2.0) 0.6 0.3 - 1.4 0.278 
Standing water in the compound 
No 2219 53 (2.4) Ref. Ref. Ref. 
Yes 255 8 (3.1) 1.3 0.6 - 2.8 0.467 
Sheep abortion 
No 1449 23 (1.6) Ref. Ref. Ref. 
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Variable 
Tested 
(n) 
Positive 
(n (%)) OR 95% CI P- value 
Yes 1027 38 (3.7) 2.38 1.4 - 4.0 0.00117 
Sheep death by disease 
No 1065 21 (2.0) Ref. Ref. Ref. 
Yes 887 31 (3.5) 1.82 1.0 - 3.2 0.0369 
Aedes spp suitability (continuous) 1.01 0.8 - 1.3 0.949 
Culex spp suitability (continuous) 0.80 0.6 - 1.0 0.0818 
 
5.3.2.2 Multivariable logistic regression analysis of risk factors for 
seropositivity in livestock 
Factors included in the multivariable model for all livestock species combined include age of 
livestock, species, age, occurrence of abortions, and confining cattle with small ruminants. 
Two factors (age and abortions) were observed as significant for all three livestock species 
combined as well as for sheep and goats when species were treated separately. Table 5.5 
summarises risk factors as identified by the multivariable models for all species, cattle, goats 
and sheep respectively. 
Table 5.5 Multivariable analysis of risk factors for RVFV seropositivity in all species combined, 
cattle, goats and sheep in northern Tanzania 
Variable OR 95% CI P-value 
All species combined 
  Species 
   Cattle ref. ref. ref. 
Goats 0.4 0.3 - 0.6 <0.001 
Sheep 0.8 0.5 - 1.1 0.100 
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Variable OR 95% CI P-value 
Age (years) 1.3 1.2 - 1.3 <0.001 
Abortions in past 12 months 1.5 1.1 - 2.1 0.017 
Cattle 
   Age (years) 1.2 1.1 - 1.3 <0.001 
Confine cattle with small 
ruminants 0.2 0.1 - 0.9 0.035 
Goats 
   Age (years) 1.6 1.4 - 1.8 <0.001 
Abortions in past 12 months 2.5 1.1 - 5.4 0.023 
Sheep 
   Age (years) 1.7 1.4 - 2.1 <0.001 
Abortions in past 12 months 2.7 1.1 - 6.3 0.025 
 
Cattle had higher odds of seropositivity than sheep and goats. The odds of seropositivity 
increased with age of animals of all species. Seropositivity in cattle increased 1.2 times with 
each increase in age by one year and herds that confined cattle with small ruminants were 
about 0. 2 times more likely to be seropositive. In goats and sheep, seropositivity increased 
about 2 times with increase in age by one year. On the other hand, the odds of seropositivity 
in goats and sheep from flocks that had abortions were about three times higher than those 
with no record of abortions.   
5.3.3 Seroprevalence in humans 
In humans, the overall RVFV seroprevalence was 8.5% (n=565, 95% CI: 6.4 - 11.2). Although the 
difference in exposure between males and females was not statistically significant, 
seroprevalence was relatively higher in males (10.4%, n=270, 95% CI: 7.1 - 14.8) than females 
(6.8%, n=295, 95% CI: 4.3 - 10.4). Seropositivity was also recorded in young people <13 years 
old. Seropositivity was recorded in 15 out of 37 villages sampled with notably higher 
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seroprevalence (>20%) recorded in 5 villages across the study area (Figure 5.5). 
Seroprevalence in humans varied between villages and between households within villages. 
Seroprevalence varied by around four times (MOR=4.4) between villages and by almost five 
times (MOR = 4.6) between households.  
 
Figure 5.5. Map of northern Tanzania showing study regions, districts and the village-level 
seroprevalence in humans.  
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5.3.4 Risk factors for seropositivity in humans 
5.3.4.1 Univariable logistic regression analysis of risk factors for RVFV 
seropositivity in humans 
Table 5.6 summarizes the potential risk factors that were considered for inclusion in a 
multivariable logistic regression analysis.  
Table 5.6 Univariable analysis of risk factors for RVFV seropositivity in human 
Variable Tested Prevalence (% (n)) OR 95% CI P-value 
Sex 
     Female 295 6.8 (20) ref ref ref 
Male 270 10.4 (28) 1.8 0.8 - 3.7 0.12 
Age (years) 
  
1.0 0.9 - 1.0 0.52 
Farming classification 
     Small holder 143 1.4 (2) ref ref 
 Agro-pastoral 231 2.6 (6) 3.2 0.5 - 21.8 0.229 
Pastoral 235 14 (33) 11.5 2.1 - 64.3 0.005 
Education 
     No formal education 208 12 (25) ref ref ref 
Primary education 342 4.1 (14) 0.6 0.3 - 1.4 0.257 
Secondary/High school 44 16.7 (2) 1.5 0.2 - 9.7 0.696 
University education 11 10 (1) 1.6 0.1 - 22.9 0.746 
Occupation 
     Agric/crop production 128 2.3 (3) ref ref ref 
Livestock/rancher 358 10.1 (36) 5.1 1.1 - 23.6 0.04 
Other 121 2.5 (3) 1.3 0.2 - 8.1 0.76 
Milked animals  
     No 375 6.9 (26) ref ref ref 
108 
 
Variable Tested Prevalence (% (n)) OR 95% CI P-value 
Yes 234 6.8 (16) 0.7 0.3 - 1.5 0.392 
Sleep in the same house as 
animals 
    No 512 6.8 (35) ref ref ref 
Yes 96 7.2 (7) 1.3 0.5 - 3.8 0.618 
Handled animal waste  
     No 328 8.5 (28) ref ref ref 
Yes 281 5 (14) 0.4 0.2 - 0.9 0.0428 
Birthing animals 
     No 385 3.4 (13) ref ref ref 
Yes 222 13.1 (29) 2.7 1.2 - 6.1 0.0137 
Handled placenta  
     No 431 6 (26) ref ref ref 
Yes 178 9 (16) 0.97 0.4 - 2.2 0.933 
Handled aborted 
product  
     No 548 5.7 (31) ref ref ref 
Yes 61 18 (11) 3.5 1.4 - 9.0 0.008 
Slaughtered animals  
     No 351 3.7 (13) ref ref ref 
Yes 258 11.2 (29) 2.4 1.1 - 5.3 0.024 
Handled carcass  
     No 453 5.3 (24) ref ref ref 
Yes 156 11.5 (18) 1.8 0.8 - 4.2 0.129 
Consumed raw milk 
     No 512 4.1 (21) ref ref ref 
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Variable Tested Prevalence (% (n)) OR 95% CI P-value 
Yes 94 22.3 (21) 3.6 1.5 - 9.1 0.005 
Consumed raw yoghurt 
     No 379 4.7 (18) ref ref ref 
Yes 229 10.5 (24) 1.4 0.6 - 3.1 0.397 
Seropositive livestock 
     No 334 5.1 (17) ref ref ref 
Yes 175 14.3 (25) 3 0.9  - 3.7 0.065 
 
5.3.4.2 Multivariable logistic regression analysis of risk factors for 
seropositivity in humans 
Factors that were significant in the multivariable model included handling of aborted 
material, and consumption of raw milk (Table 5.7). People who had handled aborted material 
and those who consumed raw milk were four times more likely to be RVFV seropositive than 
those who did not.  
 
Table 5.7 Multivariable analysis of risk factors for RVFV seropositivity in humans 
Variable OR 95% CI P-value 
Handled aborted material 
 
4.3 1.7 -10.8 0.002 
Consumed raw milk 4.1 1.8 - 9.3 0.001 
 
5.4 Discussion 
The sero-epidemiological study presented here reports detection of RVFV antibodies (IgG and 
IgM) in apparently healthy domestic ruminants and also evaluates the risk of exposure to the 
virus in livestock and human populations of northern Tanzania. Although recent outbreaks 
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have been reported in neighbouring countries, Uganda , Kenya and Rwanda (Anyamba et al., 
2018), no RVF outbreak has been reported in Tanzania since the last epidemic of 2006–2007.  
This study reports evidence for RVFV exposure in domestic ruminants and humans in northern 
Tanzania ten years after the last outbreak. Inter-epidemic seropositivity  in livestock has been 
reported by similar studies in the region including 10% (n=654) seroprevalence in small 
ruminants in central Mozambique (Fafetine et al., 2013), 16.8% (n=595) in cattle in Rwanda 
(Umuhoza et al., 2017) and 9.8% (n=1470) in small ruminants in Uganda (Magona et al., 2013). 
Inter-epidemic seropositivity in humans has also been reported (LaBeaud et al., 2008, Lichoti 
et al., 2014a, Mbotha et al., 2018) including 13% (n=248) in north-eastern Kenya (LaBeaud et 
al., 2008) and 12% (n=655) in Kabale district, Uganda (Nyakarahuka et al., 2018).   
In the current study, seroprevalence was significantly higher in cattle than sheep or goats.  
Difference in seroprevalence between ruminant species has been reported in other parts of 
Tanzania (Sumaye et al., 2013, Sindato et al., 2015), Kenya (Lichoti et al., 2014a) and Uganda 
(Nyakarahuka et al., 2018) suggesting different levels of exposure between host species. The 
effect of species remained significant even when controlling for age, indicating that the 
species effect cannot be explained  only by the greater longevity of cattle in comparison with 
sheep and goats.  The difference in seroprevalence could  also be due to mosquito feeding 
behaviour, as mosquitoes tend to select large (Takken and Verhulst, 2013) and coloured host 
species. In periods of drought, pastoralists would prefer to take cattle than small ruminants 
for seasonal camps (ronjo) searching for pasture and water in areas which stay wet most of 
the year, usually lowlands experiencing floods or with permanent water bodies. This would 
also expose cattle to potential mosquito bites and infection as many herds gather together at 
these camps.  
In this study, RVFV seropositivity was detected across all age groups of ruminant species 
tested, with an increase with age consistent with endemic circulation of the virus. Similar 
observations were reported in serosurveys in Kenya (Anyamba et al., 2009, LaBeaud et al., 
2008) and Mozambique (Fafetine et al., 2007) which were conducted one and two years from 
the 2006-2007 outbreak in East Africa. In this study we report seropositivity in animals as 
young as 1-2 years and the detection of IgM antibodies may suggest recent infections of the 
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virus in the study area about ten years from the previous outbreak. These findings suggest 
undetected circulation of the virus in the area outside of an epidemic period. The detection of 
IgM antibodies illustrates recent infection preceding the serosurvey as IgM antibodies to RVFV 
can only be detected up to two months after infection (Morvan et al., 1991, Paweska et al., 
2003a). The circulation of RVFV during the inter-epidemic period suggests that clinical RVF 
cases may have occurred but have been mistaken for other diseases or not reported in the 
absence of public awareness. 
In addition to age of an animal, occurrence of abortions in the herd/flock was associated with 
inter-epidemic seropositivity. Although abortions can be linked to a number of other 
infections, the association of RVFV seroposivity with abortions may be attributed to missed or 
unreported RVF cases in the study area.  This could be due to a lack of adequate surveillance.  
Abortions could also represent an RVFV transmission route within herds/flocks through contact 
with aborted materials. This also poses a risk for RVFV transmission to humans which is 
supported by findings from the current study and other studies (LaBeaud et al., 2008, Magona 
et al., 2013) which have found a strong association between seropositivity in humans and 
handling aborted materials. 
Since the last RVF outbreak in Tanzania, seropositivity in human populations has been 
reported in other parts of the country (Heinrich et al., 2012b, Sumaye et al., 2015, Ahmed et 
al., 2018). In the current study 8.5% seroprevalence is reported in northern Tanzania, 
including in young people less than 13 years old. Although a higher seroprevalence in humans 
was observed in pastoral than agro-pastoral and smallholder settings, the difference was not 
statistically significant.  RVF is typically reported as outbreaks in pastoral areas of Tanzania, 
but the finding of human seropositivity across settings suggests that RVF cases may be 
occurring in other agro-ecological systems and surveillance efforts should not be directed 
exclusively to pastoral settings.  This conclusion is further supported by results from Chapter 
Six. 
The current study reports a significant association between RVFV seropositivity in people and 
consumption of raw milk. The consumption of raw milk  has been considered an important risk 
factor for human exposure during epidemics (Woods et al., 2002, LaBeaud et al., 2008, 
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LaBeaud et al., 2011) and other studies have reported similar observations (Anyangu et al., 
2010, Nicholas et al., 2014). Small amounts of RVFV have been found in the milk of 
experimentally infected cattle, (Alexander, 1951), and saliva and nasal discharges of infected 
sheep and cattle (Swanepoel and Paweska, 2011a), suggesting that consuming infected raw 
milk could represent another pathway for the virus to be introduced into the body (Nicholas et 
al., 2014). This question needs to be further explored as there is not enough evidence 
supporting RVFV transmission through milk. However, unpasteurised milk is known to be 
associated with a number of other diseases including tuberculosis and brucellosis. It is 
important therefore, to ensure people are aware of the risks of raw milk consumption 
especially in communities where this is a traditional and widespread practice.  
People who handled aborted materials were more likely to be seropositive than those who did 
not. Similar observations have been reported in other studies in Tanzania (Sumaye et al., 
2015), Kenya (Anyangu et al., 2010), and Uganda (Nyakarahuka et al., 2018). This could be 
possible because RVFV is highly infectious via the aerosol route, which is evident by the 
number of laboratory workers who have become infected (Alexander, 1951) and the potential 
for infection of  veterinarians and abattoir workers who handle infected animals (Hoogstraal 
et al., 1979, Ross et al., 2012). Infection might also be possible through broken skin if handled 
infected material without appropriate protective equipment.  
5.5 Conclusion  
Results reported here shows RVFV seropositivity in cattle, goats and sheep of all age groups 
and human populations during an inter-epidemic period in northern Tanzania and identifies 
risk factors for exposure.  The association of seropositivity with abortions may suggest missed 
or unreported cases due to lack of active surveillance. Therefore, enhanced surveillance of 
RVF and other abortigenic pathogens is recommended. This should involve specific training to 
livestock field officers and community healthcare workers to be able to quickly identify the 
initial RVF cases for immediate response and reporting which would improve preparedness, 
response and control strategies. In addition, continuous farmer education and awareness or 
sensitization on zoonoses such as RVF and risks for exposure, is essential. The education of 
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farmers should be in a simple language and translated to local languages for specific 
communities. The education materials should include messages that emphasize animal disease 
signs and symptoms, reporting of suspect RVF cases to livestock field officers or veterinarians, 
general hygiene such as washing hands after handling aborted materials or other animal 
materials of suspect case, cooking meat and boiling milk thoroughly. 
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Chapter Six 
6 Molecular survey of Rift Valley fever virus in mosquitoes and 
diagnostic samples and milk from aborting livestock in northern 
Tanzania 
6.1 Introduction 
Rift Valley fever virus (RVFV) is a zoonotic Phlebovirus that can be transmitted to ruminants 
and humans by mosquitoes or through direct contact with contaminated bodily fluids and 
tissues (Davies et al., 1985, Gerdes, 2004). In East Africa, major Rift Valley fever (RVF) 
outbreaks have occurred in intervals of 5 to 15 years (Mohamed et al., 2010, Nderitu et al., 
2010) usually associated with unusually heavy rains. The most recent outbreak in East Africa 
was reported in Kenya, Uganda and Rwanda between June and August 2018, but, despite an 
RVF alert being issued by the Ministry of Livestock and Fisheries in Tanzania, no outbreak was 
reported at the time. Although RVFV has been studied for about eight decades since it was 
first reported in East Africa, many aspects of its maintenance and ecology in periods between 
the epidemics (“inter-epidemic periods”) are not fully understood.  Evidence for RVFV 
circulation in the region has been supported by studies that are based primarily on serological 
evidence and limited molecular epidemiological studies, mostly following outbreaks. 
Epidemiological studies following the 2007 outbreak in Kenya detected RVFV using molecular 
techniques performed on samples from cattle, sheep and goats (Munyua et al., 2010) and 
mosquitoes (Lutomiah et al., 2014, Sang et al., 2010). In Tanzania, similar studies involving 
humans (Mohamed et al., 2010) and livestock (Chengula et al., 2014) were conducted using 
molecular tests using samples collected following the outbreak of 2006/2007. However, there 
is still limited molecular evidence for the inter-epidemic circulation of RVFV in Tanzania and  
the region.  Molecular diagnostic tools provide confirmation of the presence of RVFV RNA for 
improved confidence in clinical diagnostic results and confirmation of RVF cases (Njenga et 
al., 2009). Molecular techniques such as reverse-transcriptase polymerase chain reaction (RT-
PCR)  allow for a rapid and accurate detection of RVFV (Escadafal et al., 2013, Njenga et al., 
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2009) and is recommended as an efficient diagnostic tool for the investigation of endemic 
circulation of the RVFV. It allows the detection of low viral RNA loads adapted for the 
investigations of reservoirs or specific epidemiological situations such as inter-epidemic 
periods (Maquart et al., 2014). 
Human exposures to RVFV have been attributed to a number of infection routes as observed in 
previous outbreaks. These routes include direct contact with infected animal tissues, blood, 
or other body fluids by handling aborted materials, helping with parturition, and slaughter, 
inhalation of aerosolized infected fluids, and transmission through bites of infected mosquito 
vectors (Gerdes, 2004, Pepin et al., 2010, Anyangu et al., 2010). Ingestion of raw and 
unpasteurized milk has also been epidemiologically associated with RVF exposure in humans in 
previous outbreaks (LaBeaud et al., 2011, Mohamed et al., 2010, Woods et al., 2002). 
However, the link between consumption of milk from infected animals and human exposure 
has not been demonstrated conclusively, and there is only limited evidence from 
experimentally infected animals (Alexander, 1951) and no reports of RVFV detection in milk 
from naturally infected animals. Findings from our serological study (see Chapter four) and as 
analysed previously (Grossi-Soyster et al., 2019) suggests an association of consumption of raw 
milk with human exposure to RVFV.  
The main aim of this study was to detect RVFV genomic RNA in mosquitoes, aborted materials 
and milk samples collected during the inter-epidemic period in study areas of northern 
Tanzania during a time period (2017-2019) when there were no outbreaks reported in study 
areas of northern Tanzania. This study used RT-PCR to investigate RVFV circulation during the 
inter-epidemic period through testing of (a) mosquito vectors and (b)  diagnostic material 
collected from abortion cases reported in cattle, sheep and goats. Data generated in this 
study will lead to a better understanding of RVFV maintenance in the inter-epidemic periods 
and risk factors for human exposure. This will also inform surveillance strategies and national 
and regional emergency preparedness and response plans, and identify avenues for future 
research.  
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6.2 Methods 
6.2.1 Study area 
The study involved analysis of mosquitoes, aborted materials and milk samples collected from 
Arusha, Kilimanjaro and Manyara Regions of northern Tanzania (Figure 6.1) between March 
2016 and August 2019. The area include districts where RVF cases were reported in previous 
outbreaks in 1977, 1998 and 2006/2007 (Mohamed et al., 2010, Fyumagwa et al., 2011, 
Chengula et al., 2013). Samples used in this study were collected as part of the two 
epidemiological studies carried out in the area, namely 'Social, Economic and Environmental 
drivers of Zoonoses' (SEEDZ) and 'Supporting Evidence Based Interventions to Achieve 
Agricultural Development Goals in Tanzania' (SEBI-TZ) described in Chapter Two.    
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Figure 6.1 Map of northern Tanzania (Arusha, Kilimanjaro and Manyara regions) showing 
districts and location of SEEDZ villages where mosquito sampling was carried out and villages 
where abortion events were reported and from which samples were collected through the 
SEBI-TZ study project. 
 
6.2.2 Sample collections 
Details of sample collection and processing are described in Chapter two. Briefly, mosquitoes 
were collected in 12 villages randomly selected from the 20 SEEDZ study villages between 
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2015 and 2017. Collected mosquitoes were identified to genera or species level using 
morphological identification keys (Gillies and Coetzee, 1987, Huang, 2001, Jupp, 1996), 
separated according to genera, sex, trap type, site and date of collection, into pools of 1-25 
mosquitoes and preserved in labelled 2-ml cryovials containing TRIzol reagent (Thermo Fisher 
Scientific, Loughborough, UK) and stored in -80 0C freezer until further RNA extraction and 
PCR.  
Livestock abortion samples and milk, were collected in response to reported abortion events 
from the SEBI study villages. Following the report of an abortion or peri-natal mortality event, 
recruited Livestock Field Officers (LFOs) or members of the study field team attended the 
cases to collect samples within 72 hours of the abortion/still birth event. In addition to basic 
farm level data, the following samples were collected: (i) blood, milk and vaginal swab 
samples from the aborting cow/ewe/doe; (ii) tissue from the placental inter-cotyledonary 
space; (iii) placental cotyledon; (iv) foetal organs (liver, lung and kidney, thymus); and (iv) 
foetal stomach contents. Only four sample types were used in the current study, namely 
vaginal swabs and milk samples from the aborted dam, swabs from aborted foetus, placenta 
cotyledon tissue samples. The abortion cases reported here are those which were recorded, 
followed by sample collection as part of the SEBI-TZ study, between October, 2017 when the 
study began and July, 2019.  
6.2.3 RNA preparation  
The RNA extraction process is described in detail in Chapter two.  RNA extraction from 
mosquito samples  was based on Direct-zolTM (Zymo Research, CA, U.S.A) RNA preparation 
protocol  as per manufacturers' instructions. Whereas RNA preparation from swabs, milk and 
placental tissue was based on the Qiagen RNeasy Mini kit (QIAGEN, Manchester, UK) according 
to manufacturer's instructions with slight modification.  
6.2.4 Quantitative reverse transcription polymerase chain reaction (RT-qPCR) 
Detection of RVFV by one-step quantitative reverse-transcription real-time PCR (RT-qPCR) 
using RNA samples was carried out as previously described (Drosten et al., 2002). One-step 
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assay combine reverse transcription and PCR in a single tube, using a reverse transcriptase 
along with a DNA polymerase and utilizing sequence-specific for RVFV Gc gene primers RVS 
(AAAGGAACAATGGACTCTGGTCA[349-371]), RVAs (CACTTCTTACTACCATGTCCTCCAAT [443-
417]), and dual-labelled probe RVP (FAM-AAAGCTTTGATATCTCTCAGTGCCCCAA-BHQ1 [388-
416]).   
6.2.5 Data management 
Data from sample collection records and laboratory results were managed in Excel 2007. Data 
were cleaned and analysed in R version 3.5.3 (R Core Team, 2019). In this study, samples 
(mosquitoes and/or abortion materials) with complete information (ID, date, village, species, 
sample type) and RT-PCR results for RVFV were considered for analyses. Maps were produced 
in QGIS v 2.14.0-Essen. Sample collection villages were geocoded using GPS coordinates 
recorded during sample collections. 
6.3 Results  
Three hundred and twelve pools of mosquitoes, 190 vaginal swabs from dams, 61 foetal swabs, 
42 aborted placenta cotyledon tissue samples, and 159 milk samples from abortion events 
involving cattle, goats and sheep were tested for RVFV by real time RT-qPCR. About 190 
abortion events were investigated.   
6.3.1 RVFV detection in mosquito vector species 
A total of 312 mosquito pools, including 17 Aedes spp, 137 Culex spp, 20 Mansonia spp, 133 
Anopheles spp, and 5 Coquillettidia spp, were screened for Rift Valley fever virus by RT-qPCR. 
None of the mosquito pools tested positive for RVFV infection (Figure 6.2). 
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Figure 6.2 Amplification curves for RT-qPCR of RVFV, showing normalized fluorescence 
intensity over time (PCR cycles) for mosquito samples, positive controls and negative controls. 
The black and red curves above the amplification threshhold  in duplicates are positive 
controls (two different dilutions) and the lines below the threshold line are negative controls 
and test samples which did not amplify above the threshold. 
6.3.2 RVFV detection in vaginal and foetal swabs, placenta tissue and milk  
RVFV was detected in 14 (7.4%) out of 190 abortion cases tested by RT-qPCR. RVFV was 
detected in 11 (5.8%) of the 190 dam vaginal swabs, 9 (14.8%) of the 61 foetal swabs, 6 
(14.3%) of the 42 aborted placenta cotyledon tissue samples, and 3 (1.9%) of the 159 milk 
samples tested. All positive swabs, placenta tissue and milk samples were from cattle, no 
RVFV was detected in samples from goats and sheep. The prevalence of RVFV based on RT-
qPCR by species and sample type is shown in Table 6.1.  
 
Table 6.1 RT-qPCR results of samples collected from abortion cases clustered by species and 
sample type showing number of each sample type tested and those tested positive for RVFV 
Species Sample type Tested (n) Positive (n) Prevalence (%) 
Cattle Dam-swab 64 11 17.2 
 
Foetus-swab 35 9 25.7 
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Species Sample type Tested (n) Positive (n) Prevalence (%) 
 
Milk 63 3 4.8 
 
Placenta 34 6 17.7 
Goats Dam-swab 85 0 0 
 
Foetus-swab 21 0 0 
 
Milk 76 0 0 
 
Placenta 7 0 0 
Sheep Dam-swab 41 0 0 
 
Foetus-swab 5 0 0 
 
Milk 20 0 0 
 
Placenta 1 0 0 
Total 
 
452 29 6.42 
 
In this study four sample types (dam swab, foetus swab, milk, and placenta tissue) collected 
from abortion cases were used. Serological (ELISA) testing was also carried out for each case 
and results for the same are included in Table 6.2. It is worth noting that of the 14 abortion 
cases which were  RVFV positive, 11 tested positive for more than one sample type. Two of 
the three positive milk samples corresponded with the positive swabs from the dam and 
foetus, whereas one corresponded with the positive placenta tissue. Table 6.2 shows RT-qPCR 
results of different sample types per abortion case clustered by study village. 
 
Table 6.2 RT-qPCR results of samples collected from abortion cases clustered by site abortion 
case and sample type showing RVFV status as positive (+) or negative (-) and unavailable 
sample (na) 
Village Sample/ 
case ID 
Serum 
serology 
Dam 
swab 
Foetus 
swab Milk Placenta 
Arusha chini  SEBI-051 + + + - na 
 SEBI-058 + + + + na 
 SEBI-064 + + + + na 
 SEBI-075 + + + - na 
 SEBI-076 + + + - + 
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Village Sample/ 
case ID 
Serum 
serology 
Dam 
swab 
Foetus 
swab Milk Placenta 
 SEBI-079 + - - + + 
 SEBI-084 + - + - + 
 SEBI-089 + + na - na 
 SEBI-095 + + na - na 
 SEBI-106 + + + - na 
Rau SEBI-094 + + + - na 
Machame mashariki SEBI-099 + - na - + 
 SEBI-110 + + + - + 
Kindi SEBI-115 + + na - + 
 
 
RVFV was detected in samples from abortion events that occurred between May and August, 
2018 (Figure 6.3). Other abortion cases were either found negative for all pathogens under 
study or were associated with other abortigenic pathogens the results of which  are not 
described in this thesis. 
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Figure 6.3 Outbreak curve showing all abortion cases (blue bars) included in the study and the 
number which were RVFV positive (orange bars). 
6.3.3 Distribution of the RVFV positive cases 
All of the RVFV positive samples were collected from abortion events from four villages in 
Kilimanjaro Region (Table 6.2) with the majority from Arusha chini. Figure 6.4 shows the 
location of the four villages. 
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Figure 6.4 Map of northern Tanzania - Arusha, Kilimanjaro and Manyara regions, showing 
districts and mosquitoes and abortions study sites and locations of the RVFV positive abortion 
cases based on RT-qPCR 
6.4 Discussion 
This study reports detection of RVFV RNA in aborted materials and milk from cattle but not 
goats or sheep in northern Tanzania outside a reported outbreak period. In addition, this study 
reports no RVFV was detected in potential mosquito vectors collected from the study area. 
The inability to detect RVFV in mosquitoes can be explained by low numbers of mosquitoes 
collected and timing of collection (mostly the dry season) outside the outbreak period. The 
detection of RVFV in aborted materials and milk provides strong evidence for a previously 
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unreported outbreak of RVF occurring in Moshi and Hai Districts below the detection threshold 
of current surveillance systems in northern Tanzania, despite the existence of an RVF alert 
that had been issued by the Ministry of Livestock and Fisheries. 
Although a number of other pathogens can cause abortions in livestock in the study area, some 
of these abortions are linked to RVFV infection as evidenced by data from the current study 
where 14 out of 190 abortion cases tested were RVFV-positive. To our knowledge, this is the 
first report of the detection of RVFV in milk samples from naturally infected livestock using 
RT-PCR. A number of epidemiologic studies have suggested that consumption of unpasteurized 
milk is associated with RVFV infection in humans (Woods et al., 2002, Anyangu et al., 2010, 
LaBeaud et al., 2011). This is supported by results of the serological study detailed in Chapter 
five suggesting a strong association between RVFV exposure in humans and consumption of 
raw milk. Other recent studies following the 2006/2007 RVF outbreak in Kenya suggested that 
individuals who milked and also consumed raw milk had greater odds of RVFV exposure than 
individuals whose only contact to raw milk was through milking (Grossi-Soyster et al., 2019). 
However, there has been little direct evidence that raw milk may be a high-risk driver of 
human RVFV transmission. There is limited data on studies that have attempted to examine 
the potential infectivity and risk of raw milk and milk products obtained from infected 
animals. The study that confirmed shedding of live infectious virus in the milk of 
experimentally infected lactating cows was conducted in 1951 (Alexander, 1951), suggesting 
that virus could be found in milk from  acutely infected cattle for 3-5 days (Alexander, 1951). 
Although the current study reports detection of RVFV in cattle milk, it is clear that there is 
still a requirement for additional data to address this question. Further studies are required to 
explore and accurately communicate the potential food-borne risk of RVFV in raw milk.  
However, it is essential to emphasise the importance of pasteurising or boiling milk in 
preventing human exposure to RVFV and other potential pathogens in raw milk.  
The detection of RVFV in aborted materials (foetus and placenta) from livestock poses risks of 
animal-to-animal and animal-to-human infection risks especially in farming communities 
where unprotected handling and disposal of aborted materials is a common practice. In 
approximately 70-90% of affected livestock animals, RVFV virus easily crosses placental 
126 
 
barriers and can cause a variety of foetal malformations or death (Bird et al., 2009, Bird and 
McElroy, 2016, Ali et al., 2012). Typically, aborted foetuses and fluids contain exceptionally 
high viral titres, often exceeding 1.0 x 107 plaque forming units (PFU)/g and pose a great risk 
for human infection (Swanepoel and Coetzer, 2004, Ali et al., 2012). Therefore, it is of the 
utmost importance that emphasis is given to safe handling of animals during helping with 
birthing and handling of aborted materials. It is also essential to determine other causes of 
abortion in livestock as this study demonstrates that not all the abortion cases recorded were 
associated with RVFV. This suggest that the identification of all possible causes of abortions 
and implementation of integrated control measures will reduce devastating socio-economic 
losses owing to abortions.   
In the current study, RVFV was detected in samples collected between May and August 2018 
which was towards the end of the long rainy season in Kilimanjaro Region. This is the season 
when there is high potential vector (Aedes spp) activity in the region (Hertz et al., 2016), 
which could play a role in virus circulation in the area. All of the RVFV-positive samples were 
from smallholder farms in the lower lands around Moshi, suggesting a rather small, localized 
outbreak that was not detected by standard surveillance. This coincided with events of heavy 
rains in parts of East Africa which led to floods and RVF outbreak in Kenya, Uganda and 
Rwanda in mid-2018. Despite the fact that there were unusual rains, floods and increased 
mosquito activity, including reported outbreaks of dengue fever in different parts of Tanzania, 
there were no reports of RVF cases.  
Enhanced surveillance that integrate RVF and other emerging zoonotic diseases would help 
generate real time, and accurate data enabling better preparedness and response plans and 
inform the development of control strategies. This is demonstrated by RVF enhanced 
surveillance applied in a pilot study in Kenya (Oyas et al., 2018) which enabled collection of 
useful data on RVF-associated syndromes, particularly abortions and hemorrhagic disease 
(Oyas et al., 2018). In Uganda, RVF enhanced surveillance under the Viral Haemorrhagic Fever 
(VHF) surveillance program,  enabled detection and recording of 10 RVF sporadic outbreaks 
between 2016-2018 (Maurice, 2016, Nyakarahuka et al., 2019).  
127 
 
Although cattle are said to be less susceptible to RVFV infection than sheep (Gerdes, 2004, 
Swanepoel and Coetzer, 2004, Magona et al., 2013), in the current study all of the RVFV-
positive samples were from the 14 cattle abortion cases and none from sheep and goats. 
Swanepoel and Coetzer (2004) suggest that cattle are less susceptible to lethal RVFV 
infections than sheep, with estimates of mortality ratios range from 10% to 70% in calves 
(Swanepoel and Coetzer, 2004) and around 40–100% of pregnant cows reportedly abort at any 
gestational stage, particularly imported breeds (Gerdes, 2002, Coetzer, 1982). Sheep are 
highly susceptible to RVFV infection (Bird et al., 2009, Gerdes, 2002, Gerdes, 2004), with 
mortality rates typically reaching approximately 90% to 100% of lambs and approximately 10% 
to 30% among affected adults (Bird et al., 2009). Abortion rates can be high (90% to 100%), 
which gives rise to the characteristic abortion storms (Bird et al., 2009, Easterday et al., 
1962). Although goats are also susceptible to infection, they appear to be more refractory to 
severe or lethal disease than sheep (Easterday et al., 1962). The absence of RVFV detection in 
sheep and goats in the current study could be explained by the small number of sheep and 
goats kept by smallholder farmers in villages where cattle abortion cases were positive for 
RVFV. Farmers from around Moshi, for example, keep mostly dairy breeds or cross breeds of 
cattle for milk. Sheep and goat abortion cases from other villages particularly agro-pastoral or 
pastoral communities could be associated with other abortogenic pathogens that are not the 
reported in the current study. 
Results from the current study suggest that prompt reporting of suspect cases by mobile 
phones, timely sample collection and transportation, and existence of a laboratory facility 
with RVF diagnostic capacity can make a big difference on the amount and quality of data on 
the status of circulation of RVFV and other zoonotic pathogens. In order to enhance RVF and 
other emerging diseases surveillance in both animal and human populations, it is important to 
strengthen laboratory facilities in terms of trained personnel, equipment and reagents in the 
country and the East African region. Although the available vaccines have limitations (Dungu 
et al., 2010, Botros et al., 2006), vaccination would not only protect animals and reduce 
socio-economic losses, potentially, it would also prevent human RVF cases. Additionally, 
public awareness creation involving mass media such as radio and television programmes 
among others has also demonstrated success in getting the message to the public, for instance 
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the use of mosquito nets as part of malaria control programmes (Bowen, 2013, Ankomah et 
al., 2014). Making use of the available media platforms to send would be useful in creating 
public awareness on RVF and risks for exposure. 
6.5 Conclusion 
Strong surveillance in both animal and human populations is critical for early detection of RVF 
and timely response. This will minimize the extent and impact of potential outbreaks and 
widespread transmission of the virus. It is also critical that the mass media be engaged for the 
dissemination of factual information regarding the health risks of RVFV infection and to 
highlight measures the public can take to reduce potential exposures through unsafe handling 
of abortions and consumption of raw milk consumption. 
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Chapter Seven 
7 Discussion 
7.1 Ecology of RVF virus vectors in northern Tanzania  
Rift Valley fever virus (RVFV) infects a wide range of host species including livestock, wild 
animals and humans, and a number of mosquito species are also known to be involved in the 
transmission of the virus. However, many gaps still exist in our understanding of the complex 
ecology and maintenance of RVFV, particularly in the inter-epidemic period. Although the 
current study did not find evidence of RVFV in mosquitoes collected, the entomological study 
described in chapter three reports varied abundance and distribution of the potential RVFV 
vectors in the study area. Culex spp and Anopheles spp were the most abundant in all 12 
sampled villages, Aedes spp recorded in seven villages, Mansonia spp recorded in four villages, 
and Coquillettidia spp recorded in two villages only. All these mosquito genera are known to 
be able to transmit RVFV to livestock and wild ruminants (Swanepoel, 1976, McIntosh et al., 
1980, Logan et al., 1991) hence the occurrence of these vectors suggest their potential role in 
RVFV circulation in the area. The relatively high abundance of Anopheles and their potential 
to act as vectors may warrant further investigation as to the role of this mosquito genus in 
RVF epidemiology. 
Species distribution modelling by MaxEnt, indicate wide and different extents of overlapping 
distribution of suitable habitat for Aedes, Culex and Anopheles mosquitoes including areas 
within and around the Serengeti ecosystem. Suitable habitats identified in the current study 
include districts in northern Tanzania which were not sampled before and the distribution of 
RVF vector species was previously not known. This suggests that potential RVFV vectors could 
be widely distributed across the country in areas with similar environments that are conducive 
to vector survival. Although the association of mosquito habitat suitability with seropositivity 
in livestock or humans was not statistically significant, it was noted that some of the highly 
suitable parts of the study area include areas that have reported repeated RVF outbreaks in 
the past (Sindato et al., 2014), and include districts within which high RVFV seroprevalence 
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(chapter five) was recorded as well as where RVFV was detected in aborted materials (chapter 
six). This suggest that the potential role of local occurrence and abundance of vectors in local 
RVFV circulation. However, further entomological surveillance is needed to detect and/or 
isolate the virus in mosquitoes in the inter-epidemic period to confirm this role.   
While some risk maps for RVF in the region have identified parts of northern as risk areas 
(Anyamba et al., 2010, Anyamba, 2015, Mweya et al., 2013, Njenga and Bett, 2019), the 
current study validates previous predictions and provides evidence and details of local 
occurrence of the potential vectors in the area. This is based on collection of potential vector 
mosquitoes across 12 districts in northern Tanzania.   
Results of the species distribution modelling shows that the distribution of Aedes, Anopheles 
and Culex genera of mosquitoes was influenced by varied ecological requirements and 
overlapping habitats related to soil characteristics, amount of rainfall and vegetation, 
confirming findings of other studies  (Minakawa et al., 1999, Mahande et al., 2007, Sattler et 
al., 2005, Arum et al., 2016). The distribution of Aedes spp and Culex spp was positively 
correlated with precipitation of the wettest month, temperature seasonality, and enhanced 
vegetation index (EVI) respectively and negatively correlated with elevation. Similar to 
findings of other studies in East Africa (Anyamba et al., 2009, Sang et al., 2010, Sang et al., 
2017), the distribution of Anopheles spp was predicted by temperature and rainfall. 
Integrating climate and other environmental factors, vector distribution and records of inter-
epidemic RVF cases would help to more precisely identify risk areas.  The need for greater 
spatial resolution is reinforced by findings from the serological analyses, which demonstrate 
high variability in RVF exposure patterns across villages in northern Tanzania (chapter five). 
7.2 RVFV infection in livestock in northern Tanzania 
Since RVF outbreaks are periodic in nature, a number of questions remain regarding the 
maintenance of the RVFV during inter-epidemic periods (IEP). In line with other studies from 
East Africa (Njenga and Bett, 2019), this thesis provides evidence of RVFV exposure in people 
and domestic ruminant species, as well as evidence of variable, but widespread infection in 
villages of Northern Tanzania. Serology results demonstrate increase in seropositivity with 
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animal age, consistent with a pattern of endemic circulation of RVFV. The detection of 
seropositivity in animals as young as 1-2 years also provides evidence of inter-epidemic 
transmission of RVFV, given the previous large outbreak was reported in 2006/7.  
Data on risk factors for seropositivity in livestock (Chapter five) demonstrate that age of an 
animal and occurrence of abortion cases in the herd/flock were associated with inter-
epidemic seropositivity. Although abortions can be linked to a number of other infections, the 
association of RVFV seropositivity with abortions suggests that abortions caused by RVF are 
being missed or mis-diagnosed during inter-epidemic periods, and/or that RVF abortions may 
be a source of infection for other livestock in the herd/flock.   
The finding of RVFV as a cause of livestock abortions during a previously unreported outbreak 
(chapter six) is consistent with the hypothesis that cases of RVF are being missed and are 
occurring below current surveillance detection and reporting thresholds. Enhanced 
surveillance of livestock abortion events would clearly be valuable for detection of RVF cases 
and would improve capability for early detection and response to cases that could potentially 
prevent large outbreaks.   
7.3 Detection of Rift Valley fever virus RNA in milk 
This study provides valuable evidence in relation to RVFV infection in milk which has 
important public health implications. Very little has previously been reported on shedding of 
RVFV in milk with evidence of RVFV in milk limited to one experimental study (Alexander, 
1951), reported about six decades ago. The current study presents two key findings that 
provide evidence of the potential risks of RVFV transmission from consumption of milk.  First, 
consistent with previous studies (Woods et al., 2002, LaBeaud et al., 2008, LaBeaud et al., 
2011, Anyangu et al., 2010, Nicholas et al., 2014), analysis of human serological data showed 
that consumption of unboiled milk was a highly significant risk factor for seropositivity 
(chapter five).  Second, the detection of viral RNA in milk from aborting cattle confirmed that 
the virus can be shed in milk (chapter six). These findings indicate that public health 
information given during RVF outbreaks needs to include advice as to the risks of consuming 
unboiled milk, particularly from aborting animals.  
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Strains of RVFV has been shown to be inactivated by heat treatment of 56°C for 80 minutes  
(Daouam et al., 2014, Szemiel and Willett, 2019) and Szemiel and Willett personal 
communication,  but some viral activity can be detected following heat treatment (at 56°C) 
for up to 70 minutes (Daouam et al., 2014), raising concerns about the thermal stability of the 
virus.  OIE regulations stipulate the need for pasteurization of imported milk and milk 
products from infected areas in order to prevent introduction and spread of infection into 
countries that are not free of RVF (OIE, 2017).  However, little, if any, published data exist on 
the effectiveness of pasteurization, heat-treatment and fermentation in inactivating RVFV in 
milk and milk products, and further work is clearly needed.  
7.4 RVF as an emerging disease threat in urban communities 
The RVF cases detected in this study affected improved breed dairy cattle in smallholder 
farms and raises questions about the potential for RVF to emerge as a disease threat to peri-
urban and urban communities. A particular concern in relation to the detection of RVF in milk 
from peri-urban dairy cattle is that most of the dairy products consumed within the 
municipality of Moshi (predominantly milk and fermented milk, mtindi) originate from milk 
produced by smallholder farmers in areas surrounding the town (Ladbury, 2018). While the 
peri-urban dairy cattle sector in Tanzania is targeted for rapid expansion (Katjiuongua and 
Nelgen, 2014).  Awareness is also needed about potential risks during RVF outbreaks, with the 
possibility of infected milk products being consumed by a very large urban population.  
Particular attention needs to be given to risks that may arise from the common practice of 
bulking milk that has been sourced from multiple different farms, and the widespread 
consumption of mtindi, which is often made from unboiled leftover milk and may be highly 
contaminated (Ladbury, 2018).  
While this study provides a significant contribution to our understanding of the public health 
risks of unboiled milk consumption, it also raises questions as to the potential role of milk as a 
source of infection to suckling livestock.  However, the finding of a very low seroprevalence in 
young animals suggests that transmission in milk is unlikely to be an important element of 
transmission dynamics in livestock and RVFV transmission via vectors or through direct contact 
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with aborted materials or infected carcasses remains a more likely explanation for livestock-
to-livestock transmission both within and between large outbreaks.    
7.5 RVFV infection among humans in northern Tanzania 
While there is no documentation of human-to-human transmission of RVF, human cases and 
exposure have been widely reported and attributed to handling infected animals or animal 
material coupled with behaviours related to occupational tasks, homestead responsibilities, or 
consumption of animal products such as meat and milk. In the current study (chapter five) 
8.5% of RVFV seroprevalence was reported in northern Tanzania including in young people less 
than 13 years old (i.e. people born since the previous large outbreaks in 2006/7). As for 
livestock a higher seroprevalence was recorded in pastoral than agro-pastoral and small-holder 
settings, but with evidence of widespread infection and high variability between villages.  In 
addition to the findings on consumption of raw milk, the risk factor analysis demonstrated a 
significant association between RVFV seropositivity in people with handling of aborted 
materials.  This finding further suggests that livestock abortion cases caused by RVF are being 
missed during inter-epidemic periods. Public health recommendations should also continue to 
highlight the risks associated with handling of aborted materials, including periods outside the 
large reported outbreaks.   
7.6 Serological and molecular detection of RVFV infection  
This study demonstrated the value of serological and molecular data for RVFV epidemiological 
studies, but also identified several challenges that had to be overcome in generating reliable 
data for analyses.  The in-house serological test which was initially trialled as a more cost-
effective approach to screening large numbers of serum samples was shown to be highly non-
specific.  The commercial assay performed well, but the relatively high costs are likely to 
preclude widespread application for large-scale studies in low-resource settings.   
The real-time PCR assay (Drosten et al., 2002) performed well in detecting RVFV cases in 
aborted tissues as well as in vaginal swabs.  However, challenges were encountered in 
extracting sufficient quantities of RNA during the initial stages of the study. This study also 
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demonstrates that vaginal swabs as low-cost, safe, and practical samples for surveillance 
which can be collected up to 72 hours after abortion, hence should be considered for RVF 
surveillance  
7.7 Future prospects for RVF research, surveillance and control in Tanzania 
To further understand the inter-epidemic RVFV circulation in livestock and human 
populations, we should consider the following: 
1) Further entomological surveillance is needed to detect and/or isolate the virus in 
mosquitoes in the inter-epidemic period and typing of RVFV strains circulating in the 
area.  
2) The use of rapid field diagnostic capabilities for infections in livestock and humans, 
vector identification, virus isolation.  
3) Enhanced surveillance of livestock abortion events to detection of RVF cases. 
These will help improve our capability for early detection, preparedness and response to cases 
that could potentially prevent large outbreaks.   
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Appendices 
 
Appendix I: Mosquito survey consent form (English version) 
 
“Zoonoses and Emerging Livestock Systems (ZELS) Research Project 
 
RVF Mosquito Vector study 
Household Participant Consent (English) 
 
Introduction 
You are being asked to take part in a research study to find out if mosquitoes in this area are carrying 
diseases that can also cause illness in people. We hope that the results from this research will lead to 
recommendations for control of these diseases in animals, and particularly ways to stop people 
catching these diseases. This research is being conducted by experts from the Kilimanjaro Christian 
Medical Centre, Kilimanjaro Clinical Research Institute and Nelson Mandela African Institution of 
Science and Technology in Tanzania, and the University of Glasgow in the UK. The work is funded by 
research councils and the Department of International Development in the UK. Please read or have 
read to you the information in this sheet which explains what is involved and any benefits or dangers 
for your household. We encourage you to ask the study representative to explain parts of the study 
that are not clear or if you have further questions. Take as much time as you need to make a decision 
about whether you would like to be involved.  
Why has my household been chosen?  
Your village and household were chosen at random. Your household is one of several in this village that 
have also been randomly selected to be involved. 
What is involved in the study? 
We will do mosquito trapping in your compound and ask you some questions about the structure of 
your household, the belongings that you own, animal ownership, the way that you look after your 
animals, and illnesses of people and animals. Some basic information about you, such as your 
education, will also be collected.  
Are there dangers of being involved? 
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The equipment used for mosquito trapping are not harmful to humans. However, the discussion of 
illness or personal details could cause feelings of discomfort, sadness or anxiety. You do not have to 
answer any questions that make you uncomfortable, and you can stop the discussion at any time. 
What are the costs and compensation? 
There will be no additional costs to you other than your time and the information you provide as a 
result of being in this study.  No compensation will be provided for your participation.  
What will happen to my information? 
We will keep personal identifiers (such as your name) in locked storage in Tanzania and, unless 
required by law, we will not give this information to anyone outside the study. The mosquitoes trapped 
and the answers you give during the questionnaire will be sent to the University of Glasgow, where 
scientists will look for reasons why disease in people and animals is more likely to occur in some 
households than others. Again, your name and other personal identifiers will not be included in this 
information. 
What are the benefits of being involved? 
You may not receive any direct benefit from participating.  We hope that in the future the information 
learned from this study will benefit people in this area and help to prevent human and animal disease. 
What do I do if I decide I no longer want to be involved?  
You can withdraw from the study at any time and you do not need to give a reason. Withdrawal will 
not incur any sort of penalty. If you make this decision whilst project staff are still in your household, 
please talk to the study coordinator. If you decide to withdraw, no new information will be collected, 
and you can also ask us to not use any information we have already collected about your household and 
animals. If you would like to withdraw after we have left your household, please call Mr. James 
Nyarobi on +25578459998. Alternatively, you can write to: Prof. Sarah Cleaveland, c/o Prof. Blandina 
Mmbaga, KCRI-KCMC, PO Box 2236, Moshi, Tanzania.  
Whom do I call if I have questions or problems? 
For questions about the study or if you have complaints, concerns or suggestions about the research, 
please contact Mr. James Nyarobi on +255784459998. For questions about your rights as a research 
participant, or to discuss problems, concerns or suggestions related to the research, or to obtain 
information or offer input about the research, contact Prof. Blandina Mmbaga on +255-27-275-4201 or 
the National Health Research Ethics committee (NatHREC) on +255-22-2121400. 
On behalf of the whole project team, thank you for your time. 
………………………………………………………………………………………………… 
Statement of consent 
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"The purpose of this study, and the study procedures, risks and benefits have been explained to me. I 
have been allowed to ask questions, and my questions have been answered to my satisfaction. I have 
been told that I may contact the National Health Research Ethics committee (NatHREC) on +255-22-
2121400 if I have questions about my rights as a research subject, to discuss problems, concerns, or 
suggestions related to the research, or to obtain information or offer input about the research. I 
confirm that I have had time to read the information in this document, or that it has been read to me. 
I understand that my participation is voluntary and that I am free to withdraw at any time, without 
giving any reason and without my legal rights being affected. I agree to take part in this study.” 
           
Name of subject    Date   Signature 
    
Name of Person taking consent   Date   Signature 
   
Witness (if applicable)   Date   Signature 
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Appendix II: Mosquito survey consent form (Swahili version) 
 
“Zoonoses and Livestock Systems Research” (ZELS) Project 
Utafiti wa Mbu waenezao ugonjwa wa Homa ya Bonde la Ufa 
Fomu ya maelezo kwa mshiriki na ridhaa ya kushiriki katika utafiti 
 
Unakaribishwa kushiriki kwenye utafiti kuangalia kama mbu katika eneo hili wanabeba magonjwa yanayoweza 
kusababisha maradhi kwa wanyama na binadamu. Tunatumaini kuwa matokeo ya utafiti yatatuwezesha 
kupendekeza kuzuia magonjwa haya kwa wanyama, na njia za kuzuia watu wasipate haya magonjwa. Utafiti huu 
unaendeshwa na wataalam kutoka Hospitali ya rufaa ya KCMC, Tasisi ya Utafiti wa Kitabibu KCRI na Chuo kikuu cha 
sayansi na Teknolojia cha Mandela cha Tanzania, na Chuo Kikuu cha Glasgow cha Uingereza. Kazi imefadhiliwa na 
wahisani na kitengo cha maendeleo ya kimataifa cha Uingereza. Tafadhali soma au utasomewa taarifa kwenye 
fomu hii ambayo inaelezea nini kinachohusika na faida yeyote au madhara kwa kaya yako. Tunakuhamasisha 
umuulize mwakilishi wa utafiti akueleze vipengele vya utafiti ambavyo hujaelewa vizuri au kama una maswali ya 
ziada. Chukua muda wa kutosha kufanya maamuzi kama utataka kushiriki. 
 
NI KWANINI KAYA YAKO IMECHAGULIWA 
Kijiji chako na kaya yako vimechaguliwa kwa bahati nasibu. Kaya yako ni miongoni mwa kaya  katika kijiji iliyo 
chaguliwa kwa bahati nasibu kushiriki. 
 
UTAFITI HUU UNAHUSU NINI?  
Tutatega mbu katika boma/kaya yako kwa kutumia aina tofauti za mitego ya mbu, ndani ya nyumba na nje ya 
nyumba. Pia tutakuuliza baadhi ya maswali kuhusu muundo wa kaya yako vitu unavyomiliki, umiliki wa mifugo, 
jinsi unayotunza wanyama wako, na magonjwa ya wanyama na binadamu. Taarifa muhimu kuhusu wewe, kama 
vile elimu yako pia vitakusanywa.  
 
 
KUNA MADHARA YEYOTE KAMA NITASHIRIKI? 
Vifaa tunavyotumia kutegea mbu havina madhara yoyote kwa binadamu.  
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KUTAKUWA NA MALIPO AU GHARAMA? 
Hakutakuwepo na gharama ziada ya muda wako na taarifa utakazotupatia kama sehemu ya kushiriki utafiti. 
Hakuna malipo yeyote kwa ushiriki wako 
 
NINI KITATOKEA KWA TAARIFA ZANGU? 
Tutaweka taarifa za mtu binafsi (kama jina lako) sehemu iliyofungwa hapa Tanzania na labda kama zitahitajika 
kisheria, hatutatoa taarifa hizi kwa mtu yeyote nje ya mradi. Matokeo ya utafiti wa mbu pamoja na majibu 
utakayotoa wakati wa dodoso yatatumwa Chuo kikuu cha Glasgow, ambapo wanasayansi wataangalia kwanini 
magonjwa ya binadamu na wanyama yanatokea sana kwa baadhi ya kaya kuliko nyingine na uhusiano wa 
magonjwa hayo na kuwepo kwa mbu. Kwa mara nyingine jina na taarifa zako na utambulisho binafsi 
havitajumuishwa kwenye taarifa hii. Sampuli za mbu na taarifa nyingine zilizokusanywa katika utafiti, 
vitahifadhiwa kwa miaka 10 au zaidi. 
 
MATOKEO YA UTAFITI YATATUMIKAJE? 
Matokeo ya utafiti huu yanachangia sehemu ya  Shahada ya Uzamivu ya James Nyarobi katika Chuo Kikuu cha 
Glasgow cha Uingereza. Taarifa za matokeo ya utafiti huu pia zitakabidhiwa katika Hospitali ya rufaa ya KCMC, 
Taasis ya Utafiti wa Kitabibu KCRI, Taasis ya Taifa ya Utafiti wa Kitabibu NIMR, Tume ya Sayansi na Teknolojia 
COSTECH na Wizara ya Kilimo, Mifugo and Uvuvi. Jina lako na vitu vingine vinavyokutambulisha wewe havitakuwa 
kwenye taarifa hizi. 
 
 
NINI FAIDA YA KUSHIRIKI? 
Unaweza usipate faida ya moja kwa moja kwa kushiriki. Tunaamini kuwa kwa baadae taarifa tuliojifunza katika 
utafiti huu itawafaidisha watu katika eneo hili na kusaidia kuzuia magonjwa ya binadamu na wanyama 
  
NITAFANYA NINI KAMA NITAAMUA KUTOKUENDELEA KUSHIRIKI? 
Unaweza kujitoa ushiri wako wakati wowote na huhitaji kutoa sababu. Kujitoa kwako hakutasababisha adhabu 
yeyote. Kama utaamuwa kujitoa wakati mwakilishi wa utafiti bado yuko kwenye kaya yako  tafadhali ongea na 
mratibu wa utafiti. Kama utaamuwa kujitoa hakuna taarifa mpya itakayochukuliwa juu yako, na unaweza pia 
kutuambia tusitumie taarifa  ambayo tumeshakusanya kuhusu kaya na wanyama wako. Kama unataka kujitoa 
wakati tumeshaondoka kwenye kaya yako  tafadhali mpigie Bwana James Nyarobi kwa +255784459998. Badala 
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yake  unaweza kumwandikia Prof. Sarah Cleaveland, kupitia kwa Prof. Blandina Mmbaga, KCRI-KCMC, PO Box 
2236, Moshi, Tanzania.  
 
NITA WASILIANA NA NANI KAMA NINA MASWALI  AU MATATIZO? 
Kwa maswali kuhusiana na utafiti au kama unamalalamiko, wazo au ushauri kuhusu utafiti , tafadhali wasiliana na 
Bwana James Nyarobi kwa +255784459998. Kwa maswali kuhusina na haki zako kama mshiriki wa utafiti au 
kujadili matatizo, mawazo au ushauri kuhusiana na utafiti au kupata taarifa au kutoa mapendekezo kuhusiana na 
utafiti wasiliana na Prof. Blandina Mmbaga kwa +255-27-275-4201 au kamati ya maadili ya NIMR (National Health 
Research Ethics committee (NatHREC)) kwa +255-22-2121400. 
 
Kwa niaba ya wawakilishi wote wa utafiti, asante kwa muda wako 
……………………………………………………………………………………………………………. 
NENO LA IDHINI YA RIDHAA 
“Lengo la utafiti huu na taratibu za utafiti, madhara na faida imeelezwa kwangu. Nimeruhusiwa kuuliza maswali na 
maswali yangu yamejibiwa nikaridhika. Nimeelezwa kwamba naweza kuwasiliana na kamati ya maadili ya NIMR 
(National Health Research Ethics committee (NatHREC)) kwa +255-22-2121400, kama nina maswali kuhusiana na 
haki zangu kama mshiriki wa utafiti  na kujadili matatizo, mawazo, au ushauri kuhusiana na utafiti au kupata 
taarifa au kutoa mapendekezo kuhusu utafiti. Nathibitisha kwamba nilipata muda kusoma taarifa katika nakala hii 
au nilisomwewa. Naelewa kwamba ushiriki wangu ni wa hiari na niko huru kijitoa wakati wowote bila kutoa 
sababu na bila kunyimwa haki zangu za msingi. Nakubali kushiriki kwenye utafiti huu.” 
 
           
Jina la mshiriki     Tarehe    Saini 
 
    
Jina la mtu anaepewa idhini   Tarehe    Saini 
 
   
Shahidi (kama anahitajika)    Tarehe    Saini  
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Field trip 
Date 
Village name 
Sub-village 
Household ID 
GPS Northing’s 
GPS Easting’s 
Trap ID 
Trap location 
Taxon (Tx) 
Taxon Description 
Total Male 
Fed 
Unfed 
Gravid/semi gravid 
Sample label code 
Number of individuals 
Number in pool 
Number of pools 
Notes/observations 
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